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ABSTRACT 
 
Maternal nutrition during pregnancy is an important intrauterine factor that results in 
persistent alteration of the offspring epigenome and associates with health outcome later 
in life. Both DNA methylation and histone modifications have been reported in a range of 
rat tissues including liver, kidney, skeletal muscle and adrenal gland following a restricted 
diet during gestation. These epigenetic events have also been shown to affect tumor 
suppressor loci in mammary gland cancer cells. However, it is not known how these 
tumor-suppressive genes are regulated by epigenetic changes in the mammary glands in 
vivo under maternal low-protein (LP) diet. One of my published projects examined the 
effect of maternal low-protein diet on the regulation of the p16 cell-cycle gene expression 
in the mammary gland of offspring rats. Timed-pregnant Sprague-Dawley rats were fed 
during gestation one of two isocaloric diets, control (18% casein) or low protein (LP, 9% 
casein). The expression of p16 mRNA in the mammary gland of the LP offspring was 
decreased by 75% vs. control. We also detected decreased p16 protein content in the 
mammary glands of pups gestated under the LP diet. Chromatin immunoprecipitation 
(ChIP) assay demonstrated that the altered p16 mRNA level and transcription rate in LP 
offspring resulted from histone modification changes, including the reduced acetylation 
of histone H4 and the dimethylation of histone H3 at lysine 4 residues within the p16 
promoter region. I also found maternal protein restriction down-regulate p21 gene 
expression in the mammary gland of rat offspring. p21 is a key factor responsible for 
tumor suppressor p53-dependent cell cycle arrest  and has been accepted as a prognostic 
marker of breast cancer. DNA methylation analysis using bisulfite sequencing did not 
detect a differing pattern at the p21 promoter between the offspring of control and LP 
groups. Reduced acetylation of histone H3 and dimethylation of H3K4 within the p21 
promoter region was observed. These results supported the hypothesis that maternal 
protein restriction during pregnancy programs p16 and p21 expression through histone 
modification alterations in offspring mammary gland. 
 
Maternal nutrition restriction can also lead to low birth weight, which is associated with 
increased risk of type II diabetes. In our recent study, we investigated the impact of a 
               iii
aternal low protein diet on the expression of the transcription factor 
CCAAT/enhancer-binding protein (C/EBPβ) in offspring skeletal muscle. C/EBPβ 
belongs to a family of transcription factors that regulates the expression of genes 
involved in energy homeostasis and muscle development. We observed sex-dependent 
differences in C/EBPβ expression in offspring skeletal muscle subjected to a maternal 
protein-restricted diet. In female offspring skeletal muscle, both C/EBPβ mRNA and 
protein levels were increased by maternal protein restriction. However, C/EBPβ 
expression was not altered in other tissues or male offspring. Analysis of transcriptional 
and epigenetic regulation showed acetylated histone 3 and acetylated histone 4 at 
significantly increased levels at the C/EBPβ promoter region in female LP pup’s muscle. 
Correspondingly, downstream phosphoenolpyruvate carboxykinase (PEPCK) gene 
transcription was also up-regulated in female LP pups through the increased binding of 
C/EBPβ at its promoter. On the other hand, GLUT4 is an insulin-regulated glucose 
transporter involved in insulin sensitivity and carbohydrate metabolism in muscle cells. 
We observed sex-dependent GLUT4 mRNA expression and increased GLUT4 protein 
content in female pup skeletal muscle with maternal low protein. The protein level of 
myocyte enhancer factor 2A (MEF2A), which has been known as an activator of GLUT4 
transcription via the ability to carry out specific binding to the GLUT4 MEF2 binding 
sequence, increased in female LP pups. Modifications of chromatin structure, including 
acetylated histone 3, acetylated histone 4 and di-methylated histone 3 at lysine 4, were 
detected at a significantly increased level at the GLUT4 promoter region in female pup 
muscle following a maternal low protein diet. Glycogen content was also detected as 
up-regulated, accompanied by increased glycogen synthase in LP female offspring 
muscle. The induction of C/EBPβ and GLUT4 expression in female offspring skeletal 
muscle by maternal protein restriction during pregnancy may indicate sex-dependent 
signaling response in energy metabolism to a low maternal protein diet. 
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Chapter 1. Introduction 
 
The importance of maternal nutrition during gestation with regard to pregnancy outcome 
has long been acknowledged. The tendency of mothers to briefly overhaul their lifestyle 
and diet is a classic one, with many women changing their habits, and abandoning many 
of their vices, such as alcohol and caffeine drinking or cigarette smoking. This 
importance has been further emphasized in the recent new understanding of fetal 
programming on adult outcomes demonstrated by numerous laboratory and 
epidemiological studies. We are only beginning to understand how maternal nutrition and 
intrauterine environment may impact not only immediate pregnancy outcomes, but also 
life and health course of the offspring. We need a better understanding of diet and dietary 
supplements during pregnancy and of whether diets are particularly low in some nutrients. 
Also, we need to understand how common epigenetic variations influence nutrient 
requirements during these periods. Associations between maternal nutrition and infant 
growth and development suggest that improving the diets of women of child-bearing age 
might be an important component of public health strategies aimed at improving the 
health, nutrition and well-being of women themselves, as well as reducing the burden of 
chronic disease in their offspring. 
 
The concept that epigenetic alterations occur during gestation and may have the ability to 
program adult diseases has lead to a multitude of studies focusing on maternal behavior 
and health during pregnancy. Epigenetics is the study of heritable alterations in gene 
expression patterns not caused by changes in genomic DNA sequence. Genetic imprinting 
and X chromosome inactivation are two well-studied examples of epigenetic mechanisms 
related to gene expression regulation. Genomic imprinting controls gene expression 
depending on the parent of origin, and X chromosome inactivation controls gene 
expression by silencing one of the two copies of the X chromosome within each cell in 
females. Maintenance of different gene expression patterns among the diverse cell types 
also relies on epigenetic modifications using the molecular mechanisms such as DNA 
methylation, micro RNA expression and covalent modifications of the histone proteins 
that package DNA into chromatin structure in the nucleus. 
                                                                                              2
 
Epigenetical alterations of chromatin structure via covalent modifications of histones 
allow for heritable gene regulation without altering the DNA sequence. Genomic DNA 
exists as a highly folded chromatin polymer wrapped around an octamer core of histones 
H2, H3 and H4 with a protruding charged 15-38 amino acid N terminus histone tail. 
These histone tails influence DNA-histone interactions and nucleosome assembly into 
higher order chromatin structure not readily accessible to gene activation. Covalent 
modifications of the H3 and H4 histone tails, such as acetylation, phosphorylation, 
methylation, ubiquitination, and poly-ADP ribosylation, alter the interaction between 
histones and DNA, which consequently affects nucleosome locations as well as higher 
order chromatin folding. In doing so, these post-translational modifications likely enable 
the regulation of contact with the underlying DNA. 
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Chapter 2. Literature Review 
 
2.1 Maternal Nutrition and Offspring Disease Risk Overview 
 
Many adult diseases have fetal origins including obesity, diabetes and cancers. Links 
between maternal nutrition, intrauterine environment of the fetus and susceptibility to 
these adult diseases have attracted numerous attentions. An unfavorable prenatal 
environment can trigger epigenetic changes that increase the risk of developing those 
diseases and reduce the chances of postnatal survival. Major epigenetic programming 
events take place during the fetal development. This chapter describes investigations that 
targeting the relationship between maternal nutrition and offspring’s obesity, diabetes, 
and cancer risks. 
 
2.1.1 Maternal Nutrition and Obesity 
 
 
Obesity is among those adult diseases that have roots in the fetal programming and is 
studied extensively because of its prevalence in the modern world {Stocker et al. 2005; 
Fernandez-Twinn et al. 2006}. Maternal nutrition status is one of the most important 
causes of programming that influence the risk of obesity of later life. Both maternal 
undernutrition and overnutrition are all linked to abnormalities of fetal growth and their 
postnatal obesity risk. The intrauterine environment for fetal growth can be altered by 
maternal calorie/protein restriction, high fat feeding, iron intake, mothers’ smoking status 
and other maternal factors. Fetal response and adaptation to the altered intrauterine 
environment during the critical period of development may leads to long-term changes 
and prevalence of many chronic diseases in their postnatal life including obesity (Table 
2.1). 
 
Maternal undernutrition during the pregnancy has been demonstrated to result in 
intrauterine growth restriction (IUGR) and low birth weight. Malnutrition of pregnant 
women is still an important public health problem in the world, especially in the 
developing countries. In order to adapt to the maternal undernutrition environment and 
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increase the chance of postnatal survival, the fetus responds with a number of strategies, 
such as changing its metabolic rate, altering the production of hormones, storing nutrients 
as fat, and redistribution of fetal blood flow to protect brain at the expenses of other 
tissues such as muscle. These factors lead to a slower fetal growth and low birth weight. 
 
The term intrauterine growth restriction (IUGR) is often used and assigned to newborns 
with a birth weight and/or length below the 10th percentile for their gestational age and 
whose abdominal circumference is below the 2.5th percentile with pathologic restriction 
of fetal growth {Wollmann et al. 1998}. During recent years significant progress has 
been made in the understanding of IUGR-associated pathophysiology. Data have shown 
that IUGR is associated with a late life increased prevalence of metabolic syndrome, like 
obesity. Large cohorts in epidemiological research programs have also studied IUGR 
phenomena. For example, an Indian cohort study showed that babies who are thin and 
lack muscle at birth gain weight rapidly in childhood, leading to a disproportionately high 
fat mass in later life {Yajnik et al. 2003}. It is also shown that timing of maternal nutrient 
restriction has a major influence on the outcome in terms of predisposing the offspring to 
adult obesity. In a Dutch Hunger Winter Study, maternal undernutrition in the first and 
second trimesters of pregnancy is associated with higher obesity rates in young men 
{Ravelli et al. 1976} and higher BMI and waist circumference in 50-y-old women 
{Ravelli et al. 1999}. 
 
A ‘thrifty phenol-type’ hypothesis was proposed by Hales and Barker in order to link the 
fetal intra-uterine environment to the susceptibility to chronic diseases in later life {Hales 
et al. 1992}. It is believed that adaptations associated with fetal malnutrition become 
detrimental to the health of the offspring if they experience a period of adequate or 
plentiful nutrition leading to postnatal obesity.  
 
Maternal calorie restriction to 50% of ad-lib in the last week of pregnancy retards beta 
cell development. Continued restriction of the mother during lactation period results in a 
permanent reduction of beta-cell mass and impaired glucose tolerance in the offspring. 
Calorie restriction in pregnancy period was also found to induce hyperphagic behavior 
and obesity of offspring {Vickers et al. 2000}. IGF-I treatment of 6-month-old 
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undernourished offspring was found to alleviate hyperinsulinemia and obesity. Leptin 
treatment of neonatal rats normalized caloric intake, body weight, fat mass and insulin 
concentrations in later life.  
 
The maternal low-protein model is one of the most-extensively studied models. Ozanne 
and coworkers tested ‘thrifty phenotype hypothesis’ and investigate the effects of fetal 
programming and post-natal catch-up growth on obesity and longevity. The offspring of 
low protein-fed dams were switch to mothers receiving control diets for lactation. The 
body weights of those rats caught up and exceeded that weight of control group by 7 days 
of age and this pattern persisted in adulthood {Ozanne et al. 2004}.  
 
Impacts of Western-style diet, which contain a high percentage of saturated fats on 
offspring risk, have attracted attentions of researchers in developed countries. Animal 
studies have shown the adverse effects caused by high fat feeding including fetal insulin 
resistance, gender-specific hypertension and increased adiposity. A markedly obesity in 
male and female offspring of Virgin Wistar rats can be induced by maternal high fat 
intake during the pregnancy. These phenomena are independent of postnatal nutrition 
{Howie et al. 2009}.   
 
Data from human studies comparing breast-fed and bottle-fed infant also suggest that the 
lactation period is a critical time window for determination of obesity risk in humans. 
Breast-fed babies are at reduced risk of obesity compared to those who were formula fed 
as bottle-fed infants have higher total and protein caloric intake {Locke et al. 2002}. 
Higher circulating leptin levels in breast fed infants may contribute to the subsequent 
reduced obesity risk. Breast milk is also rich in long chain polyunsaturated fatty acids, 
which are thought to be protective against the development of obesity. 
 
Leptin plays a major role in the regulation of metabolism and neuroendocrine functions. 
It increases energy expenditure, and modulates appetite by inhibition of hypothalamic 
arcuate nucleus neurons through the leptin receptor {Ashworth et al. 2000}. Obese 
individuals have sustained elevated adipocyte-derived leptin levels, which may cause 
selective leptin resistance at the hypothalamic level. In rodents, leptin levels are very low 
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at birth and then display a surge at the end of the second postnatal week. Injecting leptin 
into the offspring of undernourished mothers prevents hyperphagia, and excessive body 
weight and fat mass gain of neonatal rat offspring {Vickers et al. 2005}. In contrast, 
treating male offspring of normally nourished mothers caused an induced weight gain and 
increased total body adiposity {Vickers et al. 2008}. Altering leptin levels during early 
postnatal key periods of hypothalamic development may induce long-lasting 
susceptibility to a postnatal obesity depending on the pre-natal maternal nutrition status. 
In humans, fetus in gestational age and known to be at risk of obese in later life had lower 
levels of cord leptin {Ong et al. 2006}. 
 
About 50% of pregnant women are iron deficient. The main causes of iron deficiency are 
poor absorption of iron due to insufficient vitamin C levels and inadequate daily intake of 
iron or high menstrual blood loss. Maternal anemia has been shown to associate with low 
birth weight. The rodent maternal iron restriction model resulted in low birth weight 
offspring and programs hypertension and obesity though adult life {Lewis et al. 2001}. 
  
In humans, glucocorticoids are administered during pregnancy for the treatment of 
neonatal respiratory morbidity and maternal asthma. But overexposure of glucocorticoids 
results in the fetus with reduced birth weight and programme responses that lead to later 
adult disease. Glucocoiticoid is regulated by its receptor in the cell. 11β-HSD-2, an 
isoform of 11-β-hydroxy-steroid dehydrogenase, inactivates corticsol by converting it to 
corticosterone. Dietary protein restriction attenuates 11β-HSD-2 in the placenta and may 
provide a mechanism relating the maternal nutrition to fetal programming {Lindsay et al. 
1996}. In an epidemiology study, it was found that overexposure to maternal 
glucocorticoids in human are associated with reduced birth weight and an increase in 
central adiposity {Gillman et al. 2006}.  
 
In a British cohort study, Power C and Jefferies BJMH studied insult effect of maternal 
smoking during pregnancy on fetal growth and the influence of obesity risk through 
childhood to age 33. It was found the infants of mothers who smoked in pregnancy have 
lower birth weight than infants of non-smokers and had an increased risk of obesity from 
adolescence to age 33 {Power et al. 2002}. 
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2.1.2 Maternal Nutrition and Type II Diabetes 
 
Diabetes influences more than 180 million people worldwide and this number is most 
likely to double by 2030 (http://www.who.int/mediacentre/factsheets/fs312/en). Type II 
diabetes, a major prevalent form of diabetes, is suggested to have its origin during fetal 
development. Maternal nutrition during all the stages of gestation and lactation plays an 
important role in the control of type II diabetes risk. Although type 1 diabetes has been 
suggested to also have its origins in the fetal period as well, most epidemiological studies 
have confirmed the association between low birth weight and adult impairment of 
glucose metabolism and increased predisposition to type II diabetes in adult life. It was 
also suggest that some physical parameters of baby, such as abdominal circumference, 
body length, head circumference, low birth weight up to 1 year of age, and catch-up 
growth are associated with the development of type II diabetes risk in later life. As we 
discussed in the relation of maternal nutrition with obesity, it is because maternal 
undernutrition causes the fetus to adapt through endocrine and metabolic changes that 
such adaptations result in insulin resistance and a predisposition of offspring to 
developing type II diabetes.  
 
Barker is the first one who associates the birth size to the later development of metabolic 
syndrome in adult life {Barker et al. 1993}. Over 20,000 newborns between 1911 and 
1930 in a county were studied and he demonstrated that men who were smallest at birth 
(<2.5 kg) were nearly seven times more likely to have impaired glucose tolerance or type 
II diabetes than those were heaviest at birth (>4.3 kg). Hoffman and coworkers showed 
that short pre-pubertal IUGR children have a specific impairment in insulin sensitivity 
compared to their normal birth weight peers {Hofman et al. 2006}. A recent study 
conducted in Minnesota found that excess mortality for the adult onset type II diabetes 
was concentrated in individuals who have abnormal birth weight. A recent meta-analysis 
conducted by Harder and coworkers involved a total of 132,280 persons and concluded 
that low birth weight is associated with the increased risk for the onset of type II diabetes 
in the later life {Harder et al. 2007}. Another study conducted in Preston, UK, performed 
glucose tolerance tests on 226 men and women and found that an increased ratio of 
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placental weight to birth weight exhibited impaired glucose tolerance or type II diabetes 
in adult life {Godfrey et al. 2001}.  
 
Further evidences of the contribution of low birth weight to type II diabetes come from 
some animal studies. Jimenez-chillaron and coworkers performed a study to determine 
whether insulin resistance or insulin secretion dysfunction is associated with low birth 
weight and type II diabetes {Jimenez-Chillaron et al. 2005}. In offspring of 
undernourished mothers, comparisons of offspring from mice fed with a control diet and 
offspring from mice fed with an undernourished diet (restricted to 50% that of controls) 
were studied to explore whether undernutrition contributes to a defect in β-cell function 
resulting in abnormal glucose-stimulated insulin release and eventually in type II diabetes. 
Insulin content of β-cells was reduced by 25% in mice of the undernourished mothers, 
which was suggested that cause is that reduced nutrient delivery compromised insulin 
secretion. Others have also shown that nutrient restriction during pregnancy results in 
impaired glucose tolerance in low birth weight mice. A restriction in the maternal food 
intake by 50% during the last week of pregnancy led to the generation of IUGR pups with 
impaired β-cell development and a reduction in plasma glucose and insulin 
concentrations. Moreover, at approximately 8 months of age, the offspring demonstrated 
40% decrease in pancreatic insulin content and an increase in non-fasting plasma glucose 
concentrations, which eventually led to fasting hypoinsulinemia, hyperglycemia and 
insulin-to-glucose ratio, all of which contribute to the development of type 2 diabetes 
{Martin-Gronert et al. 2005}. 
 
It is recommended that the mother increase her protein intake during pregnancy to 
provide the additional nitrogen source that is demanded by both the mother and the fetus 
because an increase in protein metabolism due to the rapid growth demands of the fetus. 
In both early and late pregnancy periods, the amount of energy obtained from protein is 
positively associated with birth weight. 
 
Numerous evidences come from the extensively studied low protein animal model. Some 
mechanism insights of early growth restriction caused by insufficient protein were 
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obtained from such a model. The model was established by Snoeck and co-workers 
where dams were fed a diet containing 8% protein through out pregnancy and lactation 
and compare offspring to those of a control dam fed an isocaloric 20% protein diet 
{Snoeck et al. 1990}. The under half the protein intake of the control diet reflects the 
relevance to cultures, economies and social-economic groups for those protein sources 
are expensive. The effects on pregnancy outcome are therefore expected to have no effect 
on litter size. The model has firstly shown that protein restriction dams deliver litters with 
lower birth weight. And there were adverse effect on pancreas development, β cell 
proliferation. Insulin content was reduced and its secretion was impaired. Giving 
offspring control diet shown a time-dependent matter. After 6 weeks to 3 months, litters 
demonstrate improved glucose tolerance. But after 15 months, they had an impaired 
glucose tolerance and by 17 months, frank diabetes with insulin resistance was observed 
in male low protein offspring. Insulin-stimulated glucose uptake was reduced in both 
muscle and adipose tissue of 15-month-old males. The observation was accompanied by a 
reduction in both GLUT 4 and PKC zeta in muscle {Ozanne et al. 2003}. Female 
offspring only demonstrated hyperglycemia and impaired glucose tolerance. 
Fernandez-Twinn et al. employed a maternal protein restriction rat model throughout 
gestation and lactation. Offspring were again born smaller than controls and developed 
diabetes, hyperinsulinemia, and tissue insulin resistance in adulthood {Fernandez-Twinn 
et al. 2003}. 
 
In the mechanistic investigations, in pups delivered from low protein fed Dams, 
expression of pancreatic duodenal homeobox-1 (pdx-1) and insulin-like growth factor II 
(IGF-II) in the islet cells were reduced {Arantes et al. 2002; Petrik et al. 1998}. Pdx-1 is 
responsible for the regulation of a number of genes that are accountable for the proper 
development and maturation of the pancreas. IGF II functions in the prevention of 
apoptosis from development. When these two genes expression were reduced, the 
development of pancreas and the production of insulin are compromised, thus 
contributing to an increased predisposition to adult onset type II diabetes. In other animal 
studies, an increase in hepatic gluconeogenic phosphoenolpyrubate carboxykinase 
(PEPCK) activity {Desai et al. 1997} and reduced glycolyic glucokinase levels {Desai et 
                                                                                              10
al. 1997; Rees et al. 2000} have been reported in response to a maternal low protein diet. 
Of a note is the decrease in glycolytic glucokinase activity seen in subjects diagnosed 
with type II diabetes {Vaxillaire et al. 2006}. Over expression of PEPCK has also been 
shown to cause the development of type 2 diabetes in mice {Franckhauser et al. 2006}. 
Ozanne and coworkers reported that the offspring of low protein diet treated mothers had 
a reduction in epididymal adipocytes, and an increase in basal and insulin-stimulated 
glucose uptake. However, both the muscle and adipocyte insulin receptor expression in 
the restricted protein offspring were similar to that of the control group and that 
molecular alteration resulting in insulin resistance must occur downstream of the insulin 
receptor. In this regard, a reduction in the expression of the p110β subunit of 
phosphatidylinositol (PI3-kinase) and a reduction of the activity of insulin-stimulated 
protein kinase B were found in the adipocytes of IUGR animals at 3 and 15 months of 
age {Ozanne et al. 2005}. 
 
Accumulating evidence has shown that epigenetic regulation of transcription is a 
mechanism for inducing changes in phenotype of fetal programming and the increased 
risk of diabetes in adulthood. The reversible changes that occur as a result of heritable 
modifications without involvement of primary DNA sequence alterations are defined as 
epigenetic changes. Histone modification and DNA methylation are two main molecular 
events known to initiate and sustain such epigenetic modifications.  
 
Along this line, we investigated the impact of maternal low protein diet on the expression 
of glucose transporter 4 (GLUT4) in offspring skeletal muscle (S. Zheng & Y.-X. Pan, 
manuscript submitted). A maternal LP diet during pregnancy and/or lactation was 
reported in affecting postnatal growth, appetite, triglyceride and cholesterol 
concentrations, as well as insulin resistance in male but not female offspring {Zambrano 
et al. 2006}. However, the molecular mechanism underlying the sex-differentiated 
carbohydrate metabolism and insulin sensitivity is rarely explained. The major insulin 
responsive protein involved in glucose absorption is glucose transporter 4 (GLUT4). We 
observed sex-dependent GLUT4 mRNA expression and increased GLUT4 protein 
content in female pup skeletal muscle by maternal low protein. Analysis of transcriptional 
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and epigenetic regulation underlying increased skeletal muscle GLUT4 expression in 
offspring rats also revealed the regulatory mechanisms. Increases in regulatory genes 
associated with carbohydrate metabolism, C/EBPβ and Nur77, were observed in female 
pups whose mothers were fed a low protein diet. Modifications of chromatin structure, 
including acetylated histone H3, acetylated histone H4 and di-methylated histone H3 at 
lysine 4, were detected at a significantly increased level at the GLUT4 promoter region in 
female pup muscle following maternal low protein diet. Such modifications include 
increased levels of acetylated histone H3, acetylated histone 4 and di-methylated histone 
H3 at lysine 4 in female offspring rats. However, the restricted diet did not activate the 
amino acid response pathway or alter GLUT4 expression through DNA methylation. 
These results demonstrated that maternal protein restriction during pregnancy induces 
GLUT4 expression in female offspring skeletal muscle but not in males, which may 
indicate sex-dependent adaptation of insulin sensitivity and of glucose metabolism to low 
maternal protein diet (Figure 2.1). 
 
In another report, Burdge investigated whether the altered methylaiton of PPARg and 
glucocorticoid receptor (GR) promoters are passed to the F2 generation in response to a 
maternal low protein diet {Burdge et al. 2007}. It was observed that hepatic PPARa and 
GR promoter methylation was significantly lower in the protein restriction group in the 
F1 and F2 generations. There were also trends towards a higher expression of PPARg, 
GR, acyl-CoA oxidase, and PEPCK in the F1 and F2 males, although this was significant 
only for PEPCK. These data showed that the altered methylation of gene promoters in the 
F1 generation by maternal protein restriction during pregnancy is transmitted to the F2 
generation. This may represent a mechanism for the transmission of induced phenotypes 
between generations. The potential to affect subsequent generations by maternal under 
nutrition during pregnancy has also been reflected by other studies. The Dutch famine 
study showed that the pregnant women who experienced undernourishment during the 
famine period consisted of a 5-month of food deprivation in the winter of 1944-1945 
gave birth to offspring what were of average or normal birth weight. Those offspring 
went on to give birth to offspring of low birth weight, which illustrated again that 
maternal under nutrition can affect more than one generation {Stein et al. 2000}.  
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Maternal under nutrition can result in the overexposure of the fetus to glucocorticoids. An 
animal model showed the adverse effects of overexposure to glucocorticoids continue to 
further generations. Offspring overexposed to dexamethansone (glucocorticoid) during 
late pregnancy have low birth weight and developed glucose intolerance and 
hypertension in adulthood {Seckl et al. 2004}. When these offspring have birth to 
offspring of there own, their offspring also had low birth weights and impaired glucose 
intolerance, thus confirming that adverse events during pregnancy affect not only the first 
generation but also future generations. A recent study reveals that low protein diet during 
gestation had adverse effects on glucose, insulin and leptin metabolism, resulting in 
insulin resistance in adult F2 offspring {Lindsay et al. 1996}. Future prenatal and 
gestational nutritional recommendations may need to be formulated on the basis of region, 
culture and risk assessment criteria. 
 
Both clinical and experimental studies have shown that maternal obesity has been linked 
to the alteration in fetal development and increased risk of diabetes. Particularly, human 
studies have linked maternal diabetes with a higher incidence of type II diabetes in the 
offspring in adulthood {Hadden et al. 2008}. The concept of prediabetes has come 
recognized again with the worldwide epidemic of type II diabetes. Maternal 
hyperglycaemia has been related to fetal macrosomia in diabetic pregnancy. The recent 
large studies about the outcome of pregnancy in type II diabetic mothers in England, 
Wales and Northern Ireland in 2002-2003 shows that there is still an increase in the 
numbers of both big babies and small babies born to these diabetic women in comparison 
with the national population data, babies ≥4.5 kg with type II diabetes 5.1%, national 
population with type II diabetes 1.7% (Confidential Enquiry into Maternal and Child 
Health Pregnancy in Women with Type 1 and Type II Diabetes in 2002-2003; England, 
Wales and Northern Ireland) 
 
In a small study of 99 babies with verified birth weight > 5 kg in 45 prediabetic women, 5 
years prior to the diagnosis of diabetes, 36% of the mothers producing a big baby were 
obese, while none of the babies born to non-obese mothers weighed as much as 5 kg. A 
similar difference persisted at 1.5 years before the onset of diabetes, but was reversed 
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after the onset of diabetes, where non-obese mothers had a 28% prevalence of babies 
above 5 kg (Pedersen J. The pregnant Diabetic and Her Newborn: Problems and 
Management; 2nd edition).  
 
Hypotheses exist to explain the relationship between intrauterine nutrition and risk of 
diabetes relevant to the big baby and the small baby. The Pederson hypothesis, simply 
stated, is that maternal hyperglycaemia causes fetal hyperglycaemia by direct 
transplacental passage. After the fetal islet cells become functional, this leads to excess 
fetal insulin secretion, which facilitates excess fetal growth, particularly the fat 
component. The alternative but not exclusive concept, known as the Barker hypothesis, is 
that maternal malnutrition associated with placental insufficiency will lead to impaired 
fetal growth and small babies, which are associated with neonatal insulin resistance and 
long-term epidemiological evidence of type II diabetes and hypertension. It is possible to 
consider these two ends of the nutritional background to type II diabetes in a single 
concept of transgenerational diabetes. The studies of David McCance in the Pima Indians 
did demonstrate in that population, where type II diabetes is very prevalent, that there 
was a ‘U-shaped’ curve where type II diabetes at aged 30-34 years was more common 
among those who had been less than 2.5 kg or more than 4.5 kg at birth {McCance et al. 
1994}. 
 
2.1.3 Maternal Nutrition and Cancers 
 
Cancers are age-related diseases and caused by the interaction of genetic susceptibility 
and environmental factors {Uauy et al. 2005}. In recent years, cancer prevention has 
attracted numerous attentions. Avoiding exposures to some environmental factors, such as 
radiation, carcinogenic compounds, infectious agents, some dietary factors and 
contaminants in food, water and air, has been used to prevent cancers from occurring. 
However, the knowledge of cancer risk management is still very limited especially in the 
early life intervention. More recently, approaches to identify early metabolic syndrome 
and its underlying genetic susceptibility have shown promising prevention of cancers 
before any symptoms or laboratory indicators. For example, obesity has been recognized 
                                                                                              14
as a contributory risk factor for some types of cancers {Key et al. 2004}. Relationships 
between maternal nutrition and obesity risk have been addressed in previous discussions. 
There are research evidences indicating that maternal nutrition should be considered as a 
factor to control postnatal cancer risk. The first human evidence came from a study of 
transient exposures to chemical substances during embryonic and fetal life on triggering 
cancer in offspring in 1970 {Herbst et al. 1999}. Herbst found seven women were treated 
with diethylstilbestrol during the first trimester of pregnancy and they have a clear-cell 
vaginal adenocarcinoma. The diethylstilbestrol was a drug that was believed to reduce the 
incidence of premature births and neonatal deaths. However, Herbst study demonstrated 
that the diethylstilbestrol treatment in the pregnancy period have the potential adverse 
consequences of exposure of fetus to such a toxic substance and may increase fetal 
susceptibility to cancer during such rapid growth and differentiation period. Along this 
line, maternal intake of the synthetic estrogen during the pregnancy period increase 
multi-generational uterine cancer risk in female offspring and such effect is demonstrated 
in animals as well {Giusti et al. 1995}. Thus, recently natural estrogens have been 
classified as known human carcinogens. 
 
2.2 Maternal Nutrition and Breast Cancer Overview 
 
Maternal nutrition and maternal exposure to environmental agents may change metabolic 
process during offspring’s mammary gland growth and alter epigenome thereby 
predisposing offspring’s mammary gland to the breast cancer risk later in life 
{Hilakivi-Clarke et al. 2006}. Maternal low protein diet, one of most common diets 
encountered by mothers, has been associated with the risk of a number of adult diseases 
{McArdle HJ et al. 2006}. Despite the large distribution of breast cancer in elder women, 
the disturbing that may increase the risk of carcinogenesis could occur in younger years 
when the mammary gland is most susceptible. However limited understanding of the 
maternal nutrition effect and molecular mechanisms underlying mammary gland cancer 
retards our further determination of the optimal maternal nutrition in cancer prevention. 
Epigenetic modifications including cytosine methylation of DNA and post-translational 
modification of chromosomal structural histones alter gene functions which often 
                                                                                              15
resulting in phenotype changes without altering the DNA sequence. For instance, DNA 
hypermethylation leads to decreased expression and DNA hypomethylation leads to 
increased expression of target genes. Cytosine DNA methylation patterns are largely 
erased in the early embryos and then re-established in a tissue-specific manner {Kafri T et 
al. 1992}. Such epigenetic modifications affect cell proliferation during prenatal and 
postnatal development and may associate with the regulation of the risk for breast 
cancers. 
 
Indeed, the association between the breast cancer susceptibility and the fetal environment 
has attracted relatively extensive attentions recently. Maternal exposure to dietary factors 
during pregnancy or lactation alters the risk of offspring in developing breast cancer. 
Some exposures induce epigenetic changes and cause gene expression alteration in the 
offspring’s mammary gland development. However, it still lacks evidences to link the 
epigenetic changes in the fetal development to the increased vulnerability for malignant 
transformation in postnatal life. Thus, identification of the target genes in the epigenetic 
programming, unfolding related mechanism at molecular level and studying its 
consequences during the life span may lead to the useful approaches to prevent breast 
cancer for women. 
  
First of all, recent epidemiological studies have indicated that women with either high 
birth weight (> 4 kg) or very low birth weight (< 2.5 kg) are at increased risk of breast 
cancer {Troisi R et al. 2003}. The effect is more apparent in women who developed 
pre-menopausal rather than post-menopausal breast cancer. It’s been well accepted that 
birth weight is influenced by maternal nutrition (this part will be discussed later). In a 
British cohort of 2547 girls followed from birth in 1946 to 1999, girls who were heavy at 
birth reached menarche earlier than others with similar growth in infancy. The findings 
suggested that women who grow faster in childhood and reach an adult height above the 
average for their menarche category are at a particularly increased risk of breast cancer 
{De Stavola BL et al. 2004}. This effect is associated with greater exposure to estrogens, 
which are likely to be promoters of breast cancer. Elevated estrogenic environment is 
related to high birth weight in most studies except Asian women, who have a low risk of 
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breast cancer but have significantly higher estrogen concentrations during pregnancy than 
Caucasian women {Shibata A et al. 2002}. This phenomenon might indicate that the 
increased risk of breast cancer in daughters caused by high concentration of estrogen 
during pregnancy could be potentially overridden by other factors during the pregnancy 
or postnatal life. On the other hand, a very low birth weight may also increase the risk of 
developing breast cancer {Ahlgren M et al. 2003}. 
 
Secondly, in an animal model, exposing the mother to E2, the synthetic estrogen, during 
pregnancy increases carcinogen-induced mammary tumorigenesis in the offspring. 
Elevated maternal and /or cord-blood levels of estrogens, leptin, adiponectin and IGF-1 
might all increase the risk of a daughter developing breast cancer, but an increase in one 
of these does not necessarily mean an increase in later breast cancer risk. The finding 
suggested many alterations in utero could contribute to the later breast cancer risk 
modification.  
 
Estrogens function through the binding to estrogen receptors, ERα and ERβ. These 
estrogen receptors are nuclear transcription factors that regulate genes expressions. Genes 
encoding ERs are targets of epigenetic modifications and can be silenced by 
hypermethylation {Ottaviano YL et al. 1994}. In normal mammary epithelial cells, ERα 
is not located in the cells that proliferate, but close to them; whereas in breast tumors, 
proliferating cells frequently express Erα {Potten CS et al. 1998}. It was suggested that 
ERβ might negatively control cell proliferation and may have a protective role in the 
normal breast {Cheng G et al. 2004}. In utero exposure of increased estrogen could 
increase or reduce the concentration of ERα in offspring {Newbold RR et al. 2004}, and 
correspondingly trigger the ER-mediated pathways, including cell proliferation and 
expression of estrogen-regulated genes. It has been shown that, in utero, exposure to 
elevated E2 increases ERα levels in the offspring mammary gland and up-regulates 
estrogen-regulated genes such as cyclin D1, pSrc and pAkt and down regulate a 
suppressor gene Caveolin-1. Caveolin-1 is known that its expression inhibits 
phosphorylation deactivation of the oncogenes Src and ras and pro-survival factors such 
as Akt {Acconcia F et al. 2005}. Therefore, it was suggested that elevated exposure to 
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estrogen in utero would alter postnatal susceptibility to malignant transformation in 
breast tissue by altering the expression of ERα and ERα-meidated downstream genes 
expression. On the other hand, low concentrations of ERα in the mammary gland are also 
associated with increased risk of breast cancer. For example, rats with high birth weight 
have reduced mammary ERα and develop mammary tumors earlier than control rats {De 
Assis S 2006}.  
 
Maternal diet and nutrition are important factors because these factors during pregnancy 
may modify pregnancy hormone levels, especially estrogen levels in utero. Therefore, 
maternal diet may affect the later risk of breast cancer for offspring. High fat diet 
increases E2 concentration during pregnancy. High fat diet, which is high in n-6 
polyunsaturated fatty acids, increases the susceptibility of female offspring to develop 
carcinogen induced mammary tumors as adults12. Genistein, a phytochemical in soybeans, 
induces epigenetic changes and influence estrogenic activity by binding to estrogen 
receptors. Exposure in utero increases the number of terminal end buds (TEBs) in 
offspring mammary gland, which are targets for malignant transformation 
{Hilakivi-Clake L et al. 2001}. But maternal soy intake did not increase offspring risk of 
developing mammary tumors, although the soy diet contained high levels of genistein 
{Trock BJ et al. 2000}. The soy diet also increased pregnancy estrogen levels. These 
results indicate that soy must contain some additional components, which reverse the 
effects of genistein on offspring breast cancer risk when administered in utero.  
 
2.3 Maternal Protein Restriction and Mammary Gland Development 
 
The maternal low-protein model is one of the most-extensively studied models for 
nutrition down-regulation studies. The model was established by Snoeck and co-workers 
where dams were fed a diet containing 8% protein through out pregnancy and lactation 
and compare offspring to those of a control dam fed an isocaloric 20% protein diet 
{Snoeck A et al. 1990}. The under half the protein intake of the control diet reflects the 
relevance to cultures, economies and social-economic groups for those protein sources 
are expensive. The model has firstly shown that protein restriction dams deliver litters 
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with lower birth weight. Ozanne and coworkers tested ‘thrifty phenotype hypothesis’ and 
investigate the effects on fetal programming and post-natal catch-up growth. The 
offspring of low protein-fed dams was switched to a standard diet that mothers used for 
lactation. The body weights of those rats caught up and exceeded that weight of control 
group by 7 days of age and this pattern persisted in adulthood {Ozanne SE et al. 2003}. 
Fernandez-Twinn et al. employed a maternal protein-restricted rat model throughout 
gestation and lactation. Offspring were again born smaller than controls 
{Fernandez-Twinn DS et al. 2003}. 
 
Some mechanism insights of early growth restriction caused by insufficient protein could 
be potentially revealed by maternal low protein model. It’s been established that amino 
acid methionine and folate are methyl donors and play the central role in the epigenetic 
regulation in the process of cytosine methylation. They are essential for establishing 
genome-wide DNA methylation patterns. During pregnancy, to supply the increased 
protein synthesis associated with rapid fetal growth, methionine requirements are high 
and suboptimal status of protein nutrition could result in development defects {Essien FB 
et al. 1993}. Therefore, prenatal development is a sensitive stage when maternal diet may 
affect DNA methylation and furnish permanent fixation of aberrant methylation patterns 
that is demonstrated in an agouti mouse model {Waterland RA et al. 2003}. In postnatal 
development, DNA methylation patterns and histone modifications must also be 
maintained through multiple mitotic divisions to keep the homeostasis of most tissues 
through constant self-renewal. This process requires maintenance of appropriate 
quantities of folate or other cofactors such as methionine, vitamin B-12, choline and 
betaine that may affect normal patterns of DNA methylation and histone modifications 
{Ingrosso D et al. 2003}. Therefore, postnatal development is also a sensitive stage that 
maternal diets may affect chromatin modification and result in disease susceptibility. 
 
On the other hand, maternal low protein during the pre-implantation period in rodents 
induced a transient reduction in maternal serum essential amino acid concentrations, 
which is associated with reduction in embryo cell numbers and led to various abnormal 
postnatal phenotype changes even through offspring were fed a normal diet. Maternal 
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serum homocystein levels were elevated in response to low protein diet and therefore 
interfere with methyl group donation required for DNA methylation. The branch-chain 
amino acids, leucine, isoleucine, and valine, are significantly depleted in both serum and 
uterine fluid in response to low-protein diet {Porter R et al. 2003}. Depletion of 
branch-chain amino acids could affect a serine-threonine kinase signaling pathway, the 
mammalian target of rapamycin (mTOR) {Hentges KE et al. 2001}. Histone modification 
could also be affected by maternal diet. We also observed that maternal low protein diet 
could furnish the histone modification in the offspring rats for regulating specific gene 
expression in a tissue specific manner {Zheng S et al. 2010}. Therefore, fetal and natal 
nutritional environment likely directly or indirectly alters epigenetic modifications such 
as DNA methylation and histone modifications, and thereby affects gene transcription, 
gene expression and ultimately the development of disease. However, nowadays whether 
maternal low protein affects the incidence of breast cancer in offspring is undocumented. 
 
Breast cancer is a progressive disease that is the most diagnosed and second most fatal 
cancer in women (American Cancer Society, Cancer Facts & Figures; Atlanta, 2007). 
The age-related decline in susceptibility to mammary gland cancer has been observed 
with carcinogens and ionizing radiation in both human and animals. Patients receiving 
therapeutic ionizing radiation have shown that treatment increases breast cancer risk 
when exposure occurs during childhood and young adulthood rather than after the age of 
forty. The phenomena suggested that breast cancer arises as a consequence of disruption 
in the normal pathways during the mammary gland development and differentiation. 
 
Mammary gland is in an undifferentiated state in the prenatal gestation period. Maternal 
nutrient supplementation or exposure to environmental agents may change relevant 
metabolic processes in mammary gland and alter epigenome thereby predisposing 
mammary gland to the risk of developing cancers later in life. The development of 
mammary glands in rodents and humans is largely similar. During the fatal period, the 
mammary fat pad is formed and contains limited stroma, which is important for 
morphogenesis of the mammary epithelium {Haslam SZ et al. 2003}. In rodents, the 
epithelium is quiescent until 3 weeks after birth. The club shaped terminal end buds 
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(TEBs) appears. TEBs are the most actively growing terminal ductal structures, and are 
believed to contain stem cells that could potentially give rise to breast cancer. TEBs are 
the only structures in the rat mammary gland that transforms to microtumors and 
eventually form adenocarcinomas on exposure to a carcinogen. The corresponding 
structures in the human breast, called TDLUs, have also been suggested to be the 
locations that initiate breast cancer {Russo J et al. 2000}. TEBs lead the growth of the 
epithelial ducts and regress to terminal ducts or differentiate to alveolar buds and then to 
lobules. Although it's been shown, both in mice and rats, that in utero and neonatal 
exposure to E2 increases the number of TEBs and delays their differentiation to alveolar 
buds, it is not clear whether the changes in TEBs are linked to the risk of breast cancer. 
  
All mammary epithelial cells originate from mammary stem cells. The destination of 
stem cells can be modified epigenetically. It has been proposed that elevated hormone 
and/or growth factor concentrations in utero increase later breast cancer risk by 
increasing the total number of replicating, immature stem cells which may be at risk for 
malignant transformation. Baik have measured the concentrations of hematopoietic 
stem-cell markers CD34+, CD38- and granulocyte–macrophage colony-forming unit in 
cord blood and found them to be linked to the cord-blood concentrations of IGF-1, 
IGF-binding protein 3, estriol and testosterone {Baik I et al. 2005}. One explanation is 
that elevated concentrations of hormones and growth factors in utero might increase the 
later risk of cancer by increasing the number of stem cells during the fetal period. How 
these findings relate to the risk of developing breast cancer is still to be determined. The 
finding that high birth weight is associated with increased activation of mitogen-activated 
protein kinase (MAPK) in adult mammary glands provides indirect evidence to support 
the involvement of stem cells in the effects of fetal environment on later risk of breast 
cancer. Activation of MAPK might affect interaction between the polycomb protein 
complex and chromatin and silence specific sets of genes through chromatin 
modifications {Voncken JW et al. 2005}. 
 
 
 
                                                                                              21
2.4 Tables & Figures 
 
Table 2.1 Maternal Nutrition and Offspring’s Risk of Obesity 
Subjects Maternal Nutrition Observations Ref. 
Malnutrition Low birth weight but gaining weight rapidly in childhood Yajnik CS et al. 
Malnutrition in 
early stages of 
gestation 
Increased obesity rate in young men 
and 50-year old women 
Ravelli GP et al. 
Ravelli AC et al. 
Overexposure to 
glucocorticoids 
Reduction in body size but an 
increase in central distribution of fat 
Gillman MW et 
al. 
Human 
Smoking during 
pregnancy 
Low birth weight but elevated risk 
of obesity at age 33 Power C et al. 
Calorie 
Restriction 
Induce hyperphagic behavior and 
obesity of offspring 
Vickers MH et 
al. 
Protein 
Restriction 
Low birth weight but catch-up 
growth on obesity. Ozanne SE et al. 
High Fat A markedly obesity independent of postnatal nutrition Howie GJ et al. 
Malnutrition 
Leptin treatment of offspring 
reverses obesity risk resulting from 
relative fetal undernutrition 
Vickers MH et 
al. 
Animal 
Iron restriction Low birth weight Lewis RM et al. 
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Table 2.2 Maternal Nutrition and Offspring’s Risk of Type II Diabetes 
Subjects Maternal Nutrition Observations or Conclusions Ref. 
Smallest at birth (<2.5 kg) were 
more likely to have impaired glucose 
tolerance or type II diabetes 
Baker DJ et al. 
Low birth weight is associated with 
the increased risk for the onset of 
type 2 diabetes 
Harder T et al. Low birth weight 
An increased ratio of placental 
weight to birth weight exhibited 
impaired glucose tolerance or type II 
diabetes in adult life 
Godfrey KM et al. 
IUGR IUGR children have a specific impairment in insulin sensitivity Hofman PL et al. 
Human 
Obesity Big babies had the increased risk of developing type II diabetes Hadden DR et al. 
Calorie 
Restriction 
A defect in β-cell function, reduced 
insulin content in β-cell, 
hypoinsulinemia, hyperglycemia and 
on set of type II diabetes in later life 
Jimenez 
-chillaron JC et al. 
Adverse effect on pancreas 
development, β cell proliferation Snoeck A et al. 
A reduction in both GLUT 4 and 
PKC zeta in muscle in males. Ozanne SE et al. 
Down regulation of pdx-1 and 
IGF-II 
Arantes VC et al. 
Petrik J et al. 
Upregulation of PEPCK and 
downregulation of glycolytic 
glucokinase 
Desai M et al. 
Rees WD et al. 
Downregulation of p110β subunit of 
PI3-kinase Ozanne SE et al. 
Animal 
Protein 
Restriction 
Lower methylation level in the 
promoter regions of PPAR and GR 
promoter and higher expression of 
these genes in F1 and F2 
generations. 
Burdge GC et al. 
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Table 2.3 Maternal Nutrition and Offspring’s Risk of Cancer 
Subjects Maternal Nutrition Observations Ref. 
Diethylstilbestrol 
exposure  
in pregnancy 
Vaginal adenocarcinoma in 
mothers and increased fetal 
susceptibility to develop uterine 
cancers. 
Herbst AL et al. 
Giusti RM et al. 
Elevated estrogenic 
environment 
High birth weight and increased 
risk of breast cancer. De Stavola BL et al. Human 
Maternal intake of 
fruits, vegetables 
and fish and 
seafood 
Reduced risk of developing 
acute lymphoblastic leukemia in 
offspring 
Petridou E et al. 
Exposure to 
synthetic estrogen 
Increased carcinogen-induced 
mammary tumorigenesis in the 
offspring 
Ottaviano YL et al. 
Increased estrogen receptor α 
level in the offspring’s 
mammary gland and over 
expression of estrogen-regulated 
genes such as cyclin D1, pSrc 
and pAkt and down regulate a 
tummor suppressor gene 
Caveolin-1 
Hilakivi-Clarke  
L et al. In utero over 
exposure of 
estrogen 
Rats with high birth weight have 
reduced mammary ERα and 
develop mammary tumors 
earlier than control rats 
De Assis S et al. 
High-fat diet 
Increased E2 level in utero 
environment and increased 
susceptibility of female 
offspring to develop carcinogen 
induced mammary tumors as 
adults 
Hilakivi-Clarke  
L et al. 
Genistein exposure 
Increased number of TEBs 
which are targets for malignant 
transformation 
Hilakivi-Clarke  
L et al. 
Animal 
Soy intake  Did not increase offspring’s risk of developing mammary tumors Trock BJ et al. 
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Chapter 3. Maternal Protein Restriction during Pregnancy Induces 
CCAAT/Enhancer-Binding Protein (C/EBPβ) Expression through the Regulation of 
Histone Modification at Its Promoter Region in Female Offspring Rat Muscle 
 
3.1 Abstract 
 
Maternal nutrition during pregnancy is an important intrauterine environmental factor 
that can cause persistent alterations of the offspring genome and is associated with 
potential disease risk later in life. In the present study, we investigated the impact of a 
maternal low protein diet on the expression of a transcription factor gene, 
CCAAT/enhancer-binding protein (C/EBPβ) in offspring skeletal muscle. C/EBPβ 
belongs to a family of transcription factors that regulate expression of genes involved in 
energy homeostasis, including amino acid metabolism. We investigated C/EBPβ 
transcriptional regulation from an epigenetic aspect in this study. We first time observed 
the sex-dependent difference of C/EBPβ expression in offspring skeletal muscle treated 
by a maternal protein-restricted diet. In female offspring skeletal muscle, both C/EBPβ 
mRNA and protein levels were increased by maternal protein restriction. However, 
C/EBPβ expression was not altered in male offspring. Analysis of transcriptional and 
epigenetic regulation as the underlying causes of increased skeletal muscle C/EBPβ 
mRNA in female offspring rats with maternal low protein (LP) revealed changes in 
chromatin structure. Specifically, acetylated histone 3 and acetylated histone 4 were 
detected at significantly increased levels at the C/EBPβ promoter region in female LP 
pup's muscle. Phosphoenolpyruvate carboxykinase (PEPCK) gene transcription was also 
up-regulated in female LP pups through the increased binding of C/EBPβ at its promoter. 
The induction of C/EBPβ expression in female offspring skeletal muscle by maternal 
protein restriction during pregnancy may indicate C/EBPβ-involvement in signaling 
response in amino acid metabolism to a low maternal protein diet. 
 
3.2 Introduction 
 
Experimental studies of rodents using a variety of nutritional manipulations in pregnancy 
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demonstrate that deviations in maternal nutrition during pre- and postnatal periods plays 
an important role in the etiology of disease in offspring {Langley-Evans et al. 2006; 
Gambling et al. 2003; Khan et al. 2003}. Dietary protein intake during fetal development 
has a long-term impact on health outcomes as well as lifespan {Zimmerman et al. 2003}. 
Impaired muscle development with a decreased number of fibre cells was observed in 
offspring during the gestation stage under maternal nutrition restriction {Zhu et al. 2006}. 
Epidemiology and experimental studies have also indicated that a low protein maternal 
diet during fetal and neonatal development in both humans and laboratory animals 
increases offspring susceptibility to the later development of altered carbohydrate 
metabolism {Dahri et al. 1991}. In a recent study, a maternal low protein diet during 
pregnancy and/or lactation affected the postnatal growth of offspring, their appetitive 
behaviors, triglyceride and cholesterol concentrations in the blood, and the insulin 
resistance in male but not female offspring {Zambrano et al. 2006}. Although 
physiological consequences of maternal protein intake on offspring are well studied, the 
molecular mechanism at the gene transcription level is relatively unknown. 
 
CCAAT/enhancer-binding proteins (C/EBPs) are a family of transcription activating 
factors that regulate expression of genes involved in a wide range of physiological 
processes, ranging from the acute-phase response to the control of macronutrient 
homeostasis {Lekstrom-Himes et al. 1998}. C/EBPβ is a member of the C/EBP family 
that also includes C/EBPα, g, d, e and CHOP (C/EBP homology protein) {Ramji et al. 
2002}. C/EBPβ controls gene transcription and metabolic processes in a variety of tissues. 
For instance, C/EBPβ controls the expression of insulin-responsive genes that regulate 
glucose transport and metabolism in adipocytes {Jain et al. 1999}. It is also critical to 
adipogenesis {Tang et al. 2005} and neuron generation {Paquin et al. 2005}. Deletion of 
the C/EBPβ gene impaired carbohydrate metabolism and resulted in hypoglycemia 
{Croniger et al. 2001}. Other factors also control the expression of C/EBPβ and 
associated activities in skeletal muscle. For example, glucocorticoids increased C/EBPβ 
expression and its DNA binding activity in muscle cells {Yang et al. 2005}. Friedman et 
al. reported that the deletion of C/EBPβ increased insulin sensitivity in mice skeletal 
muscle {Wang et al. 2000}. As a transcriptional regulator, C/EBPβ binds to the CRE 
motif in the muscle PEPCK promoter, which has been reported to be critically involved 
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in the anaplerosis and cataplerosis in amino acid metabolism in muscle {Owen et al. 
2002}. PEPCK can provide phosphoenolpyruvate (PEP), a source of pyruvate, for 
re-feeding the citric acid cycle to provide energy for muscle cells. The role of C/EBPβ as 
a transcription factor in muscle provides potential insight for further investigations of 
amino acid metabolism alteration by maternal nutrition restriction.      
 
Recently, the transcriptional control of C/EBPβ has attracted some attention, albeit 
limited. Dietary protein restriction has been shown to result in higher mRNA content of 
C/EBPβ in rat liver {Marten et al. 1996}. Up-regulation of C/EBPβ was also observed 
under histine deprivation in human hepatoma cells {Siu et al. 2001}. Subsequently, Chen 
et al. demonstrated that C/EBPβ binds to the asparagine synthetase amino acid response 
element in vitro following amino acid deprivation {Chen et al. 2004}. Still, the role of 
maternal protein intake on C/EBPβ in offspring skeletal muscle is not yet known. 
Moreover, to the best of our knowledge, there are no studies that address the epigenetic 
effects of maternal nutrition including histone code modifications in C/EBPβ promoter 
region through generations. In the present study, we investigate offspring C/EBPβ gene 
transcription response in rat skeletal muscle upon maternal protein restriction. We found 
that low protein intake during the gestation period resulted in an increase in C/EBPβ 
expression at both the mRNA and protein level in female offspring skeletal muscle. We 
also confirmed the modification of histones in the C/EBPβ promoter region, which could 
potentially contribute to the up-regulated C/EBPβ as well as the changes of downstream 
genes. 
 
3.3 Material and Methods 
  
Animals and treatment 
The animal protocol for this study was approved by the International Animal Care and 
Use Committee (IACUC) at the University of Illinois. Timed-pregnant Sprague Dawley 
rats (Charles River Laboratories) were obtained on day 2 of gestation and weight 
matched into one of two isocaloric diets, control (180 g/kg casein) or low protein diet (LP, 
90 g/kg casein), which were modified according to the AIN-76 diet formula throughout 
gestation (Table 3.1). Each group contained 4 dams. Both groups had free access to rat 
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chow and drinking water. Food intake was daily monitored by recording food left over. 
Animals were individually housed in standard polycarbonate cages with corncob bedding 
and maintained in the humidity and temperature controlled colony room on a 12 hr 
light-dark cycle. Twenty-four hours after newborn, 6 pups (3 female and 3 male) were 
selected and used in the litters to minimize variation in pups’ nutrition status during 
suckling. Pups body weight was measured once a week after birth. Both groups of 
mothers were switched to standard diet through lactation {Lillycrop et al. 2005}. At day 
24, in both experimental groups, the pups were weaned from the mother to a standard rat 
chow. To get the enough size of tissues for sample analysis, pups were sacrificed when 
they were 38 days old. The gastrocnemius muscle of right hind leg, visceral adipose 
tissue (mesenteric) and liver were then collected, snap-frozen in liquid nitrogen, and 
stored at -70°C.  
 
RNA isolation and cDNA synthesis 
Frozen tissue samples were ground in a mortar and pestle with liquid nitrogen and total 
RNA was isolated with TRI reagent (Sigma, St. Louis, MO). Following isopropanol 
(Fisher Scientific, Fair Lawn, NJ) precipitation RNA was resuspended and quantified by 
spectrophotometry (BIO-RAD Smart Spec Plus, Hercules, CA) at A260/A280. 
High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA) 
was used for reverse transcription of 2 μg of total RNA. All samples that were to be 
compared were reversed transcribed from the same reaction mixture at the same time 
with a no RNA template tube as negative control. The whole procedure was performed in 
a DNA 2720 Thermal Cycler (Applied Biosystems). The samples at the 20 μl reaction 
scale were heated at 37°C for 2 hr for reverse transcription procedure following 85°C for 
5 seconds to inactive reverse transcriptase and terminate the reaction. The final 20 μl of 
cDNA was diluted up to 400 μl by nuclease free water and stored at -20°C. 
 
Real time quantitative RT-PCR (qPCR) 
To measure the relative amount of mRNA, cDNA samples were run in a 96-well plate on 
7300 Real-Time PCR Systems (Applied Biosystem, Foster City, CA)), detected by iTag 
SYBR Green Supermix with ROX (Bio Red, Hercules, CA), which is a dye binding to 
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dsDNA generated during amplification. The reactions were activated at 95°C for 10 min 
accompanied by 35 cycles of 95°C for 15 s and 60°C for 1 min. The abundance of mRNA 
was quantified according to fluorescence signal by using a cDNA standard with specific 
concentration gradient versus Ct values. The cDNA standards were made from the same 
RNA samples of frozen tissues. The PCR primers amplified these standard samples in a 
linear fashion, and the Ct values of experimental samples were within the Ct values of the 
standard samples. Ribosomal protein L7a mRNA level was also measured at the same 
time as the internal control. After PCR, dissociation curve was generated by stepwise 
increase of the temperature from 55°C to 95°C to ensure that a unique product was 
amplified. Primers for the qPCR were designed using Vector NTI software (InforMax 
Inc., Frederick, MD) to amplify the transcriptional regions of the C/EBPβ and PEPCK 
gene (Table 3.2).  
 
Western blot 
Frozen muscle sample (25 mg) was ground in liquid nitrogen and put into 500 μl of 
protein sample buffer (0.125 M Tris-HCl pH 6.8, 5% 2-mecaptoethanol, 1% SDS, 20% 
glycerol, 0.4% bromphenol blue, protease inhibitor). Protein was sonicated (model 100 
Sonic Dismembrator, Fisher Scientific, Pittsburgh, PA) on ice with 25 pulses at power 
setting 2. Lowry assay was used to determine protein content and samples containing 20 
μg of protein were resolved by SDS-PAGE. After electrotransfer to a polyvinylidene 
fluoride membrane (0.2 μm) using a wet transfer protocol, 5% milk in TBS/T (30 mM 
Tris base pH 7.6, 200 mM NaCl and 0.1% Tween 20) was performed to block the 
membrane for 1 hr at room temperature and then the membrane was incubated with rabbit 
polyclonal antibody against C/EBPβ (Table 3.3) in 5% BSA at a 1:1000 dilution at 4°C 
overnight. The membrane was washed five times for 5 min with TBS/T on a shaker the 
next day and then incubated with peroxidase-conjugated goat anti-rabbit secondary 
antibody (Kirkegaard & Perry Laboratories, Gaithersburg, MD) in 1% milk at a 1:10,000 
dilution for 1 hr at room temperature. The membrane was then washed again for 5 min by 
five times. The bound secondary antibody was detected using a SuperSignal West Dura 
Extended Duration Substrate kit (Thermo Scientific, Rockford, IL). The blots were then 
exposed and bands were quantified by a BioRad Chemi Doc machine. The background 
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signals on the western blots were subtracted from the signal of protein bands when 
quantification was done by the machine. An anti-actin antibody was used as an internal 
control to show the equality of protein levels loaded. For each protein sample, the 
intensity of the C/EBPβ bands was normalized against that of the actin band. 
   
Chromatin immunoprecipitation (ChIP) 
ChIP analysis was performed according to a modified protocol {Chen et al. 2004}. 
Briefly, 200 mg frozen skeletal muscle samples were ground in liquid nitrogen, 
resuspened in PBS and cross-linked in 1% formaldehyde for 10 min at room temperature. 
The tissue pellet was re-suspended in nuclei swelling buffer (5 mM Pipes [NaOH] pH 8.0, 
85 mM KCl, 0.5 % NP40) containing protease inhibitor. The separated nuclei were lysed 
in SDS lysis buffer (50 M Tris-HCl pH 8.1, 10 mM EDTA, 1% SDS) containing protease 
inhibitors. The resultant chromatin was sonicated (Fisher Scientific model 100 Sonic 
Dismembrator, Pittsburgh, PA) on ice with 8 bursts for 40 s at power setting 5 with 2 min 
cooling interval between each burst. The average length of sonicated chromatin was 
determined by resolving on a 1.6% agarose gel and found to be around 500 bp. The 
sample was then centrifuged at 13,000 rpm for 10 min at 4°C to remove cell debris from 
the crude chromatin lysate. One milliliter-sheared chromatin was diluted in total 10 ml 
ChIP dilution buffer. Ten percent of the diluted lysate was subsequently incubated 
overnight on a hematology mixter (model 346, Fisher Scientific) with 2 μg of primary 
antibodies at 4°C. Pre-blocked salmon sperm DNA/protein A agarose beads (60 μl, 50% 
slurry; Upstate Biotechnology, Lake Placid, NY) were then added to the chromatin for 2 
hr, followed by centrifugation at 2000 rpm for 1 min at 4°C. Supernatant of normal rabbit 
IgG was saved as the input control for PCR after clean up. The pellets containing 
immunoprecipitated complexes were washed sequentially with 1 ml of low salt solution 
(0.1% SDS, 1% triton X-100, 2 mM EDTA, 20 mM pH 8.0 Tris-HCl, 150 mM NaCl), 
high salt solution (0.1% SDS, 1% triton X-100, 2 mM EDTA, 20 mM pH 8.0 Tris-HCl, 
500 mM NaCl), and LiCl solution (0.25 M LiCl, 1% NP40, 1% sodium deoxycholate, 1 
mM EDTA, 10 mM pH 8.0 Tris-HCl) and twice with TE (pH 8.0). Antibody/protein/DNA 
complexes were eluted from Protein A agarose beads by adding twice 250 μl of the 
elution buffer (50 mM NaHCO3 and 1% SDS) followed by shaking at 37°C at 300 rpm 
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for 15 min and flash spin down at room temperature. The combined supernatants were 
incubated at 65°C for 4-5hr after addition of 20 μl 5 M NaCl and 1μg of RNase A to 
reverse the formaldehyde cross-linking and release the DNA fragments. Samples were 
then treated with Proteinase K at 37°C for 1 hr to remove protein and DNA was purified 
with QIAprep Spin Miniprep Kit (QIAGEN, Valencia, CA). Immunoprecipitated DNA 
(5%) was quantified then by real time qPCR as described above. The standards and the 
DNA samples were simultaneously amplified using the same master mixture in a 25 μl 
reaction. Primers for the qPCR were designed using Vector NTI software to amplify the 
C/EBPβ and PEPCK proximal promoter sequences (Table 3.2).  
 
Transcriptional activity 
To measure the transcriptional activity from the C/EBPβ gene, the method of Sandoval et 
al {Sandoval et al. 2004} was used, which relies on ChIP analysis to examine RNA 
polymerase II (Pol II) binding at the coding region distal to the promoter. For this purpose, 
primers were designed within the protein coding region of the C/EBPβ gene (Table 3.2). 
The qPCR analysis was then performed using a 7300 realtime PCR system (ABI) and the 
product was detected with SYBR Green. Serial dilutions of input chromatin were used to 
generate a standard curve and the results were expressed as the ratio to input DNA. 
 
Statistical analysis 
Results are expressed as mean ± SEM. Comparison of mRNA and protein expression or 
histone modification between control and treated groups were performed by two-tailed 
t-test. Significance testing was set at p<0.05 level. 
 
3.4 Results 
 
Mothers food intake and offspring body weight   
Pregnant dams were obtained on day 2 of gestation. Figure 3.1A shows mothers’ daily 
food intake from day 3 of gestation to day 21, at which they gave birth. There were no 
differences in the daily food intake between control and low protein groups (p>0.05), 
indicating the quantity of food intake per se would not affect experiment results. At birth, 
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the control pups (6.32 ± 0.19 g) weighed similar to the LP pups (5.92 ± 0.09 g). As the 
pups grew to 15 days, average body weight was significantly lower in the LP pups than in 
the control (p<0.02). Figure 3.1B provides the average offspring body weight at birth and 
at day 7, 15, 22 and 35 of postnatal life. The average weight of the LP offspring was 
significantly reduced by 12% at day 15, 16% at day 22 and 13% at day 35 (p<0.05) as 
compared to the control pups. Litter size and litter sex distribution did not differ between 
the control and LP mothers (not shown).  
 
Maternal low protein induced C/EBPβ mRNA level in female offspring muscle 
Though it is a potent transcription factor involved in muscle amino acid and carbohydrate 
metabolisms, C/EBPβ has not been previously shown to be affected by maternal nutrition 
restriction in this specific tissue. In this study, C/EBPβ mRNA levels in offspring rats 
were quantified by qPCR. Figure 3.2A shows the C/EBPβ mRNA expression levels in 
skeletal muscle, visceral adipose tissue and liver of offspring of both sex from control 
mothers versus low protein (LP) mothers. A 2.14-fold increase (*p=0.003) of C/EBPβ 
mRNA content in skeletal muscle was observed in female offspring of maternal low 
protein mothers compared to control mothers, while no change was observed in males. 
Samples from 5 animals were tested in each of the two conditions. The values represent 
the mean ± S.E.M. L7a expressions were similar between the samples of control and LP 
in all of those three tissues (not shown). Results indicate a sex-dependent C/EBPβ change 
by maternal protein restriction, which might suggest a difference in energy metabolism 
between female and male offspring muscle during early life under this maternal nutrition 
state. Since C/EBPβ gene expression did not change in other tissues (adipose tissue and 
liver) and in the males, we concentrated further study on the regulatory mechanisms for 
C/EBPβ gene in female offspring skeletal muscle only. 
 
Expression of genes related to amino acid response (AAR) pathway 
The limitation of amino acids to mammalian cells modulates gene expression through the 
AAR pathway either at the transcriptional level through activating transcription factor 3 
(ATF3), or at the translational level through ATF4, which is enhanced in stress conditions 
that lead to the increase of eukaryotic initiation factor 2a (eIF2a) phosphorylation 
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{Kilberg et al. 2005}. To identify whether or not the increased C/EBPb expression in 
female pup muscle by maternal low protein is regulated through this AAR programming, 
we tested the mRNA expression of ATF3, ATF4 as well. C/EBPb acts as a cofactor for 
ATF3 and ATF4 in the AAR pathway. The mRNA expression levels of ATF3 or ATF4 did 
not differ between the two female pup groups (Figure 3.2B; p>0.05), suggesting that the 
alteration of C/EBPb mRNA in female offspring muscle through maternal protein 
restriction may not be mediated by the AAR pathway. Samples from 5 animals were 
tested in each of the two conditions. The values represent the mean ± S.E.M. The results 
implicate C/EBPb as a mediator in regulating amino acid or carbohydrate metabolism in 
skeletal muscle independent of the AAR pathway.  
 
Maternal low protein induced the transcription rate of the C/EBPβ gene  
To confirm the transcriptional activity from the C/EBPβ gene, ChIP DNA samples were 
used to monitor RNA Polymerase II (Pol II) binding to a region distal to the promoter, as 
demonstrated by Sandoval et al {Sandoval et al. 2004}. The measurement of Pol II 
binding within the coding region of a gene reflects the transcriptional activity. For the 
C/EBPβ gene, this analysis showed that the transcription rate increased 2-fold in female 
LP pup skeletal muscle relative to control pups (*p=0.02; Figure 3.2C). Therefore, 
increased transcription appeared to account for most of the induction in C/EBPβ mRNA 
following subjection to maternal low protein. Samples from 5 animals were tested in each 
of the two conditions. The values represent the mean ± S.E.M.. 
 
C/EBPβ protein level was increased in female offspring by maternal low protein 
To examine C/EBPβ protein content in female pup skeletal muscle, we performed 
Western blot analysis using an anti-C/EBPβ antibody. According to studies in vitro, 
C/EBPβ mRNA can produce at least three isoforms, liver-enriched transcriptional 
activator protein, LAP A, LAP B and LIP (liver-enriched transcriptional inhibitory 
protein), detected as multiple bands with molecular mass from 36 to 45 kDa {Chen et al. 
2004; Ramji et al. 2002}. This may be the result of post-translational modification 
{Ramji et al. 2002; Kim et al. 2002}. As shown by our results presented in Figure 3.3, 
two LAP isoforms of C/EBPβ protein were both induced by maternal low protein in 
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female offspring skeletal muscle. The ratios of C/EBPβ protein levels in female pup 
control to LP group were determined to be 1:1.58 for LAP A (*p=0.01) and 1:1.74 for 
LAP B (*p=0.005). Significantly higher C/EBPβ protein content in female LP pups’ 
skeletal muscle was consistent with the trend observed in its mRNA expression. The LIP 
isoform was not expressed in rat skeletal muscle. An anti-actin antibody was used as an 
internal control to show the equality of protein levels loaded. Samples from 5 animals 
were tested in each of the two conditions. The values represent the mean ± S.E.M.. 
 
Chromatin structure modification at C/EBPβ promoter in female offspring muscle  
Changes in chromatin structure affected by chemical modifications of histone proteins 
such as methylation and acetylation regulate gene transcription. RNA polymerase II (also 
called Pol II) is an enzyme found in eukaryotic cells {Roeder et al. 1969}. It catalyzes the 
transcription of DNA to synthesize precursors of mRNA and most snRNA and microRNA. 
A wide range of transcription factors are required for it to bind to its promoters and begin 
transcription {Conaway et al. 1997}. To investigate Pol II binding status at the 
transcription factor C/EBPβ promoter, we performed a ChIP assay, which refers to a 
procedure used to determine whether a given protein binds to or is localized to a specific 
DNA sequence in vivo. Normal rabbit IgG antibody was used as the negative control, 
which indicats non-specific binding. Antibodies with equal or less binding than IgG (≤
0.05 ratio to input) were considered negative for binding. The supernatant isolated from 
the IgG solution was used as the input control to determine the total protein background. 
The binding of PoI II and modified histones were expressed as ratios to the input. Figure 
3.4A demonstrates the PoI II binding at C/EBPβ promoter region in female pup skeletal 
muscle with maternal low protein in comparison to control. Recruitment of PoI II at the 
promoter of the C/EBPβ was increased in female pups due to maternal low protein 
(2.53-fold; *p=0.01). Data was in agreement with the increased C/EBPβ mRNA 
expression.  
 
To determine whether the altered transcriptional level of C/EBPβ gene was regulated by 
changes of chromatin structure modification that resulted in the Pol II binding change at 
the C/EBPβ promoter, methylated histone or acetylated histone antibodies were 
                                                                                              43
incorporated into the ChIP assay. Histone acetylation is associated with increased gene 
transcription, and therefore with transcriptionally active chromatin domains. Although 
histone methylation is generally associated with transcriptional repression, methylation of 
different lysine or arginine residues of histone also results in transcriptional activation. 
For example, the acquisition of active chromatin markers, such as H3K4Me2, leads to 
opened chromatin structure, which correlates with transcriptional activation of a target 
gene, while H3K9Me3 induces transcription repression. To test the effect of maternal low 
protein on chromatin remodeling at the C/EBPβ promoter, ChIP assay was performed 
with antibodies specific for histone modifications associated with enhanced gene 
transcription: anti-acetyl-H3, anti-acetyl-H4 and anti-H3K4Me2. To examine if the 
increased C/EBPβ mRNA expression results from diminished methylation of histone at 
residues, which lead to transcriptional repression, we also included the antibody of 
anti-H3K9Me3. Figure 3.4B shows the histone code modifications at C/EBPβ promoter 
region in female pup skeletal muscle of maternal low protein versus control. Increases in 
both acetyl-H3 and acetyl-H4 that associated with the C/EBPβ gene were observed in 
female pups muscle with maternal low protein versus control, by 1.82- and 2.01-fold 
(*p<0.05), respectively. Di-methylation of H3K4 did not differ between the two groups 
and no difference was detected in H3K9me3. Data suggests that the altered C/EBPβ gene 
transcription might be regulated by the changes of histone modification at its promoter 
region, histone acetylation at lysine 4 and lysine 9 residues, which results in the change 
of PoI II binding at the promoter. There was no any change of histone modifications 
within the C/EBPβ promoter in male offspring skeletal muscle or in female offspring 
liver samples (Figure 3.4C and 3.4D). Samples from 5 animals were tested in each of the 
two conditions. The values represent the mean ± S.E.M.. 
 
C/EBPβ binding at the PEPCK promoter and PEPCK expression were increased by 
maternal low protein 
To further investigate the physiological role of C/EBPβ in nutritional regulation in muscle, 
ChIP DNA samples that were pulled down by anti-C/EBPβ antibody were used to 
determine the amount of C/EBPβ binding at the PEPCK promoter. Quantification of 
PEPCK DNA samples was obtained through qPCR assay using the PEPCK primer set 
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(Table 3.2) to amplify its promoter region, which was bound with the C/EBPβ 
transcriptional factor. Figure 3.5A shows the increased C/EBPβ binding at the PEPCK 
promoter in female offspring skeletal muscle (*p<0.05), suggesting the potentially 
enhanced role of PEPCK on pyruvate synthesis via the generation of PEP to re-feed the 
citric acid cycle in muscle. Since C/EBPβ was shown to bind at the PEPCK promoter, we 
used qPCR to measure mRNA expression of PEPCK in order to confirm the effect of 
C/EBPβ binding. Figure 3.5B demonstrates the up-regulation of PEPCK mRNA in 
female offspring muscle by maternal low protein treatment (*p<0.05). PEPCK primers 
used for checking its coding region are shown in Table 3.2. Samples from 5 animals were 
tested in each of the two conditions. The values represent the mean ± S.E.M.. 
 
3.5 Discussion 
 
The results presented in this study document for the first time that C/EBPβ is 
up-regulated in both mRNA and protein levels in the skeletal muscle of female rat 
offspring in response to a low protein diet during the maternal gestation period. 
Consistent with this observation, the ChIP results showed chromatin modifications and 
increased recruitment of RNA polymerase II at the C/EBPβ promoter region in female 
offspring muscle. The transcription of PEPCK was up-regulated via increased binding of 
C/EBPβ within its promoter, which contributes to amino acid metabolism in muscle and 
represents an important physiological impact. 
 
Maternal diet and nutrition may modify pregnancy hormone environment 
{Hilakivi-Clarke et al. 2006}. Therefore, maternal diet may affect the different adaptation 
of female or male offspring to the altered utero hormone environment, especially estrogen 
levels. It is known that C/EBPβ is a key mediator of estrogen-response cell proliferation 
and differentiation in many tissues {Mantena et al. 2006}. The findings in our study 
revealed the sex-specific difference of C/EBPβ gene expression, which reflects one of the 
effects of maternal protein restriction in offspring skeletal muscle. This sex-specific 
difference may stem from sex-dependent responses to early developmental perturbations 
including altered utero estrogen levels. In addition, maternal protein restriction may alter 
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circulating estrogen level in offspring rats and results in higher blood pressure {Musha et 
al. 2006}. On the other hand, it was reported that insulin regulates some stress-responsive 
genes through induction of C/EBPβ {Du et al. 2009}. But how insulin regulates C/EBPβ 
is still not understood. Chamson-Reig A and colleagues had reported a sex-dependent 
difference in offspring pancreatic β-islet cell insulin synthesis/secretion and circulating 
insulin concentrations due to the reduced diet protein during gestation and lactation 
{Chamson-Reig et al. 2006}. In one of our previous studies, we observed increased 
glucose transporter 4 expression in female offspring skeletal muscle only by maternal low 
protein (not published), which may be a result of insulin-responsive gene expressions 
through regulating C/EBPβ {Liu et al. 2006}. Better understanding the role of C/EBPβ as 
transcription factor in muscle nutrient metabolism could also provides potential insight to 
explain the sex-specific difference in responding to the varied hormone levels in utero. 
We also considered that maternal behaviors may be affected by gestation diet. It was 
reported that well-nourished dams spend more time with LP pups in passive nursing and 
pup grooming than with control pups {Galler et al. 1991}. However, in our animals, we 
didn’t observe any obvious variation in maternal behaviors between LP and control 
groups. 
 
Maternal nutrition may also affect fetal skeletal muscle development, which involves 
myogenesis, adipogenesis, and fibrogenesis. C/EBPβ has been known as a transcription 
factor regulating adipogenesis {Du et al. 2010}. The sex-specific C/EBPβ expression in 
our study may associate with the different phenotypes of adipogenesis in offspring 
skeletal muscle. C/EBPβ promotes the differentiation of fibroblastic cells into adipocytes. 
C/EBPβ is induced during the initial phase of adipogenesis {Du et al. 2010}, but males 
and females have similar muscle growth until puberty {Tipton et al. 2001}. Maternal 
under-nutrition has been reported to manipulate the expression of myostatin, a negative 
regulator of muscle development, has recently been shown to effect fat deposition {Peiris 
et al. 2010}. High concentration of intramuscular fat content is highly related with type 2 
diabetes {Greco et al. 2002}. In our study, the induced C/EBPβ expression that occurred 
in female puberty rats by a maternal low protein diet, may provide more information 
about the effect of maternal nutrition on fat deposition during postnatal muscle 
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development, potentially implying the risk of type II diabetes.    
 
C/EBPβ acts as a transcription factor for many genes, such as those involved in nutrient 
metabolism. PEPCK, for example, is a very important enzyme participating in not only 
gluconeogenesis in liver but also significant local metabolisms in muscle, kidney, adipose 
and small intestine {Owen et al. 2002}. Following an overnight fast or caloric restriction, 
there is a net release of amino acid from the skeletal muscle. The released amino acids, 
however, do not reflect the composition of muscle protein, suggesting local metabolism 
and interconversion of amino acids in the skeletal muscle {Owen et al. 2002}. During 
exercise, although TCA intermediates increase from the entry of amino acids, the source 
of pyruvate needs to be replenished to maintain feeding into the TCA cycle. In muscle, 
PEPCK catalyzes the conversion of oxaloacetate to PEP, which is one of the sources of 
pyruvate, for re-feeding of the TCA cycle.   
       
C/EBPβ mRNA can produce at least three isoforms in rat liver, 38 kDa (LAP*), 35 kDa 
(LAP) and 20 kDa (LIP). LAP* and LAP contain both an activation domain and the bZIP 
domain, where LIP only contains the bZIP domain {Descombes et al. 1991}. Therefore, 
LIP forms a non-functional heterodimer with the other C/EBP members and inhibits 
C/EBP function. It was reported that the LIP content was increased and LAP content 
remained unchanged in the rat liver in response to reduced dietary protein {Marten et al. 
1996}. In our case, however, the LIP was not detectable in rat skeletal muscle. LAP A and 
LAP B were up-regulated, which was consistent with the elevated mRNA expression of 
C/EBPβ in LP female offspring muscle.  
 
We observed up-regulation of C/EBPβ at both mRNA and protein levels in offspring 
skeletal muscle in response to maternal protein restriction. An increased C/EBPβ mRNA 
level was found in rat hepatoma cells following incubation in amino acid limiting 
medium {Marten et al. 1994}. Also, Dr. Kilberg et al. has demonstrated that amino acid 
deprivation of mammalian cells leads to increased transcription of C/EBPβ, synthesis of 
total C/EBPβ protein and binding to the AARE within the ASNS promoter {Chen et al. 
2004}. The increase in C/EBPβ mRNA expression following amino acid response (AAR) 
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pathway activation is primarily due to increased transcription controlled by a 93 bp 
sequence containing a regulatory element that activates transcription in response to 
amino-acid-deprivation and to elevated activating transcription factor 4, ATF4. But in 
vivo, we did not observe altered ATF4 gene transcription under maternal low protein 
condition in offspring muscle (not shown). 
 
In conclusion, the data presented here provides evidence that a maternal low protein diet 
during gestation alters C/EBPβ expression in female offspring muscle at both the 
transcriptional and translational levels, as show through by QPCR and Western blotting. 
ChIP results reveal that the altered C/EBPβ gene expression was culminated from the 
mediation of histone code modifications at its promoter region. The alteration of PEPCK 
transcription via the enhanced binding of C/EBPβ at its promoter could potentially 
impact amino acid metabolism as well as energy homeostasis in skeletal muscle. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                              48
3.6 Tables & Figures 
 
Table 3.1 Composition of the two isocaloric diets 
     C, g/kg LP, g/kg 
Casein    180 90 
Folic acid   0.001 0.001 
Cornstarch  405 465 
Sucrose   213 243 
Choline   2 2 
Cellulose   50 50 
Corn oil   100 100 
D,L-Methionine  5 5 
Vitamin mix 10 10 
Mineral mix  35 35 
Total energy, kcal/kg   3868 3868 
 
 
 
 
Table 3.2 Primer sequence used in qPCR and ChIP assay 
Gene  
(Ensembl ID) 
Forward primer (5’ → 3’) 
Reversed primer (5’ → 3’) 
Purpose 
mRNA expression 
 
Histone modification  
at C/EBPβ promoter 
C/EBPβ  
(ENSRNOG00000025114) 
 
 
  
Transcription rate 
 
mRNA expression 
PEPCK 
(ENSRNOG00000028616) 
(+822) AGAACGAGCGGCTGCAGAAGA 
(+889) GAACAAGTTCCGCAGCGTGC 
(-834) ATGTTCCCACCGCAACCACC 
(-766) GACCCCAAGAAAGACCCGCAC 
(+822) AGAACGAGCGGCTGCAGAAGA 
(+889) GAACAAGTTCCGCAGCGTGC 
(+1177) CGAACGCCATTAAGACCATCCAG 
(+1253) CCAGTAAACACCCCCATCACTTGTC 
(-148) TGTTAGGTCAGTTCCAAACCGTGC 
(-66) TGGACCTGGAGGCTCGCC 
C/EBPβ binding  
at PEPCK promoter 
Table 3.3 Antibodies used in Western blot and ChIP assay 
Antibody Introduction & company Purpose 
C/EBPβ sc-150, Santa Cruz Biotechnology, Santa Cruz, CA Protein analysis  
H3Ac Anti-acetylated histone 3 at lysine 9, 14 residues; 06-599, 
Upstate, Temecula, CA 
H4Ac Anti-acetylated histone 4 at lysine 5, 8, 12 and 16 residues; 
06-866, Upstate, Temecula, CA 
H3K4Me2 Anti-di-methylated histone 3 at lysine 4 residues; 07-030, 
Upstate, Temecula, CA 
H3K9Me3 Anti-tri-methylated histone 3 at lysine 9 residues; cs200604, 
Upstate, Temecula, CA 
IgG sc-2027, Santa Cruz Biotechnology, Santa Cruz, CA 
Histone 
modifications 
analysis 
PoI II sc-899, Santa Cruz Biotechnology, Santa Cruz, CA PoI II analysis  
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Figure 3.1 Mothers food intake and offspring body weight  
A. Mothers daily food intake curve during gestation. B. Offspring body weight at birth
and at day 7, 15, 22 and 35 of postnatal life. The values represent the mean ± S.E.M.,
*p<0.05. 
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Figure 3.2 C/EBPβ and ATFs expression analysis 
A. C/EBPβ mRNA expression levels in offspring skeletal muscle, visceral adipose tissue and
liver (n=5, samples from 5 animals were tested in each of the two conditions). The bar values
represent the mean ± S.E.M.; *indicates comparison of C/EBPβ mRNA in pups of control
and LP groups, p<0.05. B. Expression of transcription factors in AAR pathway (n=5,
samples from 5 animals were tested in each of the two conditions). All the values represent
the mean ± S.E.M. after normalization by L7a. C. Real transcription rate of the C/EBPβ gene
(n=5, samples from 5 animals were tested in each of the two conditions). The values
represent the mean ± S.E.M., *p<0.05. 
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Figure 3.3 C/EBPβ protein content in female pup skeletal muscle by Western blot 
Expression of C/EBPβ protein, LAP A and LAP B, in female offspring skeletal muscle from LP
mothers versus control (n=5, samples from 5 animals were tested in each of the two
conditions). The bands represent the average level of C/EBPβ protein in control and LP
groups. LAP A and LAP B are isoforms of C/EBPβ protein, detected as multiple bands with
molecular mass from 36 to 45 kDa. For each protein sample the intensity of the C/EBPβ
bands were normalized against that of the actin band. LP protein levels were then expressed
as a ratio to control. The values represent the mean ± S.E.M., *p<0.05. 
C LP
C/EBPβ LAP B
C/EBPβ LAP A 50kDa
37kDa
Actin
C/EBPβ LAP A 
Pr
ot
ei
n 
ex
pr
es
si
on
(r
at
io
 to
 c
on
tr
ol
 a
fte
r 
no
rm
al
iz
ed
 b
y 
ac
tin
)
Control
LP
0
1
2
3
4
5
*
Pr
ot
ei
n 
ex
pr
es
si
on
(r
at
io
 to
 c
on
tr
ol
 a
fte
r 
no
rm
al
iz
ed
 b
y 
ac
tin
)
C/EBPβ LAP B 
0
1
2
3
4
5
Control
LP *
Pr
ot
ei
n 
ex
pr
es
si
on
(r
at
io
 to
 c
on
tr
ol
 a
fte
r 
no
rm
al
iz
ed
 b
y 
ac
tin
)
Pr
ot
ei
n 
ex
pr
es
si
on
(r
at
io
 to
 c
on
tr
ol
 a
fte
r 
no
rm
al
iz
ed
 b
y 
ac
tin
)
                                                                                              52
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    A.                                      B. 
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Figure 3.4 PoI II binding and histone modifications at the C/EBPβ promoter  
A. ChIP assay demonstrates binding of RNA polymerase II (Pol II), which is an enzyme
found in eukaryotic cells to catalyze the transcription of DNA at the C/EBPβ promoter
region in female offspring skeletal muscle. Normal rabbit antibody, IgG, was used as a
negative control to show non-specific binding. Data is shown as a ratio to the input DNA,
which acts as an internal control to eliminate DNA quantity variation. B. ChIP assay
demonstrates the changes of histone modifications at the C/EBPβ promoter region in
female offspring skeletal muscle. C. Histone modifications at the C/EBPβ promoter in
male offspring skeletal muscle. D. Histone modifications at the C/EBPβ promoter in
female offspring liver. Data is shown as a ratio to the input DNA (n=5, samples from 5
animals were tested in each of the two conditions). H4Ac: acetylated histone 4; H3Ac:
acetylated histone 3; H3K4Me2: di-methylated histone 3 at lysine 4 residues; H3K9Me3:
tri-methylated histone 3 at lysine 9 residues. The values represent the mean ± S.E.M.,
*p<0.05. 
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Figure 3.5 C/EBPβ binding at PEPCK promoter and PEPCK transcription level  
A. ChIP assay was used to test the binding status of C/EBPβ within the PEPCK gene
promoter in female offspring skeletal muscle. Normal rabbit antibody, IgG, was used as a
negative control to show non-specific binding. Data is shown as a ratio to the input DNA,
which acts as an internal control in order to eliminate DNA quantity variation. B.
Expression analysis of PEPCK mRNA in female offspring skeletal muscle of control
mothers versus LP mothers by qPCR. mRNA levels are shown as the ratio to L7a
housekeeping gene, which acts as an internal control to normalize total RNA variation
(n=5, samples from 5 animals were tested in each of the two conditions). The bar values
represent the mean ± S.E.M., *p<0.05. 
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Chapter 4. Protein Restriction during Gestation Alters Histone Modifications at the 
Glucose Transporter 4 (GLUT4) Promoter Region and Induces GLUT4 Expression 
in Skeletal Muscle of Female Rat Offspring 
 
4.1 Abstract 
 
Maternal nutrition during pregnancy is an intrauterine factor that results in alteration of 
the offspring genome and associates with disease risk in the offspring. Maternal nutrition 
restriction can lead to low birth weight, which is associated with increased risk of type II 
diabetes and cancer in offspring adult life. We investigated the impact of a maternal low 
protein (LP) diet on the expression of glucose transporter 4 (GLUT4) in offspring skeletal 
muscle. GLUT4 is an insulin-regulated glucose transporter involved in insulin sensitivity 
and carbohydrate metabolism in muscle cells. We observed sex-dependent GLUT4 
mRNA expression and increased GLUT4 protein content in female pup skeletal muscle 
with maternal low protein. Analysis of transcriptional and epigenetic regulation of 
increased skeletal muscle GLUT4 expression in offspring rats revealed the regulatory 
mechanisms involved. The protein level of myocyte enhancer factor 2A (MEF2A), which 
has been known as an activator of GLUT4 transcription via the ability to carry out 
specific binding to the GLUT4-MEF2 binding sequence, increased in female pups whose 
mothers were fed a low protein diet. Modifications of chromatin structure, including 
acetylated histone H3, acetylated histone H4 and di-methylated histone H3 at lysine 4, 
were detected at a significantly increased level at the GLUT4 promoter region in female 
pup muscle following a maternal low protein diet. Glycogen content was also detected as 
up-regulated, accompanied by increased glycogen synthase in LP female offspring 
muscle. However, the restricted diet did not activate the amino acid response pathway. 
These results document that maternal protein restriction during pregnancy induces 
GLUT4 expression in female offspring skeletal muscle but not in males, which may 
indicate sex-dependent adaptation of glucose metabolism to a low maternal protein diet. 
 
4.2 Introduction 
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Maternal nutrition deviation in pre- and postnatal periods is an important determinant of 
disease risk in adult life {Langley-Evans et al. 2006}. Nutrition restriction during fetal 
development can result in low birth weight, which has long-term consequences in postnatal 
life, including predisposition of offspring to obesity and type II diabetes {Ozanne et al. 
2005}. About 13% of U.S. births involve teen mothers, who are less likely to gain adequate 
weight during pregnancy, leading to low birth weight (CDC National Vital Statistics 
Report; Volume 57, No. 7). Through the use of animal models, nutritional deficiency 
research has demonstrated the development of insulin resistance in the skeletal muscle of 
offspring that suffered from intra-uterine growth restriction (IUGR) established by dietary 
calorie restriction {Raychaudhuri et al. 2008}. Epidemiology and experimental studies 
have indicated that a maternal LP diet during fetal and neonatal development in both 
humans and experimental animals impacts an offspring’s susceptibility to later 
development of altered carbohydrate metabolism {Dahri et al. 1991}.  
 
In a recent study, a maternal LP diet during pregnancy and/or lactation affects postnatal 
growth, appetite, triglyceride and cholesterol concentrations, as well as insulin resistance 
in male but not female offspring {Zambrano et al. 2006}. However, the molecular 
mechanism underlying the sex-differentiated carbohydrate metabolism and insulin 
sensitivity is rarely explained. The predominant adaptive mechanism could be aberrant 
glucose uptake into insulin-sensitive tissue; either skeletal muscle or adipocyte tissue 
{Thamotharan et al. 2005}. The major insulin responsive protein involved in glucose 
absorption is glucose transporter 4 (GLUT4). Insulin controls glucose homeostasis by 
regulating the translocation of GLUT4 from the intracellular pool to the plasma 
membrane {Shepherd et al. 1999}. The disruption of GLUT4 results in glucose 
intolerance and insulin resistance. Macronutrient content and composition of the diet has 
proven to influence the expression of the glucose transporter genes and insulin sensitivity. 
A recent study examined mechanisms involved in the reduction of skeletal muscle 
GLUT4 mRNA in IUGR female rat offspring from dams that received 50% daily food 
intake during pregnancy and lactation {Raychaudhuri et al. 2008}. In contrast, Kahn et al. 
found that calorie restriction in fasting adult rats down-regulates GLUT4 expression in 
adipose cells but up-regulates it in skeletal muscle {Charron et al. 1990}. Tissue-specific 
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regulation of glucose transporter expression was proposed to be an adaptive response to 
altered nutrient availability {Kahn et al. 1994}, although the molecular mechanism is less 
understood. Moreover, associations of maternal nutrition restriction with gene expression 
in the offspring of carbohydrate metabolism-related genes create more complications.  
 
There is growing evidence that maternal nutritional status can alter the epigenetic state of 
the offspring. The insulin resistance phenomena in IUGR female offspring has been 
shown to be transgenerationally transmitted {Thamotharan et al. 2007}. Histone 
modifications at the GLUT4 promoter have been observed, which result in the 
transcriptional repression in female offspring when adult pregnant rats were exposed to a 
low calorie diet {Raychaudhuri et al. 2008}. Therefore, the present study investigated the 
consequence of maternal protein restriction during teenage pregnancy on GLUT4 
transcriptional regulation and epigenetic modifications in offspring skeletal muscle, 
particularly histone modifications and DNA methylation. Raychaudhuri et al. showed that 
in female IUGR pups, skeletal muscle GLUT4 transcription was repressed, which is 
accompanied by de-acetylation and di-methylation of specific amino-acid residues in the 
N-tail of histone H3. Such histone modifications contribute to co-repressor complex 
formation and destruction of co-activator complex, decreasing GLUT4 transcription at 
both birth and through later life, which increases the offspring’s risk for pre-diabetes 
{Raychaudhuri et al. 2008}. In contrast, the present data demonstrates that maternal low 
protein intake (but not calorie restriction) up-regulates GLUT4 gene expression through 
chromatin modification programming specifically in females and alters glycogen content 
in offspring skeletal muscle. 
 
4.3 Material and Methods 
 
Animals and treatments 
The animal protocol for this study was approved by the International Animal Care and 
Use Committee (IACUC) at the University of Illinois. Timed-pregnant Sprague Dawley 
rats (Charles River Laboratories) were obtained on day 2 of gestation and weight 
matched into one of two isocaloric diets, control (180 g/kg casein) or low protein diet (LP, 
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90 g/kg casein), which were modified according to the AIN-76 diet formula throughout 
gestation (Table4.1). Each group contained 4 dams. Both groups had free access to rat 
chow and drinking water. Food intake was daily monitored by recording food left over. 
Animals were individually housed in standard polycarbonate cages with corncob bedding 
and maintained in the humidity and temperature controlled colony room on a 12 hr 
light-dark cycle. Twenty-four hours after newborn, 6 pups (3 female and 3 male) were 
selected and used in per litter to minimize variation in pups’ nutrition status during 
suckling. Pups body weight was measured once a week after birth. Both groups of 
mothers were switched to standard diet through lactation {Lillycrop et al. 2005}. At day 
24, in both experimental groups, the pups were weaned from the mother to a standard rat 
chow. To get enough sizes of tissues for sample analysis, pups were sacrificed when they 
were 38 days old. The gastrocnemius muscle of right hind leg, visceral adipose tissue 
(mesenteric) and liver were then collected, snap-frozen in liquid nitrogen, and stored at 
-70°C.  
 
RNA isolation and cDNA synthesis  
Frozen skeletal muscle samples were ground in a mortar and pestle with liquid nitrogen 
prior to total RNA isolation using TRI reagent (Sigma, St. Louis, MO). Following 
isopropanol (Fisher Scientific, Fair Lawn, NJ) precipitation, RNA was re-suspended and 
quantified by spectrophotometry (BIO-RAD Smart Spec Plus, Hercules, CA) at 
A260/A280. High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, 
Foster City, CA) was used for reverse transcription of 2 μg of total RNA. All samples that 
were to be compared were reverse transcribed from the same master reaction mixture at 
the same time with a ‘no RNA template’ tube as negative control. The whole procedure 
was performed in a DNA 2720 Thermal Cycler (Applied Biosystem). The samples at the 
20 μl reaction scale were heated at 37°C for 2 hr for reverse transcription procedure 
following 85°C for 5 seconds to inactive reverse transcriptase and terminate the reaction. 
The final 20 μl of cDNA was diluted up to 400 μl by nuclease free water and stored at 
-20°C. 
 
Real time quantitative RT-PCR (qPCR) 
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To measure the relative amount of mRNA, qPCR was performed with a 96-well plate in a 
7300 Real-Time PCR System (Applied Biosystem). The reactions were activated at 95°C 
for 10 min followed by 35 cycles of 95°C for 15 s and 60°C for 1 min. The mRNA level 
of ribosomal protein L7a was measured at the same time as the internal control. After 
PCR, a dissociation curve was generated by stepwise increase of the temperature from 
55°C to 95°C to ensure that a unique product was amplified in the reaction. Primer 
efficiency was determined by a standard curve from a dilution series and used for 
calculations of ΔCTs and ΔΔCTs. Primers used for PCR are shown in Table 4.2. 
 
Protein isolation and Western blotting 
Twenty-five milligrams of frozen muscle sample was ground in liquid nitrogen and put 
into 500 μl protein sample buffer (0.125 M Tris-HCl pH 6.8, 5% 2-mercaptoethanol, 1% 
SDS, 20% glycerol, 0.4% bromophenol blue, protease inhibitor). Protein was sonicated 
(Fisher Scientific model 100 Sonic Dismembrator, Pittsburgh, PA) on ice with 25 pulses 
at power setting 2. Lowry assay was used to determine protein content. Briefly, 1 ml 
ice-cold TCA was used to precipitate protein from 10 μl of sample buffer, and the 
supernatant was completely pouring out followed by 30 min speed dry. 100 μl of 0.2% 
SDS / 0.2 M NaOH was used to resolve protein pellet, 650 μl of Lowry Copper Reagent 
and 60 μl of 1 M Folin-Ciocalteu Reagent were then added for absorbance test. Samples 
containing 20 μg of protein were resolved by SDS-PAGE. After electrotransfer to a 
polyvinylidene fluoride membrane (0.2 μm, Bio-Rad) using a wet transfer protocol, 5% 
milk in TBS/T (30 mM Tris base pH 7.6, 200 mM NaCl and 0.1% Tween 20) was used to 
block the membrane for 1 hr at room temperature. The membrane was then incubated at 
4°C overnight with a 1:1000 dilution in 5% BSA of rabbit polyclonal antibody against 
GLUT4 or glycogen synthase; or 1:500 dilution in 5% BSA for antibody against MEF2 
(Table 4.3). The next day, the membrane was washed five times for 5 min with TBS/T on 
a shaker and then incubated with peroxidase-conjugated goat anti-rabbit secondary 
antibody (Kirkegaard & Perry Laboratories, Gaithersburg, MD) in 1% milk at a 1:10,000 
dilution for 1 hr at room temperature. The membrane was then washed five times for 5 
min each wash. The bound secondary antibody was detected using a SuperSignal West 
Dura Extended Duration Substrate kit (Thermo Scientific, Rockford, IL) and Western blot 
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images were captured and analyzed by a Chemi Doc system (Bio-Rad). An anti-actin 
antibody was used as an internal control to show the equality of protein levels loaded. 
 
Glycogen content assay 
Glycogen content in female offspring muscle was tested by using a Glycogen Assay Kit 
(BioVision #K646-100, Mountain View, CA). Frozen muscle tissue (8 mg) was ground in 
liquid nitrogen and homogenized with 200 μl dH2O on ice. The homogenates were boiled 
for 5 min to inactivate the enzymes. The boiled samples were spun at 13,000 rpm for 5 
min to remove insoluble material. Hydrolysis Enzyme Mix was added into supernatant 
and the standard that comes with the kit, and then the samples were incubated for 30 
minutes at room temperature. Development Reaction Mix (50 μl) was added to each well 
containing Glycogen Standard or samples. The mixtures were incubated at room 
temperature for another 30 minutes, protected from light. The samples and glycogen 
standard were measured with the colorimetrical OD value at 570 nm. The sample’s 
readings were applied to the standard curve to get the amount of glycogen.  
 
ChIP-qPCR  
ChIP (Chromatin immunoprecipitation) analysis was performed according to a modified 
protocol {Chen et al. 2004}. Briefly, 200 mg of frozen skeletal muscle samples were 
ground in liquid nitrogen and resuspended in PBS and cross-linked in 1% formaldehyde 
for 10 min at room temperature. The tissue pellet was re-suspended in nuclei swelling 
buffer (5 mM Pipes [NaOH] pH 8.0, 85 mM KCl, 0.5 % NP40) containing protease 
inhibitor. The separated nuclei were lysed in SDS lysis buffer (50 M Tris-HCl pH 8.1, 10 
mM EDTA, 1% SDS) containing protease inhibitors. The resultant chromatin was 
sonicated (Fisher Scientific model 100 Sonic Dismembrator, Pittsburgh, PA) on ice with 
6 bursts for 40 s at power setting 5, with 2 min cooling interval between each burst. The 
average length of sonicated chromatin was determined by resolving on a 1.6% agarose 
gel and found to be around 500 bp. The sample was then centrifuged at 13,000 rpm for 10 
min at 4°C to remove cell debris from the crude chromatin lysate. One milliliter of 
sheared chromatin was diluted in ChIP dilution buffer to total 10 ml. Ten percent of the 
diluted lysate was subsequently incubated overnight on a hematology mixer (346, Fisher 
                                                                                              64
Scientific) with 2 μg of primary antibodies at 4°C (see Table4.3 for antibody information). 
Pre-blocked salmon sperm DNA/protein A agarose beads (60 μl, 50% slurry; Upstate 
Biotechnology, Lake Placid, NY) were then added to the chromatin for 2 hr, followed by 
centrifugation at 2000 rpm for 1 min at 4°C. Supernatant of normal rabbit IgG was saved 
as the input control to reflect the total chromatin content for each sample. Chromatin pull 
down with antibodies for each sample was normalized as a ratio to its total chromatin 
content after real-time qPCR analysis. The pellets containing immunoprecipitated 
complexes were washed sequentially with 1 ml of low salt solution (0.1% SDS, 1% triton 
X-100, 2 mM EDTA, 20 mM pH 8.0 Tris-HCl, 150 mM NaCl), high salt solution (0.1% 
SDS, 1% triton X-100, 2 mM EDTA, 20 mM pH 8.0 Tris-HCl, 500 mM NaCl), and LiCl 
solution (0.25 M LiCl, 1% NP40, 1% sodium deoxycholate, 1 mM EDTA, 10 mM pH 8.0 
Tris-HCl) and TE (pH 8.0), twice. Antibody/protein/DNA complexes were eluted from 
Protein A agarose beads by twice adding 250 μl of the elution buffer (50 mM NaHCO3 
and 1% SDS) followed by shaking at 37°C at 300 rpm for 15 min and a flash spin down 
at room temperature. The combined supernatants were incubated at 65°C for 4-5 hr after 
addition of 20 μl of 5 M NaCl and 1 μg of RNase A to reverse the formaldehyde 
cross-linking and release the DNA fragments. Samples were then treated with proteinase 
K at 37°C for 1 hr to remove protein and purified with a Wizard SV Gel and PCR Clean 
up System (Promega).  
 
Quantitative real-time PCR was then performed to study modified histones and 
transcription factor binding to DNA. Enrichment of ChIP-ed DNA, which was pulled 
down by specific antibodies, then reflected the binding status of protein of interest within 
the GLUT4 promoter. 5% of immunoprecipitated DNA was used for each real-time PCR 
reaction. The standards and the ChIP-ed DNA samples were simultaneously amplified 
using the same reaction master mixture at 25 μl scale. Real-time qPCR data was then 
optimized for the amount of input material (total protein) and expressed as the ratio to 
input.  Primers used to amplify genomic sequences at the promoter region of GLUT4 
are shown in Table 2. Normal rabbit IgG antibody was used as the negative control, 
which indicates non-specific binding. Other antibodies were determined to be ‘no 
binding’ if their level was equal to or less than IgG (ratio to input). All antibodies were 
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from Upstate, except C/EBPb (Santa Cruz Biotechnology, Santa Cruz, CA). 
 
Transcriptional activity 
To measure the transcriptional activity from the GLUT4 gene, the method of Sandoval et 
al. {Sandoval et al. 2004} was used, which relies on ChIP analysis to examine RNA 
polymerase II (Pol II) binding at the coding region distal to the promoter. For this purpose, 
primers were designed within the protein coding region of the GLUT4 gene (Table 4.2). 
qPCR analysis was then performed using a 7300 real-time PCR system (ABI) and the 
product was detected with SYBR Green. Serial dilutions of input chromatin were used to 
generate a standard curve and the results were expressed as the ratio to input DNA. 
 
Statistical analysis  
Results are calculated as mean ± SEM. Comparisons of mRNA/protein expressions and 
histone modification between control and treated groups were performed by two-tailed 
t-test. All of the data in LP groups was expressed as the ratio to control. Significance 
testing was set at the p <0.05 level. 
 
4.4 Results 
 
Birth and body weight of offspring  
At birth, the control pups weighed 6.32 ± 0.19 g while the LP pups weighed slightly less, 
5.92 ± 0.09 g. As the pups grew to 15 days, average body weight was significantly lower 
in the LP pups than in the control (p=0.02). Table 4.1 compares the average of body 
weight at birth and at day 7, 15, 22 and 35 of postnatal life, showing that the average 
weights of the LP offspring were reduced by 12% at day 15, 16% at day 22 and 13% at 
day 35 (p<0.05) as compared to the control pups. There were no differences in the daily 
food intake, and the body weight of the dams during pregnancy (not shown). Litter size 
and litter sex distribution did not differ between the control and LP mothers (not shown).  
 
GLUT4 mRNA expression followed sex-dependent manner in offspring skeletal muscle 
under maternal low protein intake   
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GLUT4 mRNA expression has been reported to be decreased in female skeletal muscle 
by semi-restricted maternal food intake {Raychaudhuri et al. 2008}. However, whether 
regulation of GLUT4 gene expression by maternal protein restriction is sex-dependent in 
skeletal muscle has not yet been reported. We investigated GLUT4 mRNA levels in 
38-day-old female and male offspring skeletal muscle and adipose tissue by qPCR 
(Figure 4.1A). In female pups, a 1.59-fold increase (p=0.001) in GLUT4 mRNA content 
in skeletal muscle was observed in pups from litters of mothers with a restricted protein 
diet when compared to those of control mothers. However, in male offspring skeletal 
muscle, there was no change of GLUT4 mRNA level related to maternal low protein. 
Also, in female offspring adipose tissue, a 1.45-fold increase (p=0.03) of GLUT4 mRNA 
was detected by maternal protein restriction, but it did not alter in male offspring. Since 
the amount of visceral adipose in a 38-day-old rat is not enough to do all of the assays 
involved in this study, we focused on skeletal muscle to examine the molecular 
mechanisms of GLUT4 regulation by maternal protein restriction. 
 
The affect of maternal low protein on the transcription rate of GLUT4   
To confirm the real transcriptional activity for the GLUT4 gene, ChIP DNA samples were 
used to monitor RNA polymerase II binding within the coding region. This analysis 
showed that the transcription rate was increased approximately 2.89-fold in female pup 
muscle as the result of maternal low protein diet (Figure 4.1B). Therefore, the increased 
transcription appears to account for most of the induction in GLUT4 mRNA following 
maternal low protein diet. 
  
Maternal low protein alters GLUT4 protein level in female offspring   
To detect GLUT4 protein content in pup skeletal muscle, protein samples were subjected 
to Western blot analysis using an anti-GLUT4 antibody. In all muscle samples, GLUT4 
was detected as one major band with a molecular mass of about 45 kDa (Figure 4.2). The 
ratio of GLUT4 protein level between female control and LP groups was determined to 
be 1:1.78 (Figure 4.2A; p=0.008). A significantly higher GLUT4 protein content in the 
skeletal muscle of female LP pups was consistent with the trend observed in its mRNA 
expression. Moreover, GLUT4 protein levels in male pup muscle were unchanged, which 
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also corresponds to the unchanged male offspring mRNA expression levels (Figure 
4.2B).  
 
Glycogen synthase expression in rat offspring muscle   
Glycogen synthase is an enzyme that incorporates glucose molecules into the glycogen 
particle. Recent studies suggested that glucose transport is the rate-limiting step for 
muscle glycogen synthesis {Price et al. 1996}. Therefore, the expression level of 
glycogen synthase was investigated in the offspring of maternal LP and control diets. 
Glycogen synthase levels were enhanced in the muscles of female offspring in the LP 
group, with mRNA and protein levels increase by 1.29- and 7.56-fold, respectively 
(Figure 4.3A and 4.3B). In male pups, no significant variation was observed. Since 
glucose-6-phosphate is the pre-substrate used for glycogen synthesis and is converted 
from glucose by the enzyme hexokinase, the hexokinase expression level was checked as 
well (not shown). However, there was no difference in hexokinase expression between 
LP and control groups in female offspring.  
 
Glycogen content increased in female offspring muscle by maternal protein restriction 
Skeletal muscle is the main tissue for glycogen storage, and contains 2 to 4 times more 
glycogen than the liver. The amount of glycogen was tested using a Glycogen Assay Kit. 
The results show that the glycogen content in female offspring skeletal muscle was 
increased by 35% (Figure 4.3C; p=0.018) in the maternal LP group. Thus, the potential 
physiological impact was demonstrated as corresponding to the altered GLUT4 
expression in the offspring muscle.   
 
No interaction of C/EBPb protein at the GLUT4 gene promoter 
According to the data that we previously published, amino acid response (AAR) pathway 
was not activated in female offspring muscle by this maternal protein-restricted animal 
model {Zheng et al. 2011}. But as a cofactor for ATF3 and ATF4 in the AAR pathway, 
we did observe significantly increased expression of C/EBPb mRNA in female offspring 
muscle from the maternal low protein group. To identify whether or not the increased 
C/EBPb expression could contribute to the altered GLUT4 transcription in female 
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offspring muscle, because C/EBPb also acts as a mediator in regulating carbohydrate 
metabolism in skeletal muscle independent of the AAR pathway, ChIP assay was 
performed using rabbit polyclonal antibody against C/EBPb (see Table 4.3 for antibody 
information). In Figure 4.4, the ATF3 gene was used as a positive control as it has been 
known to be regulated through direct binding by C/EBPb. The binding of C/EBPb at the 
GLUT4 promoter was found to not be present (<IgG of 0.02 ratio to input), suggesting 
that C/EBPb does not bind to the GLUT4 promoter in our case.  
 
Transcriptional enhancer - MEF2A was increased in female offspring muscle  
To further investigate the potential mechanism that contributed to the up-regulated 
GLUT4 expression, myocyte enhancer factor 2A (MEF2A), which is known as a 
transcriptional enhancer to carry out specific binding to the GLUT4 MEF2 binding 
sequence {Moreno et al. 2003}, was tested by western blot. Figure 4.5 shows that MEF2 
protein content was also increased 1.7-fold in female offspring of protein-restricted 
mothers. Since the binding of MEF2 is required for normal GLUT4 expression, the 
increased MEF2 protein could contribute to the up-regulated GLUT4 expression. We also 
tried to test the exact binding of MEF2 at GLUT4 promoter by using CHIP assay. There 
was, however, no commercial working antibody for us.  
 
Histone modifications on GLUT4 promoter in rat offspring muscle  
ChIP assays were performed to investigate the in vivo Pol II binding status at the GLUT4 
promoter. PoI II binding at the GLUT4 promoter region in female offspring skeletal 
muscle with maternal low protein was increased 1.46-fold compared to control (Figure 
4.6A; p=0.04). Data were consistent with the increased GLUT4 mRNA expression. Since 
Pol II binding status at a promoter is often regulated by chromatin structure, 
methylated-histone or acetylated-histone antibodies were used in the ChIP assay at the 
GLUT4 promoter from maternal low protein and control diet offspring. 
 
ChIP assays were performed with antibodies specific for histone modifications associated 
with either enhanced gene transcription [acetylated histone H3 (H3Ac), acetylated 
histone H4 (H4Ac), and di-methylated histone H3 at lysine 4 residues (H3K4Me2)] or 
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transcriptional repression through diminished methylation [tri-methylated histone H3 at 
lysine 9 residues (H3K9Me3)]. Increases in both acetylated histone H3 and acetylated 
histone H4 were observed in the muscle of female pup from dams fed a LP diet versus the 
control, by 2.11- and 1.81-fold (p<0.05), respectively (Figure 4.6A). Methylation of 
histone H3 lysine 4 was also increased with maternal low protein (1.66-fold; p<0.05), but 
no difference was detected at lysine 9 of histone H3. In male offspring, histone code 
modifications did not differ at the GLUT4 promoter region (Figure 4.6B). Comparison of 
histone modifications between female and male offspring from control mothers also 
revealed that the basal acetylations of histone H3 and H4 were lower in males, while the 
methylation levels of histone H3 were similar between sex.    
 
4.5 Discussion 
 
Skeletal muscle is the most important tissue responsible for whole body glucose uptake in 
humans {Shulman et al. 1990} and rodents {Kraegen et al. 1985}. Insulin resistance is 
associated with decreased glucose uptake in insulin-sensitive tissues, i.e., skeletal muscle 
{Bell et al. 2001}. In the present study, we investigated GLUT4 gene expression and 
modifications of histones within the promoter in female and male pups with maternal 
protein restriction. This study demonstrates for the first time that GLUT4 gene expression 
is significantly higher in the skeletal muscle of female offspring subjected to in utero 
maternal protein restriction. We also showed that there are sex-dependent modifications 
to the GLUT4 promoter region and that this epigenetic change significantly increases the 
expression of GLUT4 mRNA only in female pups with maternal low protein. This new 
observation suggests that skeletal muscle in female pups might have greater capability to 
make GLUT4 transporter when more glucose transporters are needed, reflecting an 
adaptation to protein restriction first, and only, encountered during gestation. It is 
interesting to think that an estrogen-involving signaling pathway may influence this 
response in a sex-specific manner. Estrogen has been reported to increase expression of 
plasma membrane GLUT4 and to boost carbohydrate metabolism {Barros et al. 2006}. 
Considering the critical role environment plays in fetus development, the observed sex 
difference in gene expression in offspring may also be due to gender-specific perturbation 
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of placental function, an idea supported by the reported alteration in gene expression 
patterns, including increased GLUT4 expression, that occurred in the placentas of male 
fetuses upon early pregnancy stress {Mueller et al. 2008}.   
 
In this study, we investigated the potential involvement of a cofactor, C/EBPb protein, in 
amino acid response pathway on altering GLUT4 expression as a consequence of 
maternal LP diet. C/EBP proteins are also involved in a wide range of cellular processes, 
such as cellular proliferation, carbohydrate metabolism, adipocyte differentiation and 
inflammation {Ramji et al. 2002}. In our case, however, we previously found no change 
in ATF gene expression upon maternal protein restriction in offspring muscle. We did 
observe a significant increase of C/EBPb in LP female offspring muscle. However, ChIP 
assays revealed that the C/EBPb protein does not interact with the GLUT4 promoter. The 
xChIP assay we performed is designed to cross-link all the interacting factors, including 
those that are not directly bound with the DNA sequence. Therefore, the mechanism 
regulating the GLUT4 gene may not involve C/EBPb as a transcription factor. 
 
It was established through transgenic investigations that conserved GLUT4 promoter 
regions play a crucial role in its expression in skeletal muscle. Myocyte enhancer factor 2 
(MEF2) is a required transcription factor for normal GLUT4 expression. In skeleton 
muscle, MEF2A has the ability to specifically bind to the GLUT4 MEF2 binding 
sequence to activate GLUT4 transcription in conjunction with the binding of GLUT4 
enhancer factor to domain 1, located upstream of the MEF2 binding site {Knight et al. 
2003}. Disruption of the MEF2-binding site turned off tissue-specific GLUT4 expression 
{Thai et al. 1998}. In our rat model, we observed the total MEF2A protein level 
increased in LP offspring muscle. In another rat study, Holmes B. F. et al. also observed 
roughly two-fold increase in total MEF2 protein upon stimulation of AMP-activated 
protein kinase in muscle {Holmes et al. 2005}. Correspondingly, nuclear MEF2A protein 
increased five-fold and MEF2 binding to the GLUT4 consensus sequence increased 
two-fold. In a transgenic mice model, the protein levels of MEF2, determined by western 
blot using a MEF2A antibody were decreased in the diabetic state and recovered 
following insulin treatment {Thai et al. 1998}. The binding activities of MEF2 to GLUT4 
                                                                                              71
reflect its protein level changes. Thus, increase of MEF2A total protein level we observed 
might suggest that MEF2A is an important transcription factor that activates GLUT4 in 
LP pup's skeleton muscle in response to maternal protein restriction.  
 
The myogenic differentiation factor D (MyoD) was reported to bind MEF2 and thyroid 
hormone receptor a1 (TRa1), synergistically driving gene expression for myogenesis, 
which would include skeletal muscle GLUT4 transcription {Santalucia et al. 2001}. 
There is also a MyoD binding site in the GLUT4 promoter region, proximal to the 
MEF2-binding site. However, we only observed marginally enhanced binding of MyoD 
protein to the GLUT4 promoter region in LP offspring with results close to significant 
(not shown).  
 
Sex-specific histone modifications at the GLUT4 promoter, as observed in our study, may 
prove to be the key changes in nuclear protein-GLUT4 promoter interaction. Such 
modifications include increased levels of acetylated histone H3, acetylated histone H4 
and di-methylated histone H3 at lysine 4 in female offspring rats following a maternal LP 
diet. Most importantly, the histone status perturbations may be memorized in the fetus 
and remain in the adult female offspring. The trans-generation transmitted insulin 
resistant phenotype of the IUGR adult female offspring has suggested similar epigenetic 
alternations on histones. In contrast to our study, diminished skeletal muscle GLUT4 
mRNA in IUGR female rat offspring was related to H3K14 de-acetylation and 
di-methylation of H3K9. It is worth to note that histone hypermethylation has both 
stimulatory and inhibitory effects on gene transcriptions, dependent on methylation sites 
on different lysines in histone H3. H3K4 methylation will generally induce gene 
transcription whereas H3K9 methylation will silence gene transcription. Nevertheless, 
both studies showed that histone modification caused by maternal diet could alter 
offspring GLUT4 expression and potentially disturb carbohydrate metabolism in skeleton 
muscle. However, the epigenetic consequences could differ substantially based on diet 
constitutions and diet quantities. On the other hand, the basal acetylations of histone H3 
and H4 were low in male offspring of control mothers with comparison to female 
offspring. This might suggest that, within GLUT4 gene promoter, females have relatively 
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more opened chromatin structure than males to recruit other transcription factors.  
 
The rate limiting reaction for the formation of muscle glycogen has been generally 
considered to be the transfer of glucose from UDP-glucose to an amylase chain, a 
reaction mediated by glycogen synthase {Ren et al. 1993}. However, it has been 
suggested that glucose transport rather than glycogen synthase activity is rate limiting for 
muscle glycogen synthesis. For example, total GLUT4 protein content in muscle has been 
investigated in numerous studies to understand the long-term metabolic and functional 
consequences on intracellular substrate utilization, glycogen synthesis and glycogen 
content for example. In transgenic mice, over expression of GLUT4 resulted in an 
increase in muscle glycogen concentration 20% above the level of the non-transgenic 
mice {Hansen et al. 1995}. Glycogen synthesis rate was 50% faster in the muscle of 
transgenic mice that over expressing GLUT4 than control mice. In addition, 
up-regulation of GLUT4 in fast-twitch muscle resulted in a 2.5-fold increase in glycogen 
storage in muscle {Tsao et al. 1996}. In our data, total expression of glycogen synthase 
and glycogen content were both up-regulated in female offspring by a low protein 
maternal diet. This up-regulation in glycogen storage may be closely associated with the 
up-regulation of total GLUT4 content. According to our previous study, gestational 
protein restriction did not cause any difference on either dams’ or pups’ glucose or insulin 
level (data unpublished). In this study, the low protein diet was used for gestation period 
only and all of dams were put onto a standard rat chew throughout the lactation. Thus, we 
studied total GLUT4 content and glycogen storage, which may reflect a sex-dependent 
adaptation in offspring to gestational protein restriction on long-term metabolic and 
functional consequences.  
 
Overall, maternal low protein intake (but not calorie restriction) up-regulates GLUT4 
gene expression through chromatin modification programming specifically in female 
offspring skeletal muscle and induces an increase of glycogen synthase and glycogen 
content. Expressions of regulatory genes associated with carbohydrate metabolism, 
C/EBPβ and MEF2A, increased in LP female pup skeletal muscle. These results strongly 
indicate sex-dependent adaptation of glucose metabolism to a low maternal protein diet. 
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4.6 Tables & Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.1 Offspring body weight  
Age (days)  Body weight (g)
   
 C (4) LP (4) p 
Birth (day 0) 6.32 ± 0.19 5.92 ± 0.09 0.11 
7 16.55 ± 0.69 14.89 ± 0.46 0.10 
15 35.06 ± 1.14 30.73 ± 0.70 0.02 
22 59.37 ± 1.40 49.98 ± 1.63 0.006 
35 138.56 ± 2.58 125.21 ± 3.54 0.006 
Number of litters shown in parentheses. Body weight was shown as 
the average value at the specific day. Data are means with ± S.E.M. 
Significance testing was set at p<0.05 derived from two-tail t-test. 
Table 4.2 Primer sequence used in qPCR and ChIP assay 
Gene (Ensembl ID) Forward primer (5’ → 3’) 
Reversed primer (5’ → 3’) 
Purpose 
GLUT4 
(ENSRNOG00000017226) 
CCATAGGAGCTGGTGTGGTCAATAC 
TCGCCCAGCTCGCTCTACTAAG 
ATF3 
(ENSRNOG00000003745) 
GGTGTCTGCACTGTGGGATGTTAAC 
GCTGAAATACTCTGGACCGCATCTC 
ATF4 
(ENSRNOG00000017801) 
GTTCCCCAGGGTTTCTGTCTTC 
CAACCTCACTTCCCAGCTCTAAAC 
C/EBPβ 
(ENSRNOG00000025114) 
AGAACGAGCGGCTGCAGAAGA 
GAACAAGTTCCGCAGCGTGC 
L7a 
(ENSRNOG00000005071) 
GAGGCCAAAAAGGTGGTCAATCC 
CCTGCCCAATGCCGAAGTTCT 
GYS1 
(ENSRNOG00000020812) 
TTGGGACACCTGCAACATC 
ACAGGACGGCATCATTGG 
mRNA expression 
 
ATF3 
(ENSRNOG00000003745) 
GGCCAGTTCTCCCTGGAAGCTAT 
CCCGCTTAACTCCTGGTTACCAAT 
Gene promoter 
GLUT4 
(ENSRNOG00000017226) 
CTTCAGCTCTCCGCATCTTTCC 
CACTGCCACAACCCAAGGAAC 
Gene promoter 
GLUT4 
(ENSRNOG00000017226) 
CTTCAGCTCTCCGCATCTTTCC 
CACTGCCACAACCCAAGGAAC 
histone modification 
GLUT4 
(ENSRNOG00000017226) 
GGGTGCCTTGGGAACACTCAAC 
CAACACCTGGGCAACCAGAATG 
transcription rate 
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Table 4.3 Antibodies used in Western blot and ChIP assay 
Antibody Introduction & company Purpose 
GLUT4 Cat # 2299, Cell Signaling Technology, 
Beverly, MA 
Glycogen synthase Cat # 3893, Cell Signaling Technology, 
Beverly, MA 
MEF2 Cat # sc-313, Santa Cruz Biotechnology, 
Santa Cruz, CA 
Protein analysis 
by Western  
C/EBPβ sc-150, Santa Cruz Biotechnology, Santa 
Cruz, CA 
C/EBPβ binding at 
GLUT4 gene promoter 
H3Ac Anti-acetylated histone 3 at lysine 9, 14 
residues; 06-599, Upstate, Temecula, CA 
H4Ac Anti-acetylated histone 3 at lysine 5, 8, 12 
and 16 residues; 06-866, Upstate, 
Temecula, CA 
H3K4Me2 Anti-di-methylated histone 3 at lysine 4 
residues; 07-030, Upstate, Temecula, CA 
H3K9Me3 Anti-tri-methylated histone 3 at lysine 9 
residues; cs200604, Upstate, Temecula, 
CA 
IgG sc-2027, Santa Cruz Biotechnology, 
Santa Cruz, CA 
Histone modifications 
analysis 
PoI II sc-899, Santa Cruz Biotechnology, Santa 
Cruz, CA 
PoI II analysis  
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Figure 4.1 GLUT4 mRNA expression and transcription rate  
A. Expression of GLUT4 mRNA in offspring skeletal muscle and adipose tissue from LP
mothers versus control (n=5). mRNA levels are expressed as mean ratio to control after
normalization by L7a. B. The transcription rate of the GLUT4 gene was analyzed by testing
the PoI II binding at the coding region. Data shown as a ratio to the input DNA. The values
represent the mean ± S.E.M., *p <0.05. 
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Figure 4.2 GLUT4 protein content by Western blot  
A. Expression of GLUT4 protein level in female offspring skeletal muscle from LP mothers
versus control. The bands shown represent the average level of GLUT4 protein in control
and LP groups (n=6). B. Expression of GLUT4 protein level in male offspring skeletal muscle
from LP mothers versus control. The bands represent the average level of GLUT4 protein in
control and LP groups (n=6). LP protein levels are expressed as mean ratio to control. The
values represent the mean ± S.E.M., *p <0.05. 
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Figure 4.3 Glycogen synthase expression and glycogen content 
A. Expression of glycogen synthase mRNA in offspring skeletal muscle from LP mothers
versus control (n=5). LP mRNA levels are expressed as mean ratio to control after
normalized by L7a. B. Expression of glycogen synthase protein level in female offspring
skeletal muscle from LP mothers versus control. The bands shown represent the
average level of glycogen synthase protein in control and LP groups (n=6). 3C.
Glycogen content in female offspring skeletal muscle from LP mothers versus control
(n=5). The values represent the mean ± S.E.M., *p <0.05. 
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Figure 4.4 Interaction of C/EBPβ protein at the GLUT4 gene promoter  
Binding of C/EBPβ at the GLUT4 promoter in female offspring muscle. Data is shown as a
ratio to the input DNA. The ATF3 gene was used as a positive control. All the values
represent the mean ± S.E.M.
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Figure 4.5 MEF2 protein content by Western blot  
Expression of MEF2 protein level in female offspring skeletal muscle from LP mothers
versus control. The bands shown represent the average level of MEF2 protein in control
and LP groups (n=6). LP protein levels are expressed as mean ratio to control. The
values represent the mean ± S.E.M., *p <0.05. 
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Figure 4.6 Chromatin modifications within GLUT4 gene promoter  
ChIP assay demonstrating histone modifications and binding of PoI II at GLUT4
promoter region in offspring skeletal muscle. Data is shown as a ratio to the input
DNA. Data is plotted as the increase relative to control. NC was negative control by
testing the up-stream 5kb region of GLUT4 genome. H4Ac: acetylated histone H4;
H3Ac: acetylated histone H3; H3K4Me2: di-methylated histone H3 at lysine 4;
H3K9Me3: tri-methylated histone H3 at lysine 9; PoI II: RNA polymerase II. All the
values represent the mean ± S.E.M., *p <0.05 (n=5). 
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Chapter 5. Histone Modifications, not DNA Methylation, Cause Transcriptional 
Repression of p16 (CDKN2A) in the Mammary Glands of Offspring of 
Protein-Restricted Rats 
 
5.1 Abstract 
 
Maternal nutrition during pregnancy is an important intrauterine factor that results in 
persistent alteration of the offspring epigenome and that associates with health outcome 
in later life. This study examined the effect of maternal low-protein diet on the regulation 
of p16 (CDKN2A) gene expression in the mammary gland of offspring rats. 
Timed-pregnant Sprague Dawley rats were fed during gestation one of two isocaloric 
diets, control (18% casein) or low-protein (LP, 9% casein). The expression of p16 
(CDKN2A) mRNA in mammary gland of the LP offspring was decreased 75% versus 
control. We also detected declined p16 (CDKN2A) protein content in the mammary 
glands of pups gestated under the low-protein diet. Analysis of transcriptional and 
epigenetic regulation in offspring rats with maternal low-protein diet revealed the 
regulatory mechanisms underlying decreased p16 (CDKN2A) expression. Chromatin 
immunoprecipitation (ChIP) assay demonstrated that the altered p16 (CDKN2A) mRNA 
level and transcription rate in LP offspring resulted from histone code changes, including 
the reduced acetylation of histone H4 and the di-methylation of histone H3 at lysine 4 
residues within the p16 (CDKN2A) promoter region. These results supported the 
hypothesis that maternal protein restriction during pregnancy programs p16 (CDKN2A) 
expression through histone code alterations in offspring mammary gland. 
 
5.2 Introduction 
 
Recently documented developmental origins of adult human diseases have emphasized 
the effects of maternal nutrition during fetal development on long-term health outcome in 
offspring. Epigenetic regulations mediated by macro- or micro-nutrients are increasingly 
recognized as prenatal mechanisms that program offspring susceptibility to disease 
development {Chavatte-Palmer et al. 2008}. Offspring gene expression alterations, 
stemming from changes in either DNA methylation or histone modifications, have been 
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reported in the rat liver, kidney, skeletal muscle and adrenal gland following a restricted 
diet during gestation {Lillycrop et al. 2005; Raychaudhuri et al. 2008; Burdge et al. 
2007}. These epigenetic events have been shown to affect tumor suppressor loci in 
mammary gland cancer cells, including p16 (CDKN2A), E-cadherin and BRCA1, {Foster 
et al. 1998; Hiraguri et al. 1998; Dobrovic et al. 1997}. However, it is not known how 
these tumor suppressive genes are regulated by epigenetic changes in the mammary 
glands in vivo under maternal low-protein diet.  
 
The prenatal period is critical in the development of the mammary gland. Findings with 
experimental rodent models revealed that exposures to dietary factors during the in utero 
and pubertal periods, when the mammary gland is undergoing extensive modeling and 
re-modeling, alter susceptibility to mammary tumor development {Hilakivi-Clarke et al. 
2007}. p16 (CDKN2A), a cyclin-dependent kinase inhibitor encoded by CDKN2A 
(INK4a/ARF), binds to cyclin/cdk4 or cyclin/cdk6 kinase complexes, thereby blocking 
their kinase activity and inhibiting cell-cycle progression at the G1/S boundary 
{Voorhoeve et al. 2004; Voorhoeve et al. 2003; Tsellou et al. 2008}. Although recent 
studies demonstrated that regulation of p16 (CDKN2A) and cyclin D1 is critical for 
growth arrest during mammary involution {Gadd et al. 2001}, the role of p16 (CDKN2A) 
in mammary gland growth before puberty is poorly understood. p16 (CDKN2A) and p53 
are two examples of genes that are frequently inactivated in many tumor types, including 
mammary carcinomas {Rocco et al. 2001}. The inactivation of p16 (CDKN2A) and p53 
occurs through a variety of mechanisms, including point mutation, deletion and 
epigenetic silencing {Zhang et al. 2006}. Recently, the Ozanne group {Fernandez-Twinn 
et al. 2007} reported that compensatory mammary growth in the offspring following 
protein restriction during both pregnancy and lactation increased the number of 
early-mammary tumors. The increased incidence of mammary tumors was accompanied 
by elevated expression of receptors to insulin, IGF-1, epidermal growth factor and 
estrogen. This report became the first study on the effect of maternal low-protein on 
mammary cancer development and provided an extremely relevant model for further 
study of such processes and, ultimately, the development of potential interventions.  
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In the present study, we employed a well-established model {Lillycrop et al. 2005; 
Fernandez-Twinn et al. 2007} to measure the effect of maternal protein restriction during 
pregnancy on the promoter chromatin status and expression of p16 (CDKN2A) in the 
mammary gland of the offspring after weaning. Our present study took advantage of the 
clinical features of the rat maternal low-protein model and addressed the mechanistic 
question by uncovering changes in epigenetic regulation related to p16 (CDKN2A). The 
results obtained from our analysis support that maternal low-protein programs p16 
(CDKN2A) gene expression in offspring mammary glands through histone modifications 
and transcriptional repression. 
 
5.3 Material and Methods 
 
Animal and diet   
Timed-pregnant Sprague Dawley rats (Charles River Laboratories) were obtained at day 
2 of gestation and fed one of two isocaloric diets, control (180 g/kg casein) or low-protein 
(LP, 90 g/kg casein) as described by Lillycrop, et al. {Lillycrop et al. 2005} throughout 
gestation. Both groups had ad lib access to food and drinking water. Animals were 
individually housed in standard polycarbonate cages and maintained in a humidity- and 
temperature-controlled room on a 12-hour light-dark cycle. Pups were weighed on a scale 
within 12 hours of birth and returned to their mother. Twenty-four hours after birth, the 
litters were limited to 6 pups to minimize variation in pups’ nutritional status during 
suckling. Dams were all fed a standard diet through lactation {Lillycrop et al. 2005}. At 
day 24, in both experimental groups, the pups were weaned from the dams and 
maintained with the same standard diet. When the pups were 38 days old, female pups 
were sacrificed, and the fourth abdominal mammary gland was collected, snap-frozen in 
liquid nitrogen, and stored at -70°C.  
 
RNA isolation and one-step real time quantitative PCR (qPCR)   
Frozen mammary gland samples were ground with a mortar and pestle in liquid nitrogen 
before total RNA was isolated with TRI reagent (Sigma, St. Louis, MO). For 
quantification, 25ng template RNA per well was mixed with iTag SYBR Green Supermix 
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with ROX (Bio-Rad, Hercules, CA), which is a dye that can bind to dsDNA generated 
during amplification, in a 96-well plate on a 7300 Real-Time PCR System (Applied 
Biosystem, Foster City, CA). The samples were first incubated at 48°C for 30 min for 
reverse transcription to take place. To determine the exponential phase of amplification, 
kinetic analysis was conducted for the different primers. Total cDNA was denatured and 
hot start RNA polymerase was activated at 95°C for 10min, followed by 35 cycles of 
95°C for 15 s and 60°C for 1 min. To ensure that a unique product was amplified in the 
reaction, dissociation curves were generated after PCR by stepwise increase of the 
temperature from 55°C to 95°C. Primers used for PCR are shown in Table 5.2. 
 
Protein isolation and Western blotting 
25 mg of frozen mammary gland sample was ground in liquid nitrogen and put into 500 
μl of protein sample buffer (0.125 M Tris-HCl pH 6.8, 5% 2-mecaptoethanol, 1% SDS, 
20% glycerol, 0.4% bromphenol blue, protease inhibitor). Protein was sonicated (Fisher 
Scientific model 100 Sonic Dismembrator, Pittsburgh, PA) on ice with 25 pulses at power 
setting 2. Lowry assay was used to determine protein content and samples containing 20 
μg of protein were resolved by SDS-PAGE. After electrotransfer to a polyvinylidene 
fluoride membrane (0.2 μm, Bio-Rad) using a wet transfer protocol, incubation in 5% 
milk in TBS/T (30 mM Tris base pH 7.6, 200 mM NaCl and 0.1% Tween 20) was 
performed for 1 hr at room temperature to block the membrane. The membrane was then 
incubated with mouse monoclonal antibody against p16 (CDKN2A) (sc-81156, Santa 
Cruz Biotechnology, Santa Cruz, CA) in 5% BSA at a 1:200 dilution at 4°C overnight. 
The next day, the membrane was washed five times for 5 min with TBS/T on a shaker 
and then incubated with peroxidase-conjugated goat anti-mouse secondary antibody 
(Kirkegaard & Perry Laboratories, Gaithersburg, MD) in 1% milk at a 1:5,000 dilution 
for 1 hr at room temperature. The membrane was then washed 5 times for 5 min. The 
bound secondary antibody was detected using a SuperSignal West Dura Extended 
Duration Substrate kit (Thermo Scientific, Rockford, IL) and western blot images were 
captured and analyzed by a Chemi Doc system (Bio-Rad). 
 
Methylation sensitive PCR   
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Methylation analysis was performed using a modified Methylation Sensitive PCR (MSP) 
protocol, based on digesting DNA with methylation sensitive enzymes and subsequently 
performing qPCR to detect DNA methylation. Following cleavage with 
methylation-specific endonucleases, promoter-specific PCR primers amplify intact 
genomic DNA, while genomic DNA that had been cleaved by one of the two restriction 
endonucleases remained unamplified. Briefly, DNA was isolated from the mammary 
gland samples and quantified using a Spectrophotometer (Bio-Rad, SmartSpec Plus). 
DNA was digested with either AciI or HhaI restriction enzymes, which are unable to cut 
at methylated sites (New England BioLabs, Ipswich, MA), using buffer 3 and 4, 
respectively.  Both “cut” and “uncut” samples were incubated in the appropriate buffer 
for 1 hr at 37°C and then incubated at 65°C to halt enzyme activity. Digestion longer than 
1 hr has been employed without any deleterious consequence (data not shown). 
Following enzyme digestion, samples were analyzed by qPCR using a 7300 Real-Time 
PCR System (Applied Biosystem). Detection of amplified products was enabled by 
SYBR Green fluorescent dye. To ensure specificity, a no-template control was included. 
The PCR amplification was performed in a 96-well optical plate with a 20 µl reaction 
volume. PCR was performed at the following conditions: 95°C for 10 min, followed by 
45 cycles at 95°C for 1 min; 60°C for 10 s. To ensure amplification of desired products, a 
dissociation curve was generated following the real-time reaction with a temperature 
range of 55°-95°C. The amount of methylation is shown as the % ratio of cut/uncut DNA 
normalized to control in each dietary treatment. 
 
Chromatin immunoprecipitation (ChIP)   
In order to determine whether a given protein binds to a specific DNA sequence in vivo, 
ChIP analysis was performed according to a modified protocol {Chen et al. 2004}. 
Briefly, 200 mg of frozen mammary gland was ground in liquid nitrogen, re-suspended in 
PBS and cross-linked in 1% formaldehyde for 10 min at room temperature. The tissue 
pellet was re-suspended in nuclei swelling buffer (5 mM Pipes [NaOH] pH 8.0, 85 mM 
KCl, 0.5 % NP40) containing protease inhibitor. The separated nuclei were lysed in SDS 
lysis buffer (50 M Tris-HCl pH 8.1, 10 mM EDTA, 1% SDS) containing protease 
inhibitors. The resultant chromatin was sonicated (Fisher Scientific, model 100 Sonic 
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Dismembrator, Pittsburgh, PA) on ice with 10 bursts for 40 s at power setting 5, with 2 
min cooling interval between each burst. The average length of sonicated chromatin was 
determined to be around 500 bp by resolving on a 1.6% agarose gel. The sample was then 
centrifuged at 13 000 rpm for 10 min at 4°C to remove cell debris from the crude 
chromatin lysate. Sheared chromatin (1 ml) was diluted in ChIP dilution buffer (total 10 
ml). Ten percent of the diluted lysate was subsequently incubated overnight at 4°C on a 
hematology mixer (Model 346, Fisher Scientific) with 2 μg of primary antibodies of 
interest. Pre-blocked salmon sperm DNA/protein A agarose beads (60 μl, 50% slurry; 
Upstate Biotechnology, Lake Placid, NY) were then added to the chromatin for 2 hr, 
followed by centrifugation at 2 000 rpm for 1 min at 4°C. Supernatant of normal rabbit 
IgG was saved as the input control for PCR after clean up. The pellets containing 
immunoprecipitated complexes were washed sequentially with 1 ml of low salt solution 
(0.1% SDS, 1% triton X-100, 2 mM EDTA, 20 mM pH 8.0 Tris-HCl, 150 mM NaCl), 
high salt solution (0.1% SDS, 1% triton X-100, 2 mM EDTA, 20 mM pH 8.0 Tris-HCl, 
500 mM NaCl), and LiCl solution (0.25 M LiCl, 1% NP40, 1% sodium deoxycholate, 1 
mM EDTA, 10 mM pH 8.0 Tris-HCl) and twice with TE (pH 8.0). Antibody/protein/DNA 
complexes were eluted from Protein A agarose beads by adding 250 μl of the elution 
buffer (50 mM NaHCO3 and 1% SDS) followed by shaking at 37°C at 300 rpm for 15 
min and a flash-spin down at room temperature. The combined supernatants were 
incubated at 65°C for 4 – 5 hr after addition of 20 μl 5 M NaCl and 1 μg of RNase A, to 
reverse the formaldehyde cross-linking and release the DNA fragments. Samples were 
then treated with proteinase K at 37°C for 1h to remove protein. DNA was purified with a 
Wizard SV Gel and PCR Clean up System (Promega, Madison, WI). 5% of 
immunoprecipitated DNA was used for each real time PCR reaction. The standards and 
the samples were simultaneously amplified using the same reaction master mixture at the 
25 μl scale. Primers were used to amplify genomic sequences at the promoter region of 
p16 (CDKN2A) gene (Table 5.2). 
 
Transcriptional activity assay   
To measure the transcriptional activity from the p16 (CDKN2A) gene, the method of 
Sandoval et al. {Sandoval et al. 2004} was used, which relies on ChIP analysis to 
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examine RNA polymerase II (Pol II) binding at a coding region distal to the promoter. 
For this purpose, primers were designed within the protein coding region of the p16 
(CDKN2A) gene (Table 5.2).  
 
Statistical analysis 
Results are expressed as mean ± SEM. Comparison of mRNA expression or histone 
modification between either control and treated groups were performed by t-test. 
Significance testing was set at p< 0.05 level (two-sided). 
 
5.4 Results 
 
Birth and body weight of offspring   
On the 21 day of gestation, the control dams delivered all pups after noon while the LP 
dams delivered 43% of the pups before noon and 57% pups after noon (Table 5.1). At 
birth, the control pups weighed 6.32 ± 0.19 g while the LP pups weighed slightly less, 
5.92 ± 0.09 g. As the pups grew to 15 days, average body weight was significantly lower 
in the LP pups than in the control (at a p value of 0.02). Table 1 compares the average of 
body weight at birth and at day 7, 15, 22 and 35 of postnatal life, showing that the 
average weights of the LP offspring were reduced by 12% at day 15, 16% at day 22 and 
13% at day 35 (p<0.05) as compared to the control pups. There were no differences in the 
daily food intake, body weight of the dams during pregnancy (data not shown), litter sizes 
or litter sex distribution (Table 5.1) between control and LP mothers.  
 
Maternal low-protein diet reduced p16 mRNA level in offspring mammary gland  
The effect of maternal low-protein diet on offspring gene expression was examined 
through real time qPCR. The p16 (CDKN2A) expression in mammary gland of the LP 
pups notably decreased by 75.8% at day 38 relative to the control pups (Figure 5.1B; p 
<0.001). The p16 (CDKN2A) mRNA level didn’t differ between the two groups of dams 
(Figure 1.5A). Because tumor protein 53 (p53) and p16 (CDKN2A) function following a 
compensatory mechanism in cell cycle arrest {Serrano et al. 1997}, the expression of p53 
mRNA was examined. However, there was no significant change of p53 expression 
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between the LP and control pups (Figure 5.1C).  
 
p16 protein content was decreased by maternal low-protein regime 
To examine if the altered p16 (CDKN2A) mRNA produces a change in protein content in 
offspring mammary gland, we performed Western blot analysis using an anti-p16 
(CDKN2A) antibody. p16 (CDKN2A) protein was reduced by maternal low–protein diet 
in female offspring mammary gland (Figure 5.2) by 71% (p = 0.004), normalized with 
internal control. Significantly lower p16 (CDKN2A) protein content in female LP pups’ 
mammary gland was consistent with the trend observed in its mRNA expression. 
 
Restricted maternal low-protein didn’t change p16 gene methylation 
DNA methylation has been reported as a mechanism to regulate p16 (CDKN2A) gene 
expression in mammary cells {Bean et al. 2007}. Figure 5.3A represents the positions of 
the p16 gene promoter and its CpG island on the intact genomic sequence. In this study, 
the p16 methylation status was assessed by methylation sensitive PCR (MSP), presented 
in Figure 5.3B and 5.3C. A methylation-specific endonuclease, AciI, was used to digest 
genomic DNA. The MSP primers we designed covered the whole CpG island as shown in 
Table 5.2. Figure 5.3B shows that a PCR product was amplified, indicating that the p16 
promoter was methylated. However, CpG mehtylation levels were consistent between 
offspring of both control and low-protein dams. Hhal endonuclease, which has no cutting 
site within the p16 promoter, was used as a positive control (Figure 5.3C). The expression 
levels of the three DNA methyltransferases, Dnmt1, Dnmt3a and Dnmt3b, were analyzed 
utilizing qPCR (Figure 5.3D, 5.3E and 5.3F). The expression levels of the 
methyltransferases were not altered in LP offspring mammary glands. Therefore, the 
reduced p16 regulation in offsprings was DNA methylation-independent under the 
treatment of maternal protein restriction.  
 
Programming chromatin structure at the p16 promoter through maternal diet  
Changes in chromatin structure caused by chemical modifications of histone proteins, 
such as methylation and acetylation, regulate gene transcription by affecting the ability of 
eukaryotic RNA polymerase II (Pol II) to transcribe DNA in order to synthesize the 
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precursors of mRNA and most snRNA and microRNA {Roeder et al. 1969; Conaway et 
al. 1997}. ChIP assays were performed to investigate Pol II binding status at the p16 
(CDKN2A) promoter. Recruitment of PoI II to the p16 (CDKN2A) promoter was 
decreased by 82.8% in LP pups compared to control (Figure 5.4A; p=0.04). Data was 
well associated with the declined p16 (CDKN2A) mRNA expression. Normal rabbit IgG 
antibody was used as negative control, indicating non-specific binding. Other antibodies 
were classified as “no bindin” if resulting value was equal or less than rabbit IgG value 
(≤0.003 ratio to input). 
 
To further determine if the altered transcriptional level of p16 (CDKN2A) was regulated 
by the changes of chromatin structure at the p16 (CDKN2A) promoter, antibodies to 
either methylated histone or acetylated histone were employed in the ChIP assay. Histone 
acetylation is associated with increased gene transcription, and hence, with 
transcriptionally active chromatin domains. Although histone methylation is generally 
associated with transcriptional repression, methylation of different lysine or arginine 
residues of histone also results in transcriptional activation. For example, methylation of 
lysine residue 4 of histone H3 (H3K4) is an activator, while methylation of lysine 9 of 
histone H3 (H3K9) is a repressor of gene transcription {Bartova et al. 2008}. Figure 4B 
shows the histone modifications at the p16 (CDKN2A) promoter in the mammary gland 
of offspring rats. An 84.6% decrease in acetylated H4 (p = 0.01) and a 92.5% decrease of 
methylation at H3K4 (p = 0.02) were detected in the LP pups, correlating to the 75.8% 
transcript repression (Figure 5.1). No difference in histone H3 acetylation or methylation 
at lysine 9 residues was detected. These data suggest that the altered p16 (CDKN2A) 
gene transcription might be regulated by the changes in histone modification at its 
promoter region, specifically histone H4 acetylation as well as histone H3 methylation at 
lysine 4.   
  
Maternal low-protein reduced the real transcription rate of p16 (CDKN2A) 
To confirm the real transcriptional activity from the p16 (CDKN2A) gene, ChIP DNA 
samples were used to monitor RNA polymerase II translocation to a region distal to the 
promoter, as demonstrated by Sandoval et al. {Sandoval et al. 2004}. The measurement 
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of Pol II binding within the coding region of a gene reflects the transcriptional activity at 
that gene, which usually has a short half-life. For the p16 (CDKN2A) gene, it has been 
reported having a short half life {Shapiro et al. 1995} and by using this analysis the 
results showed that the transcription rate decreased by approximately 85% in LP pup 
mammary gland relative to control pups (p = 0.02; Figure 5.4C). Therefore, decreased 
transcription appears to account for most of the reduction in p16 (CDKN2A) mRNA 
following maternal low-protein regime. 
  
5.5 Discussion 
 
The nutritional environment at the fetal and neonatal stages has been suggested to be a 
critical factor in breast cancer susceptibility. Our data showed for the first time that 
maternal protein restriction during gestation affected not only the growth of the pups but 
also p16 (CDKN2A) gene expression through histone code modifications. These 
observations were consistent with a previous report {Fernandez-Twinn et al. 2007} 
showing that a low-protein maternal diet resulted in offspring with not only low birth 
weight and a slow growth rate during lactation, but also retarded mammary gland 
development at three weeks of age. A rapid compensatory mammary epithelial growth in 
offspring pups after weaning with normal diet was observed, and led us to hypothesize 
that maternal protein restriction resulted in the repression of some cell cycle regulators, 
which could contribute to cancer risk. 
 
The protein p16 (CDKN2A) is known to negatively control cell cycle and to retain pRb 
in a hypo-phosphorylated form in order to inhibit cellular growth {Voorhoeve et al. 
2004}. Down-regulated p16 (CDKN2A) expression has been related to aggressive cell 
growth, leading to many types of tumors in humans {Enders et al. 2003}. In the epithelial 
cells from female mice, the p16 (CDKN2A) expression level has been found to be 
differentially expressed in a DNA methylation-independent manner during normal 
mammary gland development {Tsellou et al. 2008}. The regulatory mechanism of p16 
(CDKN2A) remains to be elucidated. As a comparison, in this study, the expression of 
p16 (CDKN2A) in the mammary gland of offspring with maternal protein restriction is 
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substantially reduced, to 24% of the control group. Potentially, down-regulation of p16 
(CDKN2A) resulting from maternal low-protein diet may increase the offspring’s breast 
cancer risk later in life. 
 
Tumor protein 53 (p53, or also known as protein 53) is a transcription factor encoded by 
the human TP53 gene. p53 can promote cell-cycle arrest or apoptosis in response to a 
variety of cellular stresses, including DNA damage and hypoxia {Graeber et al. 1996}. 
p16 gene activity inversely modulates p53 status and function in primary human 
mammary epithelial cells. p53 and p16 (CDKN2A) are mutated at high frequency in 
many tumor types, implying that their action is central to limiting tumor development. In 
fact, oncogenic Ras activates p53 and p16 (CDKN2A) to provoke premature cell 
senescence. Constitutive activation of the MEK/MAPK cascade induces p53 and p16 
(CDKN2A) simultaneously {Lin et al. 1998}. p53 and p16 (CDKN2A) can also act in a 
compensatory mechanism that suppresses Ras-induced transformation {Serrano et al. 
1997}. Disruption of either p53 or p16 (CDKN2A) prevents cell cycle arrest and is 
sufficient for Ras-induced transformation. In our study, although p16 (CDKN2A) 
expression is significantly suppressed, there is no detectable alteration in the regulation of 
p53 between control and maternal low-protein groups. This implies the presence of a 
nutritional signaling pathway that regulates p16 (CDKN2A) and p53 differently in the 
maternal protein restriction scenario. 
 
There is growing evidence that maternal nutritional status can alter the epigenetic state of 
the fetal genome through histone modifications {Burdge et al. 2007}. Histone 
modifications, such as acetylation or methylation of specific amino acid residues in the 
N-terminal tails, exhibit diversified effects on gene transcriptional regulation 
{Kouzarides et al. 2007}. Histone acetylation or methylation can alter the histone-DNA 
interactions and the affinity of histone binding to DNA, thereby affecting gene expression 
{Jaenisch et al. 2003}. Deacetylation at specific lysine residues in the histone tails is 
generally associated with transcriptional activity {Turner et al. 2000}. In contrast, 
methylation of lysine has been linked to either activation or repression, depending on 
which lysine residue is modified. Methylation of lysine 4 of histone H3 (H3K4) promotes 
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transcriptional activity {Zegerman et al. 2002, while di- and tri-methylation of lysine 9 
on histone H3 (H3K9) has been shown to inhibit gene transcription {Nakayama et al. 
2001}. However, the histone epigenetic response to environmental stimuli is much less 
studied. Our results indicated that, at the p16 (CDKN2A) promoter region, maternal 
low-protein diet resulted in deacetylation of histone H4, but not histone H3, and 
dimethylation of H3K4. A number of proteins have been identified that are recruited to 
histone modifications and bind via specific domains {Kouzarides et al. 2007}. The 
difference we observed between actylation of histone H4 and histone H3 might due to the 
varied binding proteins that recognize either the acetylated histone H4 or the acetylated 
histone H3 to tether different enzymatic activities onto chromatin. The communication is 
mechanically regulated by varieties of factors, which are much under investigated, 
although some proteins have been reported to potentially bind with modified histones, for 
example Rsc4 binding to acetylated histone H3 and Brd2 binding to acetylated histone 
H4. However, the related research is undergoing and the functions of the binding proteins 
haven’t been clearly revealed {Kouzarides et al. 2007}. In addition to the changes of 
histone modification, RNA polymerase II recruitment to the promoter is significantly 
reduced. We also observed a slight increase of methylation of H3K9, although the result 
is not statistically significant. 
 
In summary, maternal protein restriction causes a down-regulation of p16 (CDKN2A) 
transcription and protein levels in offspring mammary glands. It demonstrates that a 
histone code modification of p16 (CDKN2A) is an epigenetic outcome of maternal 
dietary low-protein intake. Although DNA methylation was also reported to regulate p16 
(CDKN2A) gene expression in mammary cells of women with high risk of breast cancer 
incidence {Bean et al. 2007}, other literature of in vivo studies showed DNA 
methylation-independent regulation of p16 {Tsellou et al. 2008}. Similarly, we did not 
observe any changes to DNA methyltransferase (Dnmt1 or Dnmt3a) expression or CpG 
island methylation status (Figure 5.3) in our animal model, suggesting it is not a DNA 
methylation-dependent regulation. A further elucidation of the signaling pathway leading 
to histone modification of p16 (CDKN2A) and other tumor suppressor genes will 
contribute to the understanding of breast cancer prevention through maternal nutrition. 
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5.6 Tables & Figures 
 
 
 
Table 5.1 Offspring Vital Results  
A. C (4)1 LP (4)1  
    
Pups delivered before noon (%)1 0 43  
Pups delivered after noon (%)1 100 57  
Litter size 11.5 ± 0.65 10.3 ± 0.86  
Litter sex distribution M:F 1.11 1.25  
B.  Body weight (g)
 3  
Age (days) C (4) LP (4) p 
Birth (day 0) 6.32 ± 0.19 5.92 ± 0.09 0.11 
7 16.55 ± 0.69 14.89 ± 0.46 0.10 
15 35.06 ± 1.14 30.73 ± 0.70 0.02 
22 59.37 ± 1.40 49.98 ± 1.63 0.006 
35 138.56 ± 2.58 125.21 ± 3.54 0.006 
1 Number of litters shown in parentheses.   
2Timing of delivery by the dams  
3Body weight was shown as the average value at the specific day. Data are means with 
± S.E.M. Significance testing was set at p<0.05 derived from two-tail t-test. 
Table 5.2 Primer sequence used in qPCR and ChIP 
Gene Forward primer (5’ → 3’) Reverse primer (5’ → 3’) 
 Analysis of mRNA expression 
p16  TCCGAGAGGAAGGCGAACTC GCTGCCCTGGCTAGTCTATCTG 
p53 CTTACCATCATCACGCTGGAAGAC GCACAAACACGAACCTCAAAGC 
 Analysis of CpG island 
p16  ACTGGGCGGGCACTGAATCTC         TTCGGGGCGTTTGGTGAAG 
 Analysis of histone modification 
p16  AGCATGGAGTCCTCTGCAGATAGAC GAAAGTGTTCGGGGCGTTTG 
 Analysis of transcription rate 
p16  GGCAACGCGAGACTAGCATA CTCCCTCCCTCTGCTAACCT 
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Figure 5.1 Expression of p16 (CDKN2A) and p53 mRNA in rat mammary gland 
Expression of p16 (CDKN2A) mRNA levels in rat mammary gland by real time qPCR. A.
p16 (CDKN2A) mRNA in dams (n=4) who were fed control or low-protein (LP) diet; B. p16
(CDKN2A) mRNA in female pups (n=6) of LP mothers versus control; C. p53 mRNA level in
female pups (n=6) of LP mothers versus control. LP mRNA levels are expressed as means
percentage of controls. Values are means ± SEM. **p <0.001 
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Figure 5.2 p16 (CDKN2A) protein content in offspring mammary gland  
Expression of p16 (CDKN2A) protein content in female offspring mammary gland by
Western blot (n=4). The bands presented the average level of p16 (CDKN2A) protein in
control and LP groups. NS: non-specific binding. LP protein levels were expressed as
means percentage to control. The values represented the mean ± S.E.M., *p <0.05. 
                                                                                              98
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    A. 
 
 
 
 
 
 
 
 
 
 
 
 
 
         
(-72 to +36)
Exon 1 Exon 2
Exon 3
Exon 4 Exon 5 Exon 6
CpG island
p16 proximal
promoter
0
50
100
150
H
ha
Id
ig
es
te
d
gD
N
A
in
 p
up
 M
G
C
ut
 to
 u
nc
ut
 ra
tio
 (%
 to
 c
on
tr
ol
)Control
LP
C.
0
50
100
150
A
ci
Id
ig
es
te
d
gD
N
A
in
 p
up
 M
G
C
ut
 to
 u
nc
ut
 ra
tio
 (%
 to
 c
on
tr
ol
)
B.
Control
LP
0
20
40
60
80
100
120
140
D
nm
t1
m
R
N
A
ex
pr
es
si
on
 (%
 to
 c
on
tr
ol
)
D.
0
20
40
60
80
100
120
140
D
nm
t3
a
m
R
N
A
ex
pr
es
si
on
 (%
 to
 c
on
tr
ol
)
Control
LP
E.
0
20
40
60
80
100
120
140
D
nm
t3
b
m
R
N
A
ex
pr
es
si
on
 (%
 to
 c
on
tr
ol
)
Control
LP
F.
Control
LP
H
ha
Id
ig
es
te
d
gD
N
A
in
 p
up
 M
G
C
ut
 to
 u
nc
ut
 ra
tio
 (%
 to
 c
on
tr
ol
)
A
ci
Id
ig
es
te
d
gD
N
A
in
 p
up
 M
G
C
ut
 to
 u
nc
ut
 ra
tio
 (%
 to
 c
on
tr
ol
)
D
nm
t1
m
R
N
A
ex
pr
es
si
on
 (%
 to
 c
on
tr
ol
)
D
nm
t3
a
m
R
N
A
ex
pr
es
si
on
 (%
 to
 c
on
tr
ol
)
D
nm
t3
b
m
R
N
A
ex
pr
es
si
on
 (%
 to
 c
on
tr
ol
)
Figure 5.3 Expression of DNMT mRNA in rat mammary gland and CpG island
methylation status. A. The intact p16 gene genomic DNA. CpG island locates between –72
to +36 bp. B, C. MSP analysis was performed at the CpG island of p16 (CDKN2A) genes.
Amount of methylation of all genes is presented as the % ratio of Cut/Uncut normalized to
control. D, E and F. Expression of DNMT1, DNMT3a and DNMT3b mRNA levels in rat
mammary gland were measured by real time qPCR. LP mRNA levels are expressed as
means percentage of controls. Values are means ± SEM. n=5.  
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Figure 5.4 Chromatin structure changes at the p16 (CDKN2A) promoter region 
A. ChIP assay to demonstrate binding of RNA polymerase II (Pol II) at the p16 (CDKN2A)
promoter region in offspring mammary gland (n=5). Normal rabbit IgG antibody was used as
negative control to show non-specific binding. Data was shown as a ratio to the input DNA,
which serves as an internal control to eliminate DNA quantity variation. B. ChIP assay
demonstrating the changes of histone modifications at p16 (CDKN2A) promoter region in
offspring mammary gland (n=5). Data was shown as a ratio to the input DNA. AcH4:
acetylated histone H4; AcH3: acetylated histone H3; dMeH3K4: di-methylated histone H3 at
lysine 4 residues; tMeH3K9: tri-methylated histone H3 at lysine 9 residues. C. Transcription
rate of the p16 (CDKN2A) gene. The real transcription rate for p16 (CDKN2A) gene was
analyzed by testing PoI II binding at the coding region. Data was plotted as the percentage
decrease relative to control (n = 5). Values are means ± SEM. *p <0.05 
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Chapter 6. Chromatin Modifications Cause Transcriptional Repression of the p21 
Gene in Mammary Gland in Offspring of Gestational Protein-Restricted Rats 
 
6.1 Abstract 
 
Maternal exposure to environmental agents throughout pregnancy may change certain 
metabolic processes during the offspring’s mammary gland growth and alter the 
epigenome. This may predispose the offspring’s mammary gland to breast cancer later in 
life. The purpose of this study is to examine the effect of maternal protein restriction on 
the regulation of p21 gene expression in the mammary gland of rat offspring. 
Timed-pregnant Sprague-Dawley rats were fed one of the two isocaloric diets, control (C, 
18% casein) or low protein (LP, 9% casein), during the gestation period. Compared to 
control, LP offspring showed a decrease of p21 in the mammary gland at both the mRNA 
and protein levels. Chromatin immunoprecipitation (ChIP) assay demonstrated that the 
down-regulation of p21 transcription in LP offspring was associated with reduced 
acetylation of histone H3 and dimethylation of H3K4 within the p21 promoter region, but 
was not associated with acetylation of histone H4 or histone methylation. DNA 
methylation analysis using bisulfite sequencing did not detect a differing pattern at the 
p21 promoter between the offspring of control and LP groups. We conclude that maternal 
protein restriction inhibits p21 gene expression in the mammary gland of offspring 
through histone modifications within the promoter region of the p21 gene.   
 
6.2 Introduction 
 
Maternal nutrient supplementation, or exposure to environmental agents, may change 
metabolic processes in the mammary gland and alter the epigenome, which predisposes 
the offspring to an increased risk of developing cancers in the mammary gland 
{Hilakivi-Clarke et al. 2006}. A maternal low protein diet has been associated with an 
increased risk of a number of adult diseases {McArdle et al. 2006}. Low birth weight, 
which results from protein restriction during the gestation period, has been shown to be 
associated with breast cancer risk {Mellemkjaer et al. 2003}. Ozanne et al. have shown, 
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in rats, that maternal exposure to a low protein diet increases mammary tumorigenesis in 
offspring {Fernandez-Twinn et al. 2007}. However, a poor understanding of the 
molecular mechanism of cancer in the mammary gland hinders our further determination 
of the role of maternal nutrition in cancer prevention. Epigenetic modifications, including 
cytosine methylation of DNA and post-translational modification of chromosomal 
structural histones, can change gene function and phenotype without altering the DNA 
sequence. Such epigenetic modifications affect cell proliferation during prenatal and 
postnatal development. A maternal low protein diet during the pre-implantation period in 
rodents induced a transient reduction in concentrations of maternal serum essential amino 
acid, which is associated with a reduction in embryo cell numbers. This led to various 
abnormal postnatal phenotype changes even though the offspring were fed a normal diet 
{Kwong et al. 2000}.  
 
As a potential tumor suppressor gene in mammary gland development, the 
cycline-dependent kinase inhibitor p21 is a key factor responsible for tumor suppressor 
p53-dependent cell cycle arrest, and may contribute to the regulation of cell proliferation, 
differentiation, and tumorigenesis. p21 has been accepted as a prognostic marker of 
breast cancer. The loss of expression of two G1-checkpoint CDK inhibitors, p21 and p27, 
has been implicated in the genesis or progression of many human malignancies {Cariou 
et al. 2000}. A recent long-term study indicates that p21 knockout mice developed 
spontaneous tumors at an average age of 16 months, in comparison to 20 months for 
wild-type animals, revealing the importance of p21 in tumor suppression 
{Martin-Caballero et al. 2001}. Given the crucial function of cell cycle control to cancer 
development, a problem in the regulation of a potent cell cycle regulator such as p21 is 
clearly a contributing determinant of the unrestrained proliferation typical of cancer cells. 
Low levels of p21 expression have been identified in patients with both early stage and 
later stage breast cancers {Van et al. 2002; Paik et al. 2004; Somlo et al. 2008}. Little is 
known regarding a dietary contribution to the epigenetic modifications of p21 gene 
regulation in mammary gland. Although a recent publication reported that 
isoflavone-deprived soy peptide can induce expression of p21 and suppresses mammary 
tumorigenesis in female rats {Park et al. 2009}, no studies examine the regulation of p21 
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through generations in mammary gland development through maternal dietary factors.  
 
The purpose of this study is to identify how maternal protein restriction affects the 
expression of the p21 gene in the mammary gland of offspring. We hypothesized that 
maternal dietary low protein modulates p21 gene expression in offspring through an 
epigenetic modification-associated mechanism at its transcriptional regulatory regions. 
 
6.3 Material and Methods  
 
Animals and treatment 
Timed-pregnant Sprague Dawley rats (65 days old; Charles River Laboratories) were 
obtained on day 2 of gestation and weight matched into one of two isocaloric diets, 
control (180 g/kg casein) or low protein (LP, 90 g/kg casein). The diets were in the form 
of premade pellets, which were adapted according to a modified AIN-76 diet formula 
(Table 6.1). Each group contained 4 dams. Both groups had free access to rat chow and 
drinking water. Animals were individually housed in standard polycarbonate cages with 
corncob bedding and were maintained in a temperature and humidity controlled colony 
room on a 12 hr light-dark cycle. Twenty-four hours after birth, 6 pups (3 female and 3 
male) were selected and used in the litters to minimize variation in pups’ nutritional status 
during suckling. Pups body weights were measured once a week after birth. Mothers 
were switched to standard rodent diet through lactation. At day 24, in both experimental 
groups, the pups were weaned from the mother to a standard rat chow. Female pups were 
sacrificed when they were 38 days old. The fourth abdominal mammary gland was 
collected, snap-frozen in liquid nitrogen, and stored at -70°C. All of the other tissues, 
pancreas, kidney, liver, brain (hypothalamus), heart, muscle (gastrocnemius), adipose 
(visceral), colon, and blood in this study were also collected from female offspring. 
Tissue samples of 5 to 6 female pups from each treatment group were randomly chosen 
for the following experiments.    
 
RNA isolation and cDNA synthesis 
Frozen tissue samples from 6 offspring of each group were individually ground with a 
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mortar and pestle in liquid nitrogen (around 100 mg of mammary tissue per animal), and 
total RNA was isolated from each sample with TRI reagent (Sigma, St. Louis, MO). 
Following isopropanol (Fisher Scientific, Fair Lawn, NJ) precipitation, RNA was 
re-suspended and quantified by spectrophotometry (BIO-RAD Smart Spec Plus, Hercules, 
CA) at A260/A280. A high-Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems, Foster City, CA) was used for reverse transcription of 2 μg of total RNA. All 
samples to be compared were reverse transcribed from the same reaction mixture at the 
same time. A template tube without RNA was used as the negative control. The whole 
procedure was performed in a DNA 2720 Thermal Cycler (Applied Biosystems). The 
samples, at the 20 μL reaction scale, were heated at 37°C for 2 hr for the reverse 
transcription procedure. Following this procedure, the samples were heated to 85°C for 5 
seconds to inactive reverse transcriptase and terminate the reaction. The final 20 μL of 
cDNA was diluted to 400 μL by nuclease free water and stored at -20°C. 
 
Real-time quantitative RT-PCR (qPCR) 
In order to measure the relative amount of mRNA, cDNA samples were run in a 96-well 
plate on 7300 Real-Time PCR Systems (Applied Biosystem, Foster City, CA)), detected 
by iTag SYBR Green Supermix with ROX (Bio Red, Hercules, CA), which is a dye that 
binds to the dsDNA generated during amplification. The reaction mixtures were activated 
at 95°C for 10 min, followed by 35 cycles of 95°C for 15 s and 60°C for 1 min. The 
volume of mRNA was quantified according to a fluorescence signal by comparing a 
cDNA standard, with a specific concentration gradient, to experimental Ct values. The 
cDNA standards were made using the same RNA samples for each type of frozen tissue. 
The PCR primers amplified these standard samples in a linear fashion, and the Ct values 
of the experimental samples were within the Ct values of the standard samples for each 
type of tissue. The origin of the standards was a standard curve performed for mRNA 
analyzed in a specific tissue. Ribosomal protein L7a mRNA level was measured at the 
same time to be used as an internal control. We also tested other housekeeping genes, for 
example 18s and actin in this study. The reason that L7a was selected as an internal 
control is because that its amplification curve in real-time qPCR has the most similar 
trend as that of p21. After PCR, a dissociation curve was generated through a stepwise 
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increase of the temperature from 55°C to 95°C to ensure that a unique product was 
amplified. Primers for the qPCR were designed using Vector NTI software (InforMax 
Inc., Frederick, MD) to amplify the transcriptional region of the p21 gene (Table 6.4).  
 
Protein isolation and Western blotting 
Protein samples were isolated from 25 mg of each frozen mammary gland tissue, which 
was ground in liquid nitrogen and put into 500 μL of protein sample buffer (0.125 mol/L 
Tris-HCl pH 6.8, 5% 2-mercaptoethanol, 1% SDS, 20% glycerol, 0.4% bromophenol 
blue, protease inhibitor). Protein was sonicated (Fisher Scientific model 100 Sonic 
Dismembrator, Pittsburgh, PA) on ice with 25 pulses at power setting 2. The Lowry assay 
was used to determine protein content, and samples containing 20 μg of protein were 
resolved by SDS-PAGE. An electrotransfer of the protein to a polyvinylidene fluoride 
membrane (0.2 μm, Bio-Rad) using a wet transfer protocol was performed. The 
membrane was blocked with 5% milk in TBS/T (30 mmol/L Tris base pH 7.6, 200 
mmol/L NaCl and 0.1% Tween 20) for 1 hour at room temperature, and then incubated 
with rabbit polyclonal antibody against p21 (Table 6.5) in 5% BSA at a 1:1000 dilution at 
4°C overnight. The next day the membrane was washed five times for 5 min each with 
TBS/T on a shaker and then incubated with peroxidase-conjugated goat anti-rabbit 
secondary antibody (Kirkegaard & Perry Laboratories, Gaithersburg, MD) in 1% milk at 
a 1:10,000 dilution for 1 hr at room temperature. The membrane was washed again five 
times, for 5 minutes each time. The bound secondary antibody was detected using a 
SuperSignal West Dura Extended Duration Substrate kit (Thermo Scientific, Rockford, 
IL) and western blot images were captured and analyzed by a Chemi Doc system 
(Bio-Rad). 
 
Genomic DNA extraction from mammary gland 
Frozen mammary gland tissues from 6 offspring of each group were individually cut into 
pieces on ice (around 100 mg of mammary tissue per animal). Proteinase K (100 μL of 10 
mg/mL) and 240 μL of 10% SDS were then added to the samples and incubated in a 
45oC water bath overnight. The next day, 2.4 mL of phenol was added to the system, 
shaken completely for 10 min, and spun at 3000 rpm for 5 min at 10oC. The supernatant 
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was collected, and 1.2 mL phenol and 1.2 mL chloroform/isoamyl alcohol (24:1) were 
added. This mixture was shaken by hand for 5 min, spun at 3000 rpm for 5 min at 10oC, 
and then the supernatant was transferred into a fresh tube. Both 25 μL of 3 mol/L sodium 
acetate (pH 5.2) and 5 mL of ethanol were added to the supernatant, shaken gently for 
DNA precipitation, and spun at 16,000 g for 20 min at 4oC. After discarding the 
supernatant, the DNA pellet was washed with 70% ethanol. The pellet was air- dried, 
suspended with 300 μL of TE, and stored at -20°C. 
 
Bisulfite sequencing 
Genomic DNA (1 μg) was utilized for bisulfite conversion with the EZ DNA 
Methylation-Gold Kit (ZYMO), following the manufacturer’s instructions. Briefly, DNA 
samples were treated with sodium bisulfite at 64°C for 2.5 hours. They were then 
desalted, desulfonated, and eluted into 40 μL of TE. Bisulfite-modified DNA (25 ng) was 
then subjected to PCR amplification of the p21 CpG islands using the bisulfite primer 
sets, designed online by the tool Methprimer (http://www.urogene.org/methprimer/ 
index.html). The PCR products obtained were cloned into pCR4.0 TOPO vectors 
(Invitrogen, Carlsbad, CA). We tested 6 animals from each group. Ten colonies of each 
animal were sequenced for each specimen in order to obtain a sufficient sampling of 
allele-specific methylation patterns. 
   
Chromatin immunoprecipitation (ChIP) 
ChIP analysis was performed according to a modified protocol {Chen et al. 2004}. 
Briefly, 200 mg of frozen tissue was ground in liquid nitrogen, re-suspended in PBS and 
cross-linked in 1% formaldehyde for 10 min at room temperature. The tissue pellet was 
re-suspended in nuclei swelling buffer (5 mmol/L Pipes [NaOH] pH 8.0, 85 mmol/L KCl, 
0.5 % NP40) containing protease inhibitor. The separated nuclei were lysed in SDS lysis 
buffer (50 mol/L Tris-HCl pH 8.1, 10 mmol/L EDTA, 1% SDS) containing protease 
inhibitors. The resultant chromatin was sonicated (Fisher Scientific model 100 Sonic 
Dismembrator, Pittsburgh, PA) on ice with 8 bursts for 40 s at power setting 5, with a 2 
min cooling interval between each burst. The average length of sonicated chromatin was 
determined by resolving it on a 1.6% agarose gel, and was found to be around 200-500 bp. 
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The sample was then centrifuged at 13,000 rpm for 10 min at 4°C to remove cell debris 
from the crude chromatin lysate. One milliliter of sheared chromatin was diluted in 10 
mL of ChIP dilution buffer. Ten percent of the diluted lysate was subsequently incubated 
overnight on a hematology mixer (346, Fisher Scientific) with 2 μg of primary antibodies 
(Table 6.5) at 4°C. Normal rabbit IgG antibody was used as the negative control to 
demonstrate non-specific binding. Antibodies were considered negative for binding if the 
resulting value was equal to or less than the IgG value (ratio to input). Pre-blocked 
salmon sperm DNA/protein A agarose beads (60 μL, 50% slurry; Upstate Biotechnology, 
Lake Placid, NY) were then added to the chromatin for 2 hr, followed by centrifugation at 
2000 rpm for 1 min at 4°C. The supernatant of normal rabbit IgG was saved as the input 
control for PCR after clean up. The pellets containing immunoprecipitated complexes 
were washed sequentially with 1 mL of low salt solution (0.1% SDS, 1% triton X-100, 2 
mmol/L EDTA, 20 mmol/L pH 8.0 Tris-HCl, 150 mmol/L NaCl), high salt solution (0.1% 
SDS, 1% triton X-100, 2 mmol/L EDTA, 20 mmol/L pH 8.0 Tris-HCl, 500 mmol/L 
NaCl), LiCl solution (0.25 mol/L LiCl, 1% NP40, 1% sodium deoxycholate, 1 mmol/L 
EDTA, 10 mmol/L pH 8.0 Tris-HCl) and twice with TE (pH 8.0). Antibody/protein/DNA 
complexes were eluted from Protein A agarose beads by adding 250 μL of the elution 
buffer (50 mmol/L NaHCO3 and 1% SDS) two times, followed by 15 minutes of shaking 
at 300rpm at 37°C and finally by flash spinning the samples down at room temperature. 
The combined supernatants were incubated at 65°C for 4-5 hr, after the addition of 20 μL 
of 5 mol/L NaCl and 1 μg of RNase A to reverse the formaldehyde cross-linking and 
release the DNA fragments. Samples were then treated with proteinase K at 37°C for 1 hr 
to remove any protein, and DNA was purified with a Wizard SV Gel and PCR Clean up 
System (promega). Each real time PCR reaction used 5% of immunoprecipitated DNA. 
The binding of PoI II and modified histones were expressed as ratios to the input. The 
standards and the samples were simultaneously amplified using the same reaction master 
mixture at the 25 μL scale. Primers were used to amplify genomic sequences at the 
promoter region of p21 (see Table 6.4).  
 
Statistical analysis 
Results are expressed as the mean ± SEM. Data comparison between control and low 
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protein groups were performed by a two-tailed t-test. Significance testing was set at the 
p<0.05 level. Sample size was calculated by statistical power analysis based on a 95% 
confidence interval using SAS.  
 
6.4 Results 
 
Mothers and offspring observations   
Pregnant dams were monitored beginning at day 2 of gestation. Table 6.2 shows mothers’ 
daily food intake and body weight during the gestation period. Body weights of the LP 
dams during pregnancy were reduced by 13% both at day 16 and at day 21 (p<0.05). 
There were no differences in the daily food intake between the control and low protein 
dam groups (p>0.05), indicating that the quantity of food intake should not affect 
experimental results. At birth, the control pups weighed 6.32 ± 0.19 g, which was similar 
to the weight of the LP pups at 5.92 ± 0.09 g. As the pups grew to 15 days, the average 
body weight was significantly lower in the LP pups than in the control (p<0.02). Table 3B 
provides the average offspring body weight at birth and at day 7, 15, 22 and 35 of 
postnatal life. The average weight of the LP offspring was reduced by 12% at day 15, 
16% at day 22 and 13% at day 35 (Table 6.3; p<0.05) compared to the control pups. 
Control dams delivered all pups after noon. Percentages of pups delivered by the LP 
dams before noon and after noon were 43% and 57% respectively (Table 6.2A), 
suggesting a preterm risk, which has been known for frequent occurring in low birth 
weight infant {Sluncheva et al. 2010}. There were no differences in the litter size or litter 
sex distribution between control and LP mothers (Table 6.3A).   
 
Maternal low protein diet specifically repressed p21 gene expression in offspring 
mammary glands 
The effect of a maternal low-protein diet on offspring gene expression was examined 
through real-time qPCR. Figure 6.1A shows the tissue distribution of p21 mRNA 
expression in female offspring rats. The mRNA of the p21 gene in the mammary gland of 
the LP pups was decreased by 38% relative to the control pups (p<0.05), but it did not 
differ in any other tissue. Therefore, we concentrated our study on the regulatory 
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mechanisms for the p21 gene in only the female offspring mammary gland. Expression of 
p53 was not affected by maternal low protein (data not shown). 
 
p21 protein content was decreased by maternal low-protein regime 
To examine if the altered p21 mRNA produces a change in protein content in offspring 
mammary gland, we performed Western Blot analysis using an anti-p21 antibody. p21 
protein was reduced by 60% (p<0.05) with a maternal low-protein diet in female 
offspring mammary gland (Figure 6.2). Significantly lower p21 protein content in LP 
pups’ mammary gland tissue was consistent with the trend observed in its mRNA 
expression. An anti-actin antibody was used as an internal control to show the equality of 
protein levels loaded.  
 
Maternal low-protein diet did not change p21 gene methylation pattern in offspring 
To determine whether CpG islands at the p21 promoter exhibited DNA methylation 
related to its mRNA expression, two pairs of bisulfite primer sets were designed at the 
p21 promoter region. These primer sets span from -481 to +7 bp and -16 to +386 bp, 
containing 26 and 30 CpG sites, respectively (Figure 6.3). Figure 3A represents the 
positions of the p21 gene promoter and its CpG islands on the intact genomic sequence. 
In this study, the p21 methylation status was assessed by bisulfite sequencing analysis 
(Figure 6.3B and C). CpG methylation levels were similar between offspring of both 
control and low-protein dams. Therefore, the reduced p21 mRNA expression in offspring 
was DNA methylation-independent under the maternal protein restriction.  
 
Chromatin modifications at the p21 promoter were associated with the maternal diet  
Changes in chromatin structure caused by chemical modifications of histone proteins, 
such as methylation and acetylation, regulate gene transcription by affecting the ability of 
eukaryotic RNA polymerase II (Pol II) to transcribe DNA in order to synthesize 
precursors of mRNA and most snRNA {Roeder et al. 1969; Conaway et al. 1997}. ChIP 
assays were performed to investigate Pol II binding status at the p21 promoter in 
offspring mammary gland tissue. Normal rabbit IgG antibody was used as the negative 
control, indicating non-specific binding. Antibodies were considered negative for binding 
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if the resulting value was equal or less than the IgG value (≤0.002 ratio to input). Female 
offspring liver was used as a negative control to test the changes of the same set of 
modified histones at the p21 promoter, which is used to support the result specificity in 
mammary gland (Figure 6.4A). Recruitment of PoI II to the p21 promoter was decreased 
in LP pup mammary gland compared to control (Figure 6.4B; p<0.05).  
 
To further determine if the altered transcriptional level of p21 was regulated by the 
changes of chromatin structure at the p21 promoter, antibodies to either methylated 
histone or acetylated histone were utilized in the ChIP assay. Figure 6.4C shows the 
histone modifications at the p21 promoter in the mammary gland of offspring rats. A 33% 
decrease in acetylated H3 (H3Ac) (p<0.05) and a 34% decrease of methylation at H3K4 
(H3K4Me2) (p<0.05) were detected in the LP pups, correlating to the 38% transcriptional 
repression (Figure 6.1B). No difference was detected in histone H4 acetylation (H4Ac) or 
methylation at lysine 9 residues (H3K9Me3). This data suggests that the altered p21 gene 
transcription might be regulated by the changes in histone modification at its promoter 
region, specifically histone H3 acetylation as well as histone H3 methylation at lysine 4 
(Figure 6.5).  
 
6.5 Discussion  
 
The mechanism of p21 regulation during mammary gland development, specifically in 
regards to maternal dietary factors, may provide new approaches to reducing breast 
cancer risk. In the current study, we used a gestational low protein diet with 9% of protein 
to investigate the maternal protein restriction that highly likely occurs in teen mothers in 
the US. Similar animal model has been used by many researchers to study the effect of 
maternal protein restriction on offspring gene regulation {Fernandez-Twinn et al. 2007; 
Lillycrop et al. 2005 11 /id}, while some other research groups used a more restricted 
protein diet to trigger more straightforward consequences {Buffat et al. 2007}. According 
to Acceptable Macronutrient Distribution Ranges (AMDR), 10%-35% of energy is from 
protein. 9% of protein we used in this study is right close to the range. One goal of our 
designed study is to mimic a protein-restricted status that teen mothers usually experience 
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in reality. We presented several results demonstrating that a maternal low protein diet can 
down-regulate p21 expression in offspring mammary glands in a rat model. We also 
revealed that the suppression of p21 is caused by histone modifications, but not DNA 
methylation, within the p21 promoter region. 
 
p21 alone represents an important tumor suppressor gene. As a prognostic marker in 
cancer, p21 has been extensively investigated. When the susceptibility of p21-deficient 
mice to the colon carcinogen azoxymethane was studied, enhanced formation of aberrant 
crypt foci in p21-deficient mice suggestss a tumor suppressor function for p21 in the 
colon {Poole et al. 2004}. Similarly, loss of p21 allowed proliferation of cells with DNA 
damage and resulted in cancer development in liver and kidneys of fumarylacetoacetate 
hydrolase-deficient mice {Willenbring et al. 2008}. Ozanne et al. have shown, in rats, 
that maternal exposure to a low protein diet increases mammary tumorigenesis among the 
offspring. Changes in p21 expression have also been reported in the pancreas, in the low 
protein exposed offspring. Also, clinical data suggests that loss of p21 expression in 
patients marks the switch from hepatocyte dysplasia to HCC {Plentz et al. 2007}. These 
results suggest that p21 may represent an important tumor suppressor that is inactivated 
in liver and renal cancer. However, little is known about the role of repressed p21 in 
mammary gland growth.  
 
Mammary glands develop all through different growth cycles. They exist during the 
embryonic stage, but form only a rudimentary duct tree at birth. At this stage, mammary 
gland development is systemic hormone independent {Watson et al. 2008}. Under the 
regulation of paracrine communication between neighboring epithelial and mesenchymal 
cells, a primary duct tree is formed before puberty. Extensive proliferation of mammary 
tissue occurs in females in response to circulating ovarian hormones from puberty 
{Wysolmerski et al. 1998}. In terms of the SD rats that we used in this study, their 
puberty period is within 6 to 8 weeks after birth, but the area of abdominal mammary has 
a dramatic increase between day 35 and day 40 {Sinha et al. 1966}. In order to avoid the 
impact of extensive mammary gland development during puberty, but still have enough 
mammary gland tissue to perform a variety of experiments, we chose day-38 offspring to 
                                                                                              114
investigate the changes of p21 gene expression in neonatal mammary. Another animal 
study in our laboratory is currently ongoing and focuses on more time points in adult rats 
to further investigate the effect of maternal protein restriction on offspring mammary 
gland development during and after puberty.    
 
Results regarding DNA methylation in this study did not differ within the p21 promoter, 
which extends from around -500 to +400 regions on the p21 genome. This has been 
known as the most important region, which includes 8 CpG islands on the p21 promoter 
and also contains cumulative binding sites for its transcription factors. There are two 
additional CpG islands on the p21 genome. One is proximally located around -3000 and 
the other is approximately at the +5000 region. We cannot deny the possibility that those 
two proximal regions might be methylated, but the regulatory role of that has never been 
reported. 
 
Histone acetylation patterns and methylation patterns were analyzed by ChIP. Histone 
acetylation is associated with increased gene transcription, and therefore, with 
transcriptionally active chromatin domains. As a posttranslational modification, histone 
acetylation is maintained by a dynamic balance between the activities of histone 
acetyltransferases (HATs) and histone deacetylases (HDACs). The acetylation of lysine 
residues on histones H3 and H4 represents the active or open state of chromatin, which 
allows various transcription factors access to the promoters of target genes. In contrast, 
shifting the promoter occupancy from HATs to HDACs to deacetylate lysine residues will 
result in chromatin compaction and transcriptional repression. Recruitment of HDACs by 
Sp1/Sp3 sites at the p21 promoter, which in turn represses p21 transcription, is a potential 
model for p21 down-regulation by a maternal diet. We determined a decrease in 
acetylated H3 (p<0.05), which may indicate increased binding of HDACs to the p21 
promoter through certain machinery. Histone H3 hypoacetylation has been reported to be 
associated with reduced p21 expression by gastric carcinoma, but there is no association 
between p21 expression and histone H4 acetylation status in the p21 promoter {Mitani et 
al. 2005}. Similar results were found in our study. It is histone H3 hypoacetylation, but 
not H4 acetylation, that is associated with reduced p21 expression in offspring mammary 
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gland through maternal protein restriction. Distinct roles for acetylation of histones H3 
and H4 have been reported in yeast {Wan et al. 1995}. Although a number of proteins 
have been identified that are recruited to specific histone code modifications, further 
studies in mammalian also need to reveal the functional significance of histones H3 and 
H4.  
 
With regard to histone methylation, we found reduced di-methylation of H3K4 (p<0.05), 
but unchanged tri-methylation of H3K9, at the p21 promoter in LP offspring mammary 
gland. Histone methylation appears to have multiple effects on chromatin function in a 
system- and site-specific manner. Methylation of H3 on K4 is implicated in the activation 
of transcription. In budding yeast, H3K4Me3 localizes to the 5’ end of the target gene and 
is found to be associated with the initiation of RNA PoI II {Kouzarides et al. 2007}. 
Methylation of H3 on K9, on the other hand, is largely associated with silencing and 
repression in many species {Bartova et al. 2008}. Our results indicate that methylation of 
H3K9 in the p21 promoter region is not an absolute requirement for p21 repression.  
 
The regulation of p21 gene transcription is controlled by both p53-dependent and 
-independent mechanisms. For instance, p53 mutant mouse p53R172P lost its ability to 
induce apoptosis, but retained its capacity to induce p21. When these mice were crossed 
onto a p21-null background, loss of p21 entirely eliminated the cell cycle arrest function 
of p53R172P {Barboza et al. 2006}. Other p53-independent pathways in regulating p21 
are also reported. MYC represses p21 transcription by binding to and inhibiting SP1 
{Gartel et al. 2003}. This can be alleviated through the binding of the ligand-independent 
nuclear receptor hepatocyte nuclear factor 4α1 (HNF4α1) to SP1 {Hwang-Verslues et al. 
2008}. In response to DNA damage, MYC is recruited to the p21 promoter by MIZ1, and 
forms a ternary complex with the DNA methyltransferase DNMT3a, which represses p21 
transcription {Brenner et al. 2005}. Additionally, AP4, a basic helix–loop–helix protein 
and a transcriptional target of MYC, represses the p21 promoter through binding to four 
proximal E-box motifs independently of MIZ1, SP1 or SP3 {Jung et al. 2008}. Taken 
together, these mechanisms could potentially provide several lines of evidence for further 
investigation of the altered p21 expression by a maternal low protein diet. 
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In summary, we documented here that maternal dietary low protein modulates p21 gene 
expression and histone modifications within its promoter in the mammary gland of 
offspring rats (Figure 6.5). The findings suggest that a maternal protein-restricted diet 
during pregnancy may potentially alter cell cycle control pathways, thereby predisposing 
offspring rats to the risk of developing breast cancer later in life. 
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6.6 Tables & Figures 
 
 
Table 6.1 Composition of the two isocaloric diets 
Ingredients  C, g/kg LP, g/kg 
Casein  180 90 
Folic acid  0.001 0.001 
Cornstarch  405 465 
Sucrose  213 243 
Choline  2 2 
Cellulose  50 50 
Corn oil  100 100 
D,L-Methionine  5 5 
Vitamin mix (AIN-76A)* 10 10 
Mineral mix (AIN-76A) 35 35 
Total energy, Kcal/g 3.868 3.868 
* Vitamin mix (AIN-76A) is folic acid free 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6.2 Mother observations 
A.                                   C (4)1              LP (4)1 
Pups delivered before noon (%)          0                  43 
Pups delivered after noon (%)2           100                57 
B. 
 
Body weight (g)3 
  p value  
Days during pregnancy C (4) LP (4)  
2 195.78 ± 8.33  180.12 ± 2.93 0.09 
9  240.08 ± 12.49 217 ± 2 0.08 
16  290.38 ± 13.32 253.1 ± 5.93 0.03 
21  362.88 ± 18.92  315.36 ± 6.89 0.04 
C. 
 
Daily food intake (g)3 
 p value 
Days during pregnancy C (4) LP (4)  
3 18.75 ± 2.1 17.22 ± 0.67 0.47 
9 19.73 ± 0.89 17.2 ± 0.96 0.1 
16 22.25 ± 1.32 20.5 ± 0.58 0.23 
21 21.53 ±1.75 19.24 ±1.29 0.32 
1Number of dams shown in parentheses. Data are means with ± S.E.M. 
2Timing of delivery by the dams 
3Body weight and food intake are shown as the average value at the specific 
day. Data are means with ± S.E.M. Significance testing was set at p<0.05
derived from two-tail t-test. 
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Table 6.3 Offspring observations 
A.    
 C (4)1 LP (4)1  
Litter size 11.5 ± 0.65 10.3 ± 0.86  
Litter sex distribution male to female 1.11 1.25  
B.   
    Body weight (g)
 2   p  value 
   
Age (days) C (4) LP (4)  
Birth  6.32 ± 0.19 5.92 ± 0.09 0.11 
7 16.55 ± 0.69 14.89 ± 0.46 0.10 
15 35.06 ± 1.14 30.73 ± 0.70 0.02 
22 59.37 ± 1.40 49.98 ± 1.63 0.006 
35 138.56 ± 2.58 125.21 ± 3.54 0.006 
1 Number of litters shown in parentheses.   
2Body weight is shown as the average value at the specific day.  
Data are means with ± S.E.M. Significance testing was set at p<0.05 derived from 
two-tail t-test. 
Table 6.4 p21 primer sequence  
Gene  
(Ensembl ID) 
Forward primer (5’ → 3’) 
Reversed primer (5’ → 3’) 
Purpose 
(+208) CCGAGAACGGTGGAACTTTGAC  
(+278) GAACACGCTCCCAGACGTAGTTG 
mRNA expression 
(-259) CTGGTGGGCTGCGTGACAAG  
(-110) GGACCAGCCGCTCCTTCAC 
Histone modifications 
at gene promoter 
(-481) GAATTTTTATGTTTAGTTTATGGGA 
(+7) AACACTATAACAACTCACACCTCTC 
p21  
(ENSRNOG00000000521) 
 
 
 
 
(-16) GAGGTGTGAGTTGTTATAGTGTT 
(+386) AACTAAAAAAATACCTACCATCC 
Bisulfite sequencing 
Table 6.5 Antibodies used in Western blot and ChIP assay 
Antibody Introduction & company Purpose 
p21 sc-397, Santa Cruz Biotechnology, Santa Cruz, CA Protein analysis by Western 
H3Ac Anti-acetylated histone 3 at lysine 9, 14 residues; 
06-599, Upstate, Temecula, CA 
H4Ac Anti-acetylated histone 4 at lysine 5, 8, 12 and 16 
residues; 06-866, Upstate, Temecula, CA 
H3K4Me2 Anti-di-methylated histone 3 at lysine 4 residues; 
07-030, Upstate, Temecula, CA 
H3K9Me3 Anti-tri-methylated histone 3 at lysine 9 residues; 
cs200604, Upstate, Temecula, CA 
IgG sc-2027, Santa Cruz Biotechnology, Santa Cruz, CA 
Analysis of histone  
modifications 
PoI II sc-899, Santa Cruz Biotechnology, Santa Cruz, CA RNA polymerase II analysis 
                                                                                              119
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   A.                                           B.                            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         
0
2
4
Pa
nc
rea
s
Kid
ne
y
Liv
er 
Blo
od
Ma
mm
ary
p2
1
m
R
N
A
 le
ve
ls
 
(r
at
io
 to
 L
7a
)
C
LP
*
p2
1
m
R
N
A
 le
ve
ls
 
(r
at
io
 to
 L
7a
)
0
10
20
30
40
50
Br
ain
He
art
Mu
sc
le
Ad
ipo
se
Co
lon
C
LP
p2
1
m
R
N
A
 le
ve
ls
 
(r
at
io
 to
 L
7a
)
p2
1
m
R
N
A
 le
ve
ls
 
(r
at
io
 to
 L
7a
)
Figure 6.1 p21 mRNA tissue distribution in female offspring  
Expression of p21 mRNA in female offspring pancreas, kidney, liver, blood, mammary gland,
brain, heart, muscle, adipose, and colon of control mothers versus LP mothers by qPCR
(n=6, samples from 6 animals were tested in each of the two conditions). mRNA levels are
shown as the ratio to L7a housekeeping gene, which acts as an internal control to normalize
total RNA variation. The bar values represent the mean ± S.E.M.; *indicates comparison of
p21 mRNA in pups of control and LP groups, p<0.05. 
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Figure 6.2 p21 protein content in pup mammary gland by Western blot 
Expression of p21 protein in female offspring mammary gland from LP mothers versus
control. LP protein levels were expressed as mean ratio to control. The values represent
the mean ± S.E.M., *p<0.05. 
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Figure 6.3 DNA methylation status within the p21 promoter in offspring mammary
gland 
A. Rat p21 gene promoter includes two major CpG islands, which were amplified by two sets
of bisulfite sequencing primers, respectively. B. Bisulfite sequencing results amplified by the
primers, which cover -481 to +7 at the p21 promoter. C. Bisulfite sequencing results
amplified by the primers, which cover -16 to +386 at the p21 promoter. In Figure 3B and 3C,
each solid bar on the top line represents a CpG site at the p21 promoter. 10 clones were
picked from each animal and 6 animals were involved for each group, control versus low
protein group. Each set of 10 circles represents the average level of DNA methylation
CpG 2
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CpG 1
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Figure 6.4 PoI II binding and histone modifications at the p21 promoter  
A. ChIP assay demonstrates the changes of histone modifications at the p21 promoter
region in female offspring liver (n=5, samples from 5 animals were tested in each of the two
conditions). B. ChIP assay demonstrates binding of RNA polymerase II (Pol II), which is an
enzyme found in eukaryotic cells to catalyze the transcription of DNA at the p21 promoter
region in female offspring mammary gland (n=5, samples from 5 animals were tested in
each of the two conditions). Normal rabbit antibody, IgG, was used as a negative control to
show non-specific binding. Data is shown as a ratio to the input DNA, which acts as an
internal control to eliminate DNA quantity variation. C. ChIP assay demonstrates the
changes of histone modifications at the p21 promoter region in female offspring mammary
gland (n=5, samples from 5 animals were tested in each of the two conditions). Data is
shown as a ratio to the input DNA. H4Ac: acetylated histone 4; H3Ac: acetylated histone 3;
H3K4Me2: di-methylated histone 3 at lysine 4 residues; H3K9Me3: tri-methylated histone 3
at lysine 9 residues. The values represent the mean ± S.E.M., *p<0.05. 
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Figure 6.5 A summary scheme to show the changes of acetylation of H3 and methylation
of H3K4 within the p21 promoter in offspring mammary gland, comparing control and low
protein groups.   
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Chapter 7. Future Directions 
 
7.1 Background 
 
Breast cancer is partially caused by the disruption in the normal pathways involved in 
mammary gland development and differentiation. Maternal nutrient supplementation or 
exposure to environmental agents may change a host of metabolic processes in mammary 
gland and the accompanied alteration in epigenome thereby predisposing mammary gland 
to the development of cancers later in life. The responses may relate to changes in 
hormonal and growth factor status and modifications to the chromatin structure and 
epigenome regulation. All these alterations may change gene expression during 
development that could lead to either regulatory malfunction later in life and predispose 
to breast cancer development or long-term protection against breast cancer by modulating 
fetal ductal development in mammary gland. 
 
Transcriptional regulation of cancer genes, particularly tumor suppressor genes, during 
cancer development is governed by epigenetic mechanisms, which makes it an important 
area of investigation. Our contribution here is to clarify the specific mechanism(s) by 
which a maternal low protein diet participates in regulation of p21, a potential breast tumor 
suppressor gene. 
 
7.2 Significance 
 
This contribution is significant because it is expected to expand our understanding of 
epigenetic control of tumor suppressor gene expression by maternal nutrition and also 
provide valuable insight into new avenues for clinical intervention and treatment. Once 
such strategies become available, novel therapeutic approaches targeting this level of 
gene regulation will undoubtedly emerge. 
 
Nutritional environment likely directly or indirectly alters epigenetic modifications such 
as DNA methylation and histone modifications, and thereby affects gene transcription, 
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gene expression and ultimately the development of disease. However, nowadays whether 
maternal low protein affects the incidence of breast cancer in offspring is undocumented. 
In addition, the study of maternal protein intake in the contribution to the transgenic 
epigenetic modifications for genes regulation in mammary gland development will assist 
the determination of optimal low costing maternal nutrition in breast cancer preventions.  
 
The cycline-dependent kinase inhibitor p21 is a key responsible factor regulating cell 
proliferation, differentiation, and tumor genesis. Low level of p21 expression has been 
identified as a molecular marker for patients with both early stage and higher stage breast 
cancers30. Little is known about the dietary contribution to the epigenetic modification for 
p21 regulation in mammary gland. Although one report did show that 
isoflavone-deprived soy peptide can induce expression of p21 and suppresses mammary 
tumorigenesis in female rats {Park K et al. 2009}, there is no study to date to examine the 
regulation of p21 through generations in mammary gland development by maternal 
dietary factors. We are interested in effects of maternal low protein in the regulation of 
p21 and the associated molecular mechanisms in mammary gland. We are hoping that an 
improved understanding of the influence of a maternal low protein diet on offspring gene 
expression will allow us to identify the specific molecular target that could provide new 
opportunities for significantly lowering breast cancer risk. 
 
 
7.3 Research Proposal for Future Study  
 
This section is written to correspond to the outline in the specific aims section, and each 
series of experiments has an experimental design paragraph followed by a rationale 
paragraph. The experiments will test the hypothesis that maternal low protein diet 
modulates p21 gene expression in offspring through an epigenetic mechanism in its 
transcriptional regulatory regions. The experiments have been integrated so that often 
data from more than one scientific approach will be used in a complementary fashion to 
provide multiple lines of evidence to test the hypothesis. We believe that the proposed 
experiments test important hypotheses and that they will generate valuable new 
information regarding the mechanisms by which offspring senses and responds to 
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changes in maternal nutrient availability. 
 
Two of our main goals of this project are firstly to identify the target genes in the 
epigenetic programming and secondly to unfold related mechanism at molecular level 
thereby providing us meaningful guide to develop useful approaches to prevent breast 
cancer for women. We have identified that maternal dietary low protein modulates p21 
gene expression in offspring rats. In most cases of breast cancer, p21, a negative regulator 
of the cell cycle, is generally down-regulated. Therefore, we plan to start investigating the 
mechanisms that control p21 expression transcriptionally and how deregulation of these 
mechanisms may lead to tumorigenesis. 
 
Understanding of the role of epigenetic information in the development of breast cancer 
and its significance as predictive markers for fetal origin of tumor genesis can potentially 
offer new approaches for breast cancer preventions. Deacetylation/acetylation of histone 
is one of the best-known epigenetic events in mammalian cells and is involved in the 
complex mechanism that regulates promoter transcription. The exact interplay of these 
factors in transcriptional repression activity is not yet well understood. Histone 
acetylation pattern is maintained by a dynamic balance between the activities of histone 
acetyltransferases (HAT) and histone deacetylases (HDAC). The acetylation of lysine 
amino acids on histones H3 and H4 represent the active or open state of chromatin, which 
allow various transcription factors access to the promoters of target genes. In contrast, 
shifting the promoter occupancy from HAT to HDAC to deacetylate lysine amino acids 
will result in chromatin compaction and transcriptional repression. Recruitment of 
HDACs at the p21 promoter, which in turn represses p21 transcription, is a potential 
model for p21 down-regulation by maternal diet. 
 
HDAC1 and HDAC6 are over-expressed in breast cancer samples, while HDAC2 and 
HDAC3 are commonly found in colon cancers {Bolden JE et al. 2006}. Some evidence 
correlating HDAC binding status with p21 expression has been reported. Dissociation of 
HDAC1 from the C terminus of Sp1 reduces the binding of HDAC1 at the p21 promoter 
and induces p2143. The growth factor independent 1 (GFI1) is a transcriptional regulator 
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and has ability to recruit HDAC1 on the promoter of p21. As the result, down-regulation 
of p21 was observed {Duan Z et al. 2005}. HDAC inhibitors (HDACi) induce p21 
expression mainly by activating the Sp1/Sp3 pathway independent of p53. Upon HDACi 
treatment in vitro, HDAC1 is released from the Sp1-binding site at the p21 promoter 
leading to a loss of repression and an induction of transcription {Ocker M et al. 2007}. 
Trichostatin A, one of HDACi’s, effectively induces p21 expression and cell cycle arrest 
in human gastric and oral carcinoma cell lines {Suzuki T et al. 2000}. The HDACi 
butyrate induces p21 and apoptosis in colorectal cancer cells {Mahyar-Roemer M et al. 
2001}. Another HDACi, SAHA, induces nine-fold increase in p21 mRNA and protein in 
T24 bladder cancer cells due to the enhancement of acetylation of histones H3 and H4 
around the promoter region {Richon VM et al. 2000}.  
 
Histon acetyltransferases (HATs) transfer an acetyl group from acetyl-coenzyme A 
(acetyl-CoA) to certain lysine side chains of histone, which neutralizes part of a N-tail 
region’s positive charge and weakens histone-DNA interactions. This signals a chromatin 
conformational change and gives transcription activators more access to a genetic locus, 
which is associated with states of transcriptional activation. GCN5 (general control 
nonderepressible-5) is the best-characterized HAT in yeast, both structurally and 
functionally in vivo and in vitro. In mammals, the GCN5 subclass is represented by two 
closely related proteins, GCN5 and PCAF (p300/CREB-binding protein-associated 
factor). These proteins share about 70% identity and 80% similarity throughout their 
sequences {Xu W et al. 1998}. The substrate specificity of GCN5 is particularly 
interesting to us. In vitro, recombinant GCN5 or PCAF were found to acetylate primarily 
on lysine-14 of histone H3, and more weakly on lysine-8 of histone H4 {Schiltz RL et al. 
1999}. 
 
In previous study, compared to control, offspring rats from the LP group showed a 
decrease of p21 expression in both mRNA and protein levels in mammary gland. ChIP 
assay demonstrated that the down-regulation of p21 transcription in LP offspring was 
associated with reduced acetylation of histone H3 and di-methylation of H3K4 within the 
p21 promoter region, but not acetylation of histone H4 or tri-methylation of H3K9. DNA 
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methylation was also tested using bisulfite sequencing. However, it did not indicate any 
difference at the p21 promoter between offsprings of control and LP groups. 
 
7.3.1 Specific Aim I: determine the extent to which expression of HDACs in 
offspring mammary is associated with decreased histone acetylation at the p21 gene 
promoter 
 
The objective of this aim is to determine whether the decreased histone acetylation 
observed within the p21 gene promoter in offspring mammary is accompanied by the 
changes of HDAC1 or HDAC6 expression and their interactions within the p21 promoter. 
Our preliminary data has shown that maternal protein restriction down-regulated histone 
3 acetylation at the p21 promoter in offspring mammary gland. We therefore hypothesize 
that the altered histone acetylation could be affected by HDAC1 or HDAC6 expression 
level and their interactions with the p21 promoter.   
 
7.3.1a Aim IA: identify whether maternal protein restriction affects HDAC1 or 
HDAC6 expression in offspring mammary gland 
 
In addition to p21 gene we have tested, this initial experiment will test the expression of 
HDAC1 and HDAC6 in offspring mammary gland. 
 
Experiment Design: mRNA and protein expressions of HDAC1 or HDAC6 
Briefly, frozen mammary will be randomly chosen from six animals (offspring) of each 
group, control versus low protein group, for sampling. Total RNA will be isolated using 
Tri-reagent (Sigma, St. Louis, MO). cDNA will be synthesized in a 20 ul reaction volume 
using the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster 
City, CA) and a thermal cycler (Applied Biosystems), with the following program: 25°C 
for 10 min, 37°C for 120 min, 85°C for 5 s, and a 4°C hold. To measure the relative amount 
of mRNA, Real-Time qPCR will be performed using 25 ng cDNA as the template and 
SYBR Green PCR Master Mix (Applied Biosystems) in the 7300 Real-Time PCR System 
(Applied Biosystems), with the following program: 95°C for 10 mins, 95°C for 15 s, 60°C 
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for 1 min, 95°C for 15 s, 55°C for 1 min, 95°C for 15 s, with 40 cycles of step 2 and 3.  
 
For isolating protein, frozen mammary sample will be ground in liquid nitrogen and put 
into protein sample buffer (0.125 M Tris-HCl pH 6.8, 5% 2-mecaptoethanol, 1% SDS, 
20% glycerol, 0.4% bromphenol blue, protease inhibitor). Samples will be then sonicated 
(Fisher Scientific model 100 Sonic Dismembrator, Pittsburgh, PA) on ice with 25 pulses 
at power setting 2. Lowry assay will be used to determine protein content and samples 
containing 20-30 μg of protein were resolved by SDS-PAGE. After electrotransfer to a 
polyvinylidene fluoride membrane (0.2 μm, Bio-Rad) using a wet transfer protocol, 
5-10% milk in TBS/T (30 mM Tris base pH 7.6, 200 mM NaCl and 0.1% Tween 20) will 
be performed to block the membrane for 1 hr at room temperature and then the 
membrane will be incubated with antibody against HDAC1 or HDAC6 in 5% BSA at 4 
°C overnight. The membrane will be washed five times for 5 min with TBS/T on a shaker 
the next day and then incubated with secondary antibody in 1-5% milk for 1 hr at room 
temperature. The membrane will be then washed again for 5 min by five times. The 
bound secondary antibody will be detected using a SuperSignal West Dura Extended 
Duration Substrate kit (Thermo Scientific, Rockford, IL) and western blot images will be 
captured and analyzed by a Chemi Doc system (Bio-Rad). 
 
Rationale and expected results 
This series of experiments is designed to perform a concrete expression analysis of 
HDAC1 and HDAC6, which are an important class of enzymes in mammary that remove 
acetyl groups from a ε-N-acetyl lysine amino acid on a histone. Real-time qPCR is an 
efficient assay to analyze gene mRNA expression. A housekeeping gene L7a and a set of 
standard cDNA will be used to control the validation of the experiment. Western blot 
analysis will further reveal the functional change of HDAC1 and HDAC6 from protein 
aspect. We expect that maternal protein restriction will affect the expression of HDAC1 or 
HDAC6. Thus, the result will potentially contribute to the declined histone acetylation.  
 
7.3.1b Aim IB: determine the interaction of HDAC1 or HDAC6 within the p21 gene 
promoter in offspring mammary gland 
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In order to determine whether HDAC1 or HDAC6 is playing a role in the regulation of p21 
transcription, the interaction of HDAC1 or HDAC6 within the p21 promoter will be 
investigated in vivo.   
 
Experiment Design: the interaction of HDAC1 or HDAC6 within the p21 promoter 
Cross-linked chromatin immunoprecipitation (xChIP) assays will be performed according 
to our previously published protocol to determine the promoter binding of HDAC1 or 
HDAC6. Briefly, 200 mg of frozen mammary tissue will be homogenized and cell protein 
will be cross-linked using formaldehyde. Nuclear extract will be isolated and chromatin 
will be sonicated into around 500 bp fragments. Aliquots of diluted sample will then be 
incubated overnight with 2 ug of antibody against HDAC1 or HDAC6. After incubation, 
the immune complex will be captured by incubating with Protein G Sepharose beads. An 
antibody to normal IgG will be used as a negative control, indicating non-specific binding. 
All samples will then be washed sequentially with low salt buffer, high salt buffer, LiCl 
buffer and TE. Immuoprecipitated DNA will be eluted and reverse cross-linked. 
Proteinase K will be added into samples to remove protein and DNA will be purified with 
a Wizard SV Gel and PCR Clean up System (promega). Real-time qPCR will then be 
carried to test the amount of immuoprecipitated DNA using p21 promoter primers, which 
reflecting the binding of HDAC1 or HDAC6 to the p21 promoter region. 
 
Rationale and expected results  
This experiment will investigate the interaction of HDAC1 or HDAC6 within the 
promoter region of p21 gene in order to reveal the potential mechanism that resulting in the 
alteration of chromatin remodeling. In the consideration of the role of HDACs, which may 
be recruited by other transcription factor to the p21 gene promoter, xChIP is designed to 
cross-link all the interacting factors, including those that are not directly bound with DNA 
sequence. Recruitment of HDACs by Sp1/Sp3 sites at the p21 promoter, which in turn 
represses p21 transcription, is a potential model for p21 down-regulation by maternal diet. 
 
7.3.1c Aim IC: determine whether HDAC1 or HDAC6 is necessarily required for the 
regulation of p21 transcription 
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In order to confirm our hypothesis that HDACs is indispensable for the down-regulation 
of p21 observed in offspring mammary by maternal diet, we will isolate normal 
mammary cell from living rats to explore, when HDACs is inhibited, how p21 
transcription will change in vitro.   
 
Experiment Design: the change of p21 expression in vitro under HDAC-inhibited 
condition 
 
Primary Culture of Mammary Epithelial Organoids 
Female Sprague Dawley rats (Charles River Laboratories) at 56-66 days of age will be 
used for primary culture of rat mammary epithelial cell. All animals will receive care 
according to the National Institute of Health guidelines for the care and use of laboratory 
animals. The animals will be anesthetized with eter and operated upon using an aseptic 
technique under laminar airflow. The mammary gland will be removed, minced, and 
digested with collagenase III (Worthington Biochemical Corp., Lakewood, NJ) at 172.8 
U/ml and with dispase (Roche Applied Science, Mannheim, Germany) at 1.2 mg/ml for 
12 h to isolate mammary epithelial organoids. After enrichment, the rat organoids will be 
embedded within an Engelbreth-Holm-Swarm (EHS)-derived reconstituted basement 
membrane (RBM) and cultured in an EGF-free serum-free medium (SFM) consisting of 
phenol red-free DMEM-F12 (50:50, vol:vol) with 10 ug/ml insulin, 1 ug/ml progesterone, 
1 ug/ml hydrocortisone, 1 ug/ml prolactin, 5 ug/ml transferrin, 5 uM ascorbic acid, 1 
mg/ml fatty acid-free BSA, and 50 ug/ml gentamycin. Cells will be then placed in a CO2 
stove (Nuaire) during 24 hours at 37° C. The SFM medium will be again changed on the 
4th and 5th day {Zhang J et al. 2007}. 
 
TSA Treatment 
The cells will then be seeded in 12-well dishes (Costar, Cambridge, MA) at 3-10×104 
cells/well and cultured in complete minimal essential medium (MEM) with L-glutamine 
(pH 7.4, SCS Cell Media Facility, University of Illinois at Urbana-Champaign, Urbana, 
IL), following supplementation of 10% fetal bovine serum (Cellgro, Herndon, VA) and 
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1% penicillin (Cellgro, Herndon, VA). Cells will be maintained at 37°C in a 5% CO2 
incubator and be replenished with fresh MEM 12 hr prior to initiating TSA treatment. 
TSA will be purchased from Wako Biochemicals (Osaka, Japan). A stock solution of TSA 
at the concentration of 1 mg/ml will be prepared in ethanol. The cells will be exposed to 
medium containing 0, 10, 50, 100, 500 and 1,000 ng/ml TSA for 72 hr and RNA will be 
extracted using Tri-reagent. The same amount of ethanol will be added to the MEM as the 
control experiment. All experiments will be performed in duplicate and repeated 3 times. 
 
Small Interfering RNA Assay 
Purified primary mammary cells (around 2×105 cells) will be transfected with 165 nM of 
small interfering RNA against HDAC1 or HDAC6 (Applied Biosystems/Ambion, Austin, 
TX) using lipofectamine according to the manufacturer’s instruction. Scramble siRNA 
will be used as control. After four hours post-transfection, cells will be washed once in 
HBSS buffer and resuspended in culture medium in order to avoid cellular toxicity due to 
siRNA transfection. Twenty-four hours post-transfection, cells will then be stimulated as 
described and cell-free supernatants will be harvested and tested for the presence of p21 
by ELISA or cells will be lysed for Western blot analysis {Michaud F et al. 2010} 
. 
Rationale and expected results 
Primary cell cultures closely mimic the in vivo state and generate more physiologically 
relevant data. We will absolutely confirm the importance of HDACs in the regulation of 
p21 transcription by using HDAC inhibitor treated, primary cultured, rat mammary cell. 
We believe that being able to visualize results from primary cultured mammary cell will 
provide stronger evidence to show HDACs is indispensably involved in the 
down-regulation of p21 gene expression. Small interfering RNA assay will be carried out 
as a backup option to inhibit HDAC expressions in primary cell in case the TSA treatment 
does not work.    
 
7.3.2 Specific Aim II: determine the extent to which expression of HATs in offspring 
mammary is associated with decreased histone acetylation at the p21 gene promoter 
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The objective of this aim is to determine whether the HATs is also playing a role that 
contributing to the down-regulation of histone acetylation observed within the p21 gene 
promoter in offspring mammary gland. We previously detected the decreased acetylation 
of histone 3, but not histone 4. This selective acetylation of histone during chromatin 
remodeling might be associated with specific target sites of different members in HATs. 
We hypothesize that the altered histone 3 acetylation could be affected by GCN5 or 
PCAF, which are specifically function on lysine sites in histone 3, but not histone 4. 
 
7.3.2a Aim IIA: identify whether maternal protein restriction affects HATs 
expression in offspring mammary gland 
 
It will provide more useful information about how a maternal low protein diet affects the 
balance of HATs versus HDACs in the chromatin remodeling to the p21 gene promoter. 
 
Experiment Design: mRNA and protein expressions of HATs 
The mRNA expression of HATs, particularly GCN5, will be tested using cDNA samples 
generated from offspring mammary gland. Protein level will be then tested by Western 
Bolt assay. The detailed procedure will be the same as described in Aim IA. 
 
Rationale and expected results  
This series of experiments is designed to perform a concrete expression analysis of HATs, 
which are an important class of enzymes that acetylate conserved lysine amino acids on 
histone proteins by transferring an acetyl group from acetyl CoA to form ε-N-acetyl 
lysine. Although we previously observed decreased acetylation of histone 3, this may be 
also resulted from the effect of the decreased HATs expression by maternal diet. 
Moreover, the selectivity of HATs could potentially reveal the mechanism that why the 
alteration of acetylation occurred on histone 3 only.  
 
7.3.2b Aim IIB: determine the interaction of HATs within the p21 gene promoter in 
offspring mammary gland 
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In order to determine whether HATs is also playing a role in the regulation of p21 
transcription, the interaction of HATs within p21 promoter will be investigated in vivo.   
 
Experiment Design: the interaction of HATs within p21 promoter 
Cross-linked chromatin immunoprecipitation (xChIP) assays will also be performed to 
determine the promoter binding of HATs as described in Aim IB.  
 
Rationale and expected results  
This experiment will investigate the interaction of HATs within the promoter region of 
p21 gene in order to reveal the potential mechanism that resulting in the alteration of 
chromatin remodeling. In the consideration of the role of GCN5, which only acetylate 
lysine amino acids on histone 3, we expect the decrease binding level of GCN5 at the p21 
promoter, which in turn represses p21 transcription, is another potential model for p21 
down-regulation by maternal diet. 
 
7.3.2c Aim IIC: determine whether GCN5 is necessarily required for the regulation 
of p21 transcription 
 
In order to examine whether or not GCN5 is also indispensable for the down-regulation 
of p21 by a maternal protein-restricted diet, we will use primary rat mammary cell as 
described in Aim IC to explore, when GCN5 is inhibited, how p21 transcription will 
change in vitro.   
 
Experiment Design: the change of p21 expression in vitro under GCN5-inhibited 
condition 
 
α-Methylene-γ-Butyrolactones Treatment 
Rat primary mammary cells will be isolated from 56-66 days old Female Sprague 
Dawley rats and then be seeded in 12-well dishes (Costar, Cambridge, MA) at 3-10×104 
cells/well and cultured in complete minimal essential medium (MEM) with L-glutamine 
(pH 7.4, SCS Cell Media Facility, University of Illinois at Urbana-Champaign, Urbana, 
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IL), following supplementation of 10% fetal bovine serum (Cellgro, Herndon, VA) and 
1% penicillin (Cellgro, Herndon, VA). Cells will be maintained at 37°C in a 5% CO2 
incubator and be replenished with fresh MEM 12 hr prior to initiating 
α-methylene-γ-butyrolactones treatment. The cells will be exposed to medium containing 
0, 5 and 10 mM of α-methylene-γ-butyrolactones {Biel M et al. 2004} and RNA will be 
extracted using Tri-reagent. All experiments will be performed in duplicate and repeated 
3 times. 
 
Small Interfering RNA Assay 
Purified primary mammary cells (around 2×105 cells) will be transfected with 165 nM of 
small interfering RNA against GCN5 (Applied Biosystems/Ambion, Austin, TX) using 
lipofectamine according to the manufacturer’s instruction. Scramble siRNA will be used 
as control. After four hours post-transfection, cells will be washed once in HBSS buffer 
and resuspended in culture medium in order to avoid cellular toxicity due to siRNA 
transfection. Twenty-four hours post-transfection, cells will then be stimulated as 
described and cell-free supernatants will be harvested and tested for the presence of p21 
by ELISA or cells will be lysed for Western blot analysis {Michaud F et al. 2010} 
. 
Rationale and expected results 
α-Methylene-γ-butyrolactone is the only compound that we have known to display an 
inhibition against GCN5. The proposed experiment is important to identify the role of 
GCN5 in the regulation of p21 transcription by using GCN5 inhibitor treated primary cell. 
This will be powerful way for analyzing whether or not GCN5 is indispensably involved 
in the down-regulation of p21 gene expression. Small interfering RNA assay will also be 
carried out as a backup option to inhibit GCN5 expression in case the 
α-methylene-γ-butyrolactones treatment does not work.    
 
7.3.3 Specific Aim III: determine the role of sp1 and sp3 in the regulation of p21 
promoter 
 
The objective of this aim is to determine whether Sp1 or Sp3 acts as a transcription factor 
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regulating p21 gene expression in our maternal protein-restricted animal model. Our 
preliminary data has shown that restricted maternal protein decreases p21 expression and 
acetylation of H3 as well as di-methylation of H3K4. The changed histone modification 
could potentially create less-opened chromatin structure, thus, blocking the bindings of 
transcription factors. We hypothesize that Sp1 or Sp3 can affect p21 gene transcription 
initiation frequency through direct binding to the p21 promoter, following a dose 
dependent manner.  
   
7.3.3a Aim IIIA: identify whether maternal protein restriction affects the direct 
binding of Sp1/Sp3 transcription factor within p21 promoter in offspring mammary 
gland 
 
The direct binding of Sp1 or Sp3 transcription factor at p21 promoter will be tested to 
explore further mechanism that resulting in the repressed p21 expression under maternal 
protein restriction in vivo. 
 
Experiment Design: direct binding of Sp1/Sp3 at p21 promoter in vivo  
This series of experiments will investigate the direct binding of Sp1/Sp3 within the 
promoter of p21 gene. We will perform native chromatin immunoprecipitation (nChIP) 
experiments. In brief, 300mg of mammary gland samples will be ground in liquid 
nitrogen and intact nuclei will be isolated. Nuclei (0.3 mg) will be digested with 25 U of 
micrococcal nuclease at 37°C for 6 min in 1 ml of digestion buffer (50mM NaCl, 20 mM 
Tris–HCl pH 7.5, 3.0 mM MgCl2, 1.0 mM CaCl2, 10 mM sodium butyrate, 0.1 mM 
PMSF). The digestion will be terminated by the addition of Na2EDTA to 0.5 mM and the 
salt-soluble chromatin will be isolated and concentrated using a microcon centrifugal 
filter (Amicon Inc., Bedford, PA). 250 μg of this chromatin (input) will be incubated with 
10 μl each of antisera specific for the acetylated forms of histone H3 or H4 (Upstate 
Biotech., Lake Placid, NY) in a total volume of 500 μl. Protein A–Sepharose (Amersham 
Pharmacia Biotech) precipitates will be generated, washed, and DNA will be purified 
from the pellets (bound) and supernatants (unbound). DNA samples from the input, 
bound and unbound fractions will be analyzed by electrophoresis on 1% agarose gels to 
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determine the size distribution of the resulting oligonucleosomes. Equal masses of DNA 
(100 ng) from input, unbound and antibody-bound DNA from the nChIP fractions are 
conveniently and accurately determined by real-time qPCR. Determine the enrichment of 
a given target sequence achieved by the antibody against sp1 by the ratio of the sequence 
content of the bound to input fractions. All ratios will be verified in a minimum of two 
separate experiments  
 
Rationale and expected results 
This series of experiments is designed to perform ChIP on native chromatin prepared 
from offspring mammary gland tissues, in order to analyze whether maternal protein 
restriction changes the direct binding of Sp1/Sp3 at p21 promoter. The key features of a 
native ChIP (nChIP) experiment are the fragmentation of chromatin in the nuclei by 
micrococcal nuclease and the immunoselection of chromatin fragments bearing the 
modified protein of interest using an appropriate antibody. Formaldehyde crosslinking is 
not used at any point during the preparation. It is particularly suited for proteins such as 
core histones that are tightly bound to DNA. nChIP will reveal nucleosomes bearing 
transcription factor-directly bound genomic DNA, which would not be interfered by other 
proteins in crossed-linked ChIP (xChIP). We expect to reveal the role of Sp1 or Sp3 
within p21 promoter related to maternal dietary regulation. 
 
7.3.3b Aim IIIB: determine how different doses of Sp1 transcription factor regulates 
p21 promoter activity in primary cultured mammary cells 
 
This application is to determine the essential role of sp1 regulating p21 promoter activity 
in vitro. We will use reporter gene luciferase assay and perform cell transfection to 
identify how dose dependent Sp1 protein can affect p21 gene promoter activity.       
 
Experiment Design: Sp1 regulates p21 promoter activity 
 
Cell Culture 
Primary cells isolated from rat mammary gland will be used as described in Aim IC. Cells 
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will be cultured in complete minimal essential medium (MEM) with L-glutamine (pH 7.4, 
SCS Cell Media Facility, University of Illinois at Urbana-Champaign, Urbana, IL), 
following supplementation of 10% fetal bovine serum (Cellgro, Herndon, VA) and 1% 
penicillin (Cellgro, Herndon, VA). Cells will be maintained at 37°C in a 5% CO2 
incubator and be replenished with fresh MEM 12h prior to initiating all treatments.  
 
Plasmid Construction 
For expression of Sp1 protein, rat Sp1 cDNA will be generated by PCR and subcloned 
into pcDNA3.1/zeo (Invitrogen) to generate the Sp1 expression vector driven by the 
cytomegalovirus promoter (rSp1/pcDNA3.1-zeo). It then will be used to express the 
corresponding protein in rat breast cancer cells. The reporter plasmid (p21-481/+7/luciferase) 
was made by inserting a p21 promoter fragment (nucleotides -481/+7) upstream of the 
Firefly luciferase reporter gene using the HindIII site of the pGL3 plasmid (Promega, 
Madison, WI).  
 
Transient Transfection & Luciferase Analysis 
Cells (0.2×106 cells/well) will be seeded on 24-well plates 18-24 hr before transfection 
with Superfect reagent (Qiagen) at a ratio of 6 ul of Superfect to 1 ug of DNA. For each 
transfection, 0.5 ug of p21-481/+7/luciferase plasmid will be used along with the different 
amounts of the Sp1 transcription factor expression plasmids. The total amount of 
transfected DNA will be kept constant among experimental groups by the addition of 
empty pcDNA3.1 plasmid. At 12 hr following transfection, the cells will be transferred to 
fresh complete MEM for 12 h before all treatments. At 36 hr following transfection, 
cellular extracts will be prepared for analysis of luciferase activity, by washing the cells 
with phosphate-buffered saline (PBS) and incubating in 300 ul of Passive lysis buffer 
(Promega). The lysates will be collected and stored at -80 °C until use. A 10 ul aliquot will 
be used for Firefly luciferase assays using the luciferase reporter assay system (Promega, 
Madison, WI). The luciferase values will be normalized to protein content for each sample. 
For each experimental condition, three assays will be performed for each transfection. 
 
Rationale and expected results 
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The proposed experiments are used to explore how p21 promoter activity is affected by 
Sp1 protein expression. To analyze the activity of a promoter, the putative promoter 
sequence of p21 gene must be inserted upstream of the reporter gene. The proteins of 
transcriptional factor sp1 will be incorporated into the experiments as translated from an 
expression vector. Through transfection with both p21 promoter inserted reporter gene 
and Sp1 inserted expression vector into the breast cancer cells, we will be able to reveal 
whether or not the p21 promoter activity is regulated by Sp1 protein in a dose dependent 
manner.  
 
7.4 Discussion 
 
Deregulated cell cycle progression, driven by activation of growth-stimulating oncogenes, 
is one of the primary characteristics of cancer cells. Understanding how dietary 
components regulate proliferation and cell survival could play a critical role in 
development of new agents that can prevent and/or treat cancer with low cost. Following 
successful completion of the aims outlined in this project, elucidating the mechanism by 
which maternal low protein regulates the cell cycle gene in offspring, we will further 
characterize the interaction of maternal protein and offspring cell cycle signaling pathway. 
More extensive studies would address in vitro cell culture and in vivo animal to evaluate 
whether regulation of p21 expression associates with the risk of cancer development 
programmed by maternal fetal nutrition. 
 
We are hoping that an improved understanding of the influence of maternal low protein 
diet on offspring gene expression will allow us to identify the specific molecular target 
that could provide new opportunities for significantly lowering breast cancer risk. We are 
excited about our laboratory's research to contribute to the understanding of how the 
availability of maternal nutrients controls and programs gene expression and chromatin 
modifications in offspring. 
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restriction model.  
▪ Researched related publications that discussed fetal and neonatal development of 
body structure and function, as well as disease risks later in life. 
▪ Conducted testing and experiments using nucleotides and protein isolation, 
real-time PCR, Western blotting, chromatin immunoprecipitation, luciferase 
reporter assay, cell transfection, gene cloning, bisulfite sequencing, methylation 
sensitive PCR, methylation specific PCR, MeDIP, microarray, cell proliferation 
and invasion assay, animal surgery and tissue collection, primary cell culture, 
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ELISA, H & E staining histology, siRNA and LC-MS/MS.  
▪ Supervised three undergraduate students and two visiting scholars in lab; trained 
them in experimental technologies and elements of nutrition genetics; guided new 
graduate students in laboratory skills and rules. 
▪ Selected as sole member of group to assist advisor on conducting experiment and 
writing proposal for successful NIH grant application (CA139557).  
 
Boston Medical Center, Boston, Massachusetts                        2005-2007             
Graduate Research Assistant – Department of Endocrinology, Diabetes, and Nutrition 
Advisor: Professor Tai C. Chen 
▪ Examined biological effects of vitamin D3 analogues on prostate cancer 
prevention and treatment using cancer cell line models and patient samples. 
 
Part-time Research Assistant – Steroid Hormone Assay Laboratory 
▪ Tested serum samples of normal adults and children from Framingham Heart 
Study through LC-MS/MS assay to establish national standards for testosterone 
and estradiol. 
 
Boston University School of Medicine, Boston, Massachusetts            2005-2007             
Graduate Research Assistant – Medical Nutrition Sciences 
Advisor: Professor Barbara E. Millen 
▪ Evaluated contemporary literatures and wrote review article on nutrition and 
prevention of type II diabetes. 
Advisor: Elizabeth Krall Kaye 
▪ Analyzed NHANES III (Third National Health and Nutrition Examination Survey) 
database and determined relationship between fruit intake and blood pressure 
regulation. 
 
International Life Sciences Institute (ILSI)-Focal Point in China, Beijing  2003-2004             
Chief Executive Assistant  
Advisors: Professor Chun-Ming Chen and Professor Jun-Shi Chen 
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▪ Participated in national intervention study of NaFeEDTA-fortified soy sauce for 
reduction of iron deficiency anemia in China (funded by Global Alliance for 
Improved Nutrition). 
▪ Coordinated construction of Chinese BMI model to study obesity in Chinese 
adults and children. 
▪ Organized all events for Conference on Obesity of Chinese Children and 
Adolescents, sponsored by Chinese Center for Disease Control and Prevention, 
held at Beijing in November 2003. 
  
Southern Yangtze University, Wu Xi, China                           1998-2002            
Undergraduate Research Assistant – School of Food Science and Engineering 
Advisor: Professor Zhang Wang 
▪ Developed novel food processing technique for manufacturing natural lemon 
oolong tea powder.  
▪ Optimized digestive ratio of pectinase to cellulase and created efficient way to 
extract soluble component from tea broth. 
▪ Interned in dairy, meat, other general food supply companies, and beer factories.  
▪ Conducted chip and cola sensory evaluations on behalf of Pepsi and Coca-Cola. 
 
TEACHING & RELEVANT EXPERIENCE 
 
University of Illinois at Urbana-Champaign 
Fellowship Evaluation Assistant                                          2010             
▪ Chosen as one of department’s advanced graduate students to serve on Fellowship 
Board Block Grant Area Committees on behalf of the Graduate College; helped to 
evaluate the quality of the graduate programs for university Block Grant 
applications. 
 
Teaching Assistant – Nutritional Biochemistry (FSHN 426)                    2009             
 Lectured on lipoproteins; directed review sections for students before exams; and 
prepared questions for all quizzes and exams, and graded exams.  
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Delivered lecture during PepsiCo Chicago visit on behalf of advisor; interfaced with 
company’s senior managers. 
 
PROFESSIONAL MEMBERSHIPS 
 
American Association for the Advancement of Science (AAAS)   
American Society for Nutrition (ASN)  
  
HONORS & RECOGNITION 
 
Philip L. and Juanita Fitzer Francis Fellowship in Health and Wellness           2010             
Graduate College Conference Travel Grant                                 2009             
Henry D. and Donna E. Strunk Fellowship Merit Award                   2007-2010             
Jeannette Chu and Winston Y. Lo Fellowship                           2007-2010 
Southern Yangtze University Scholarship                              1998-2001 
 
PUBLICATIONS 
Peer-Reviewed Papers 
 
S Zheng, M Rollet, Y-X Pan. Maternal Protein Restriction during Pregnancy Induces 
CCAAT/enhancer-binding protein (C/EBPβ) Expression through the Regulation of 
Histone Modification at Its Promoter Region in Female Offspring Rat Skeletal Muscle. 
Epigenetics 2011; 6: 161-170. 
 
S Zheng, Y-X Pan. Histone modifications, not DNA methylation, cause 
transcriptional repression of p16 (CDKN2A) in the mammary glands of offspring of 
protein-restricted rats. The Journal of Nutritional Biochemistry 2010. In press. 
 
JN Flanagan, S Zheng, KC Chiang, A Kittaka, T Sakaki, S Nakabayashi, X Zhao, RA 
Spaniaard, KS Persons, JS Mathieu, MF Holick, TC Chen. Evaluation of 
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19-nor-2alpha-(3-hydroxypropyl)-1alpha, 25-dihydroxyvitamin D3 as a therapeutic 
agent for androgen-dependent prostate cancer. Anticancer Research 2009; 29: 
3547-53. 
 
TC Chen, KS Persons, S Zheng, J Mathieu, MF Holick, YF Lee, B Bao, MA Arai, A 
Kittaka. Evaluation of C-2-substituted 19-nor-1a, 25-dihydroxyvitamin D3 analogs as 
therapeutic agents for prostate cancer. Journal of Steroid Biochemistry & Molecular 
Biology 2007; 103:717-720. 
 
Invited Review 
 
Maternal Nutrition, Intrauterine Development and Disease Risks in the Offspring 
through Epigenetic Regulation of Gene Expression. Yuan-Xiang Pan, Rita Strakovsky, 
and Shasha Zheng. Nutrition Epigenetic Mechanisms and Human Disease (N. 
Maulik. eds). CRC press, Taylor & Francis Group, Boca Raton, Florida.pp.229-258. 
Shasha Zheng wrote page 237-250. 
 
Manuscripts under Peer Review 
 
S Zheng, M Rollet, Y-X Pan. Protein Restriction during Gestation Alters Histone 
Modifications at the Glucose Transporter 4 (GLUT4) Promoter Region and Induces 
GLUT4 Expression in Skeletal Muscle of Female Rat Offspring. Journal of 
Nutritional Biochemistry 
 
S Zheng, M Rollet, KF Yang, Y-X Pan. Chromatin Modifications Cause a 
Methylation-Independent Transcription Repression of p21 Gene in Mammary Gland 
in the Offspring of Gestational Protein-Restricted Rats. British Journal of Nutrition 
 
S Zheng, D Iglesias-Gato, JN Flanagan, L Jiang, T Sakaki, S Nakabayashi, A Kittaka, 
NK LeBrasseur, G Norstedt1, TC Chen. The C-2 substituted 19-nor-1a,25- 
dihydroxyvitamin D3 analog, MART-10, has enhanced chemotherapeutic potency in 
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PC-3 prostate cancer cells. Journal of Steroid Biochemistry & Molecular Biology 
 
S Zheng, Q Li, R Borhan, Z Balluff, Y Zhang, H Chen and Y-X Pan. Maternal high 
fat exposure during pregnancy causes transcriptional repression of the p16INK4a gene 
in offspring mammary gland via epigenetic modulations. Epigenetics 
 
Q Li, S Zheng, Y-X Pan and H Chen. Maternal exposure to a high fat diet programs 
the microRNA expression in offspring rats. Epigenetics 
 
L Gong, S Zheng, H Chen, Y-X Pan. Amino acid response pathway is programmed 
differently by protein restriction during gestation versus whole lifelong in male 
offspring rats. Nucleic Acids Research 
 
KF Yang, S Zheng, Y-X Pan and Wei Cai. Early Life Protein Restriction Represses 
Wnt Signaling Through Epigenetic Modification in Skeletal Muscle of Rat Offspring. 
British Journal of Nutrition 
  
Abstracts 
 
S Zheng, Y-X Pan. Epigenetic Modifications Cause Transcriptional Repression of p21 
Gene in Mammary Gland in the Offspring of Protein-Restricted Rats. Experimental 
Biology 2010 (oral presentation). FASEB J. 2010 24:344.5 
 
S Zheng, M Unander, Y-X Pan. Maternal Protein Restriction Alters Histone 
Modifications and Glucose Transporter 4 Expression in Female Rat Skeletal Muscle 
during Postnatal Development. Experimental Biology 2009 (poster presentation). 
FASEB J. 2009 23:724.2 
 
S Zheng, Y-X Pan. Oral intake of genistein changes DNA methylation at the promoters 
of rat colon genes. Experimental Biology 2008 (poster presentation). FASEB J. 2008 
22:885.6 
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M Unander, S Zheng, Y-X Pan. Maternal diet programs muscle glut4 expression in rat 
offspring. UIUC Undergraduate Research Symposium 2008 abstract #25 (poster 
presentation) 
 
S Zheng, KS Persons, J Mathieu, MF Holick, YF Lee, B Bao, A Kittaka, TC Chen. 
Biological activity of 19-nor-1a, 25-dihydroxyvitamin D3 analogs for prostate cancer 
treatment. Boston University Medical School Evans Research Day 2006 abstract #38 
(poster presentation) 
 
 
 
 
 
 
 
 
 
